Investigations into the dynamics of paramyxovirus infections by high-throughput sequencing by Wignall-Fleming, Elizabeth Bowie
 
 
 
 
 
 
 
 
 
Wignall-Fleming, Elizabeth Bowie (2019) Investigations into the dynamics of 
paramyxovirus infections by high-throughput sequencing. PhD thesis. 
 
 
https://theses.gla.ac.uk/40905/  
 
 
 
Copyright and moral rights for this work are retained by the author  
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge  
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author  
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author  
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses  
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
 
 
 
 
 
 
 
Investigations into the dynamics 
of paramyxovirus infections by 
high-throughput sequencing 
Elizabeth Bowie Wignall-Fleming 
  
 
 
 
 
 
University	of	Glasgow	
 
 
 
 
A thesis submitted for the degree of Doctor of Philosophy  
College of Medical, Veterinary & Life Sciences 
 University of Glasgow 
July 2018 
	 2	
Abstract 
 
The paramyxovirus family can cause a broad spectrum of diseases from mild 
febrile illnesses to more severe diseases that may require hospitalisation and 
can in the most serious cases have fatal outcomes. Understanding the virus 
infection dynamics is fundamental to the development of novel targets for 
therapeutic and vaccine development. 
 
The advancement of High-throughput sequencing (HTS) has revolutionised 
biomedical research providing unparalleled opportunities to answer complex 
questions. In this study we developed a workflow using directional analysis of 
HTS data to gain a unique opportunity to simultaneously analyse the kinetics of 
virus transcription and replication for PIV5 strain W3, PIV2, MuV and PIV3.  The 
workflow could be used for the study of all negative strand viruses.  
 
The developed workflow was used to investigate a number of characteristics of 
paramyxovirus transcription including quantification of the transcription gradient, 
RNA editing resulting in the generation of non-templated mRNAs and the 
production of read-through mRNAs. Interestingly, the processivity of the RNA 
polymerase during transcription was shown to remain consistent throughout the 
infection amongst all of the viruses analysed.  
 
Additionally, virus replication and the generation of antigenomes were found to 
occur at early times post infection. This was surprising, as the current model for 
virus replication requires sufficient levels of NP to be present in the cytoplasm 
before the virus can enter replicative mode. These results suggest a revision of 
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this model in which the virus produces local sites of virus transcription and 
replication in the cytoplasm known as foci and it is the level of NP surrounding 
the virus genomes at these local sites that dictates the virus ability to enter a 
replicative mode.  
 
PIV5 strain W3 was shown to supress virus gene expression at late times post 
infection resulting in the establishment of a persistent infection. The developed 
workflow was used to analyse the infection dynamics of PIV5. There were no 
changes in the RNA polymerase processivity of transcription that could account 
for the suppression of protein synthesis. A comparative analysis of PIV5 strains 
W3 and CPI+ identified a mutation of a serine to a phenylalanine at position 157 
of the P protein in CPI+, a phosphorylation site that when phosphorylated by 
polo-like kinase 1 (PLK-1) was previously shown to play a role in the inhibition 
of virus RNA synthesis, that abolished the virus ability to supress protein 
synthesis and establish a persistent infection. This indicates that 
phosphorylation of serine at position 157 is responsible for the inhibition of virus 
gene expression and the establishment of persistence.  
 
 
 
 
 
 
 
 
 
	 4	
Acknowledgements 
 
First and foremost I would like to thank my supervisors Professor Rick Randall 
and Professor Andrew Davison for the guidance and support throughout my 
PhD. It would not have been so enjoyable without the members of the Randall 
lab, namely Dan, Lena, Andri, Liz and Dave who have offered not only 
knowledge and support when required but also friendship. A special note of 
thanks to Dan Young who helped me endlessly with lab work.  
 
I would not have entered into a career in bioinformatics without Derek Gatherer, 
who offered me an internship during which I gained my first glimpse into 
bioinformatics and which taught me the foundation of knowledge on which this 
PhD was built. A note of thanks must also go to Carol Leitch, who has offered 
me support and encouragement during my MRes, PhD and for my future 
career.  
 
Thank you to my Mum and Dad who have supported me throughout my 
university career, from undergraduate to masters and now as a PhD student. I 
would not have been able to achieve any of this without them. I would also like 
to thank Rona, who has offered support and advice (laughs and coffee!) over a 
decade of friendship.  
 
 
  
	 5	
Table of Contents 
Abstract	....................................................................................................................................	2	
Acknowledgements	..............................................................................................................	4	
List	of	Figures	.........................................................................................................................	7	
List	of	Tables	........................................................................................................................	10	
Abbreviations	......................................................................................................................	11	
1.0	Introduction	..................................................................................................................	14	
1.1	Viral	proteins	................................................................................................................	15	
The	nucleocapsid	protein	.........................................................................................................	15	
The	accessory	proteins	.............................................................................................................	16	
The	matrix	protein	.....................................................................................................................	19	
The	fusion	protein	......................................................................................................................	20	
The	haemagglutinin-neuraminidase	glycoprotein	..........................................................	20	
The	large	protein	.........................................................................................................................	20	
1.2	Virus	particle	................................................................................................................	21	
1.3	Paramyxovirus	transcription	and	replication	..................................................	25	
1.3.1	Virus	Transcription	.........................................................................................................	28	
1.3.2	Read-through	mRNAs	......................................................................................................	29	
1.3.3	RNA	editing	and	the	generation	of	accessory	proteins	........................................	35	
1.3.4	Viral	Replication	...............................................................................................................	36	
1.4	Evasion	of	the	Host	Immune	Response	................................................................	38	
1.4.1	Induction	of	the	Type	I	IFN	Response	........................................................................	39	
1.4.2	Type	I	IFN	Signalling	........................................................................................................	40	
1.4.3	Genes	induced	by	IFN	......................................................................................................	40	
1.4.3	Paramyxoviruses	and	the	IFN	system	.......................................................................	41	
1.5	Persistent	Infections	..................................................................................................	47	
1.6	High-throughput	sequencing	..................................................................................	50	
1.6.1	Library	preparation	.........................................................................................................	51	1.6.1.1	Purification	and	fragmentation	of	extracted	RNA	........................................................	53	1.6.1.2	DNA	fragment	enrichment	.....................................................................................................	54	
1.6.2	DNA	Sequencing	................................................................................................................	54	
1.6.3	Bioinformatic	analysis	....................................................................................................	57	1.6.3.1	Read	Quality	Control	.................................................................................................................	58	1.6.3.2	Mapping	..........................................................................................................................................	58	
1.6.4	Transcriptomics	................................................................................................................	60	
1.6.5	Detection	of	defective	interfering	genomes	............................................................	62	
1.7	Thesis	Objectives	.........................................................................................................	63	
2.1	Infection	and	treatment	of	cells	.............................................................................	66	
2.2	Extraction	of	RNA	........................................................................................................	66	
2.3	Library	preparation	and	high-throughput	sequencing	.................................	67	
2.4	Bioinformatic	Analysis	..............................................................................................	72	
2.4.1	Bioinformatic	analysis	of	virus	transcription	and	replication	.........................	73	
2.4.2	Analysis	of	virus	transcription	.....................................................................................	74	
2.4.3	Establishing	the	presence	of	defective	interfering	genomes	.............................	75	
	 6	
2.5	Immunofluorescence	.................................................................................................	75	
2.6	35S-methionine	labelling	of	proteins	....................................................................	76	
2.7	Immunoblots	of	proteins	..........................................................................................	76	
2.8	Nucleocapsid	Purification	........................................................................................	77	
3.0	Pipeline	for	analysing	virus	transcription	.........................................................	79	
3.1.1	Optimisation	of	library	preparation	..........................................................................	87	
3.1.2	Optimised	pipeline	for	analysing	transcription	and	replication	.....................	92	
3.1.3	Establishing	the	presence	of	defective	interfering	genomes	.............................	93	
3.2	Analysis	of	Parainfluenza	Virus	5	replication	and	transcription	...............	95	
3.2.1	Analysis	of	viral	transcription	.....................................................................................	97	
RNA editing and generation of the V, I and P mRNAs	.......................................	99	
Generation of read-through mRNAs	.......................................................................	101	
3.2.2	Analysis	of	viral	replication	........................................................................................	103	
4.0	Analysis	of	PIV2	and	MuV	(Rubulavirus)	and	PIV3	(Respirovirus)	
transcription	and	replication	......................................................................................	115	
4.1	Analysis	of	PIV2,	MuV	and	PIV3	Transcription	...............................................	118	
Analysis of RNA editing and the generation of accessory protein transcripts	..	121	
4.1	Analysis	of	the	Kinetics	of	Viral	Replication	....................................................	128	
5.0	Analysis	of	persistent	infection	of	A549	cells	by	PIV5	..................................	134	
5.0.2	Transcription	and	replication	of	PIV5	strain	W3	during	establishment	of	
persistent	infection	..................................................................................................................	139	
5.1	Analysis	of	the	mechanism	of	repression	of	viral	protein	synthesis	.......	156	
5.2	Analysis	of	PIV5	persistence	in	AGS	cells	..........................................................	160	
6.0	Establishment	of	a	pipeline	for	the	analysis	of	negative-strand	RNA	viral	
transcription	and	replication	......................................................................................	166	
6.1	Analysis	of	viral	transcription	for	the	rubulaviruses	PIV5,	PIV2	and	MuV	
and	the	respirovirus	PIV3	.............................................................................................	169	
6.1.1	Kinetics	and	abundance	of	viral	mRNAs	and	genomes	......................................	170	
6.1.2	Intracellular	spread	of	infection	during	viral	replication	................................	171	
6.1.3	Viral	transcription	profiles	.........................................................................................	176	
6.1.4	Read-through	mRNAs	and	transcription	termination	.......................................	179	
6.1.5	RNA	editing	and	transcription	of	the	P/V/C/D(I)	gene	.....................................	182	
6.2	Ratio	of	genome	to	antigenome	during	viral	replication	............................	188	
6.3	Transcription	and	replication	are	repressed	during	establishment	of	
PIV5	persistence	...............................................................................................................	189	
6.3.1	Analysis	of	differences	in	the	transcription	kinetics	of	PIV5	strains	W3	and	
CPI+	................................................................................................................................................	194	
6.4	Role	of	inclusion	bodies	in	the	establishment	of	persistence	....................	195	
Appendix	.............................................................................................................................	197	
References	..........................................................................................................................	202	
 
 
  
	 7	
List of Figures 
Fig 1.1. A schematic of a parainfluenza virus 5 particle  
 
Fig 1.2. A schematic depicting the hexamer phasing of the promoter 
components for rubula-and respiro-viruses. 
 
Fig 1.3. A schematic of the PIV5 genome (shown as antisense RNA) indicating 
the seven genes. 
 
Fig 1.4. A schematic showing the IFN induction and signalling pathways and the 
paramyxovirus proteins that inhibit the IFN response. 
 
Fig 1.5 A schematic of the workflow of library preparation for HTS. 
 
Fig 1.6 Overview of Sequencing by Synthesis used by Illumina sequencing 
platforms. 
 
Fig 1.7. A schematic of the generation of internal deletion and copyback Dis, 
indicating the genome positions to which the components map on the virus 
genome. 
 
Fig 3.1. BWA alignment of the PIV5 strain W3 transcriptome in HSF cells at 18 
h p.i. 
 
Fig 3.2. Schematics depicting the sorting of reads into those originating from 
viral genomes and those originating from viral mRNA/antigenomes. 
 
Fig 3.3. BWA alignments of the PIV5 strain W3 transcriptome in HFS cells at 18 
h p.i. 
 
Fig 3.4. A comparison of the abundance of viral mRNAs using polyA selection 
or total RNA with rRNA reduction library preparation methods. 
 
Fig 3.5. Abundance of viral genome reads compared to total cellular reads after 
remaining cytoplasmic and mitochondrial rRNA reads had been removed. 
 
Fig 3.6. Abundance of PIV5 strain W3 viral genome and mRNA reads at 0, 6, 
12, 18 and 24 h p.i. 
 
Fig 3.7. Transcription of PIV5 strain W3 genes at 6, 12, 18 and 24 h pi. 
 
Fig 3.8. Abundance of V, P and I mRNAs generated by PIV5 strain W3 during 
infection. 
 
Fig 3.9. Analysis of the generation of read-through mRNAs of PIV5 strain W3 at 
the intergenic regions compared to the average coverage of the gene 
immediately upstream. 
 
Fig 3.10. The ratio of PIV5 strain W3 genomes to antigenomes 
 
	 8	
Fig 3.11. Proportions of viral genome and viral antigenome reads in positions 
45-54 of the Le region, expressed as a percentage of the total. 
 
Fig 3.12. Production of viral NP at early time points during infection. 
 
Fig 3.13. Immunofluorescence staining of viral NP in the cytoplasm of A549 
cells infected with PIV5 strain W3. 
 
Fig 4.1. The abundance of PIV5 strain W3, PIV2, MuV and PIV3 viral genomes 
and mRNA reads at 6, 12, 18 and 24h p.i. 
 
Fig 4.2. Transcription of PIV5 strain W3, PIV2, MuV and PIV3 genes at 6, 12, 
18 and 24 h pi. 
 
Fig 4.3 Percentage abundances of accessory proteins generated by PIV2 and 
MuV (rubulaviruses; V, P and I mRNAs) and PIV3 (respirovirus; P, V and D 
mRNAs) at 6, 12, 18 and 24 h p.i. 
 
Fig 4.4. Analysis of the generation of read-through mRNAs for PIV5 strain W3, 
PIV2, MuV and PIV3 at the intergenic regions compared to the average 
coverage of the gene immediately upstream. 
 
Fig 4.5. Investigating the production of viral NP at early time points during 
infection. 
 
Fig 4.6. Immunofluorescence analysis of the localization of NP during infection. 
 
Fig 5.1. Phase contrast microscopy and immunofluorescence of A549 cells 
infected with PIV5 strain W3 at 24 and 96 h p.i.. 
 
Fig 5.2. Radioactive labelling of PIV5 strain W3 infected A549 cells at 24, 48, 72 
and 96 h p.i.. 
 
Fig 5.3. The abundance of PIV5 strain W3 viral mRNAs and viral genomes over 
time. 
 
Fig 5.4. The abundances of PIV5 strain W3 mRNAs at 24, 48 and 96 h p.i. 
 
Fig 5.5. The relative abundances of V, P and I mRNAs at 24, 48 and 96 h p.i. 
 
Fig 5.6. Analysis of the generation of read-through mRNAs at the intergenic 
regions of PIV5 strain W3  compared to the average coverage of the gene 
immediately upstream. 
 
Fig 5.7. Kinetics of viral mRNA production in A549 cells infected with PIV5 
strain W3 
 
Fig 5.8. Kinetics of viral mRNA and genome production during PIV5 strain W3 
or CPI+ infection. 
 
Fig 5.9. Abundances of W3 or CPI+ mRNAs in persistently infected cell lines. 
	 9	
 
Fig 5.10. Analysis of protein synthesis of PIV5-W3(S157) and rPIV5-W3(F157) 
 
Fig 5.11. Abundance of viral mRNA and genome reads for PIV5-W3(S157) and 
rPIV5-W3(F157) at 24 h p.i.. 
 
Fig 5.12. Immunofluorescence of AGS persistently infected cells. 
 
Fig 5.13. Phylogenetic analysis of the complete genome sequences of PIV5 
strains. 
  
	 10	
List of Tables 
 
Table 1.1. The genera of the family Paramyxoviridae, with virus examples  
 
 
Table 3.1. Percentages of viral mRNA reads compared to total cellular reads 
before and after cytoplasmic and mitochondrial rRNA reads were removed from 
the data obtained using polyA selection or rRNA depletion.  
 
Table 3.2. The identification of distinct copyback DIs populations, the genome 
and antigenome position of the breakpoint, the number of reads which are 
generated from the DIs and the proportions of the populations 
 
Table 3.3 Mean percentages of G inserts compared with the total number of 
reads overlapping the V/P RNA editing site. 
 
Table 4.1. Total reads containing G inserts present in reads overlapping the 
RNA editing site in PIV2, MuV and PIV3 
 
Table 5.1 Abundance of Reads Containing G Inserts that Overlap the RNA 
Editing Site 
 
Table 5.2. Percentage of viral genome reads and viral mRNA reads compared 
to total cellular reads in PIV5 strain W3- and CPI+- persistently infected cell 
lines. 
 
 
 
 
	 11	
Abbreviations 
 
PIV parainfluenza viruses  
MuV mumps virus 
MeV  measles virus 
NDV Newcastle disease virus 
SeV sendai virus 
VSV vesicular stomatitis virus 
RSV  respiratory syncytial virus 
HCV hepatitis C virus 
BTV Blue Tongue Virus 
NP nucleocapsid 
P phosphoprotein 
L large protein 
F fusion protein 
HN haemagglutinin-neuraminidase protein 
SH small hydrophobic 
PLK-1 Polo-like kinase 1 
IFN interferon 
NNS negative-sense, non-segmented 
RNP ribonucleoprotein 
UTR untranslated region 
nt nucleotides 
Tr trailer 
Le leader 
TrC antigenome promoter 
Gs gene start cis-acting elements 
Ge gene end cis-acting elements 
Ig intergenic region 
ORF open reading frame 
PAMPS pathogen-associated molecular patterns 
PRR pattern recognition receptors 
ds double-stranded 
ss single-stranded 
PKR protein kinase R 
TLR Toll-like receptors 
MAVS mitochondrial anti-viral signalling protein 
RIG-I retinoic acid inducible gene-I 
mda-5 melanoma differentiation-associated gene 5 
TBK-1 TANK-binding kinase-1 
IKKε inhibitor of κB kinase ε 
IRFs interferon regulatory factors 
IPS-1 IFN-β promoter stimulator 1 
JAK Janus kinases 
ISRE interferon-stimulated response elements 
ISGs IFN-inducible genes 
IFITM IFN-inducible transmembrane family 
DI  defective interfering  
SSPE subacute sclerosing panencephalitis 
WT wild-type 
	 12	
ts temperature sensitive 
HTS  High-throughput sequencing 
rRNA ribosomal RNA 
BWT Burrows-Wheeler Transformation 
FM-index full-text in minute space 
FPKM Fragments Per Kilobase of transcript per Million mapped reads 
RPKM Reads Per Kilobase of transcript per Million mapped reads 
MOI multiplicity of infection 
HSF human skin fibroblast cells 
pfu plaque forming units 
h p.i. hours post infection  
  
	 13	
 
 
 
 
Chapter	one	
Introduction 
  
08 Fall	
	 14	
1.0 Introduction 
The family Paramyxoviridae consists of a group of enveloped, negative-sense, 
non-segmented RNA viruses that cause a broad spectrum of diseases in a 
diverse range of hosts, including humans, other mammals, birds, reptiles and 
fish. The family contains seven genera, examples of viruses in these genera are 
shown in Table 1.1. These viruses cause disease ranging from asymptomatic 
and mild febrile illnesses to more severe respiratory diseases such as 
bronchitis, croup, pneumonia and mumps. These disease examples are caused 
by human parainfluenza viruses (PIVs) and mumps virus (MuV), and can, as is 
the case with numerous other paramyxovirus infections, result in 
hospitalisations especially in vulnerable groups such as young children, the 
elderly and the immunocompromised. Some viruses in the family confer high 
mortality rates, including the recently isolated zoonotic Nipah and Hendra 
viruses. The family also includes some of the most infectious viruses known, 
such as measles virus (MeV), as well as economically important viruses such 
as Newcastle disease virus (NDV), which infects poultry, and, until its recent 
eradication, rinderpest virus in cattle.  
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Table 1.1. The genera of the family Paramyxoviridae, with virus examples. 
Genus Examples of viruses 
Respirovirus Parainfluenza virus 1 and 3, Sendai virus 
Rubulavirus Parainfluenza virus 2 and 5, mumps virus 
Morbillivirus Measles virus, Rinderpest virus 
Henipavirus Hendra virus, Nipah virus 
Aquaparamyxovirus salmon aquaparamyxovirus 
Avulavirus Avian avulavirus 1-19 
Ferlavirus Reptilian ferlavirus 
1.1 Viral proteins 
 
The function of the viral proteins is extensively reviewed in Lamb and Parks 
(2013) and Chattopadhyay et al (2011).  
 
The nucleocapsid protein  
 
The nucleocapsid (NP) protein exists in two states, either as part of the 
nucleocapsid structure or as free soluble NP (NP0). The protein is comprised of 
two domains, the N-terminal N-core and the C-terminal N-tail (Karron and 
Collins, 2013; Lamb and Parks, 2013). The N-terminal N-core contains a motif 
that is conserved among most paramyxoviruses. It is essential for interactions 
with viral RNA and for encapsidation of the viral genome and antigenome in a 
highly stable, nuclease-resistant complex known as the nucleocapsid (Parks et 
al., 1992). The N terminus of NP0 proteins can interact with the phosphoprotein 
(P) and V proteins to form a soluble complex that prevents NP0 from interacting 
non-specifically with cellular RNA (Curran et al., 1995; Horikami et al., 1992; 
Precious et al., 1995; Spehner et al., 1997; Zhao and Banerjee, 1995). The 
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binding of NP and V may also play a role in the inhibition of viral RNA synthesis 
(Lin et al., 2005). The N-tail has not been shown to be necessary for 
encapsidation, but has been found to play an essential role in the interaction 
between encapsidated RNA and the RNA polymerase, which is required for 
RNA synthesis (Buchholz et al., 1994; Heggeness et al., 1980; Horikami et al., 
1992; Mountcastle et al., 1974). The N-tail is intrinsically unstructured but forms 
a folded structure upon interaction with P (Bourhis et al., 2005). The interaction 
between the N-tail of NP and the C-terminus of the P protein is important for 
viral replication, as P forms a complex with the large (L) protein to form the RNA 
polymerase complex.   
 
The accessory proteins 
 
The accessory proteins are non-templated transcripts that are transcribed from 
the V/P gene. It is the only paramyxovirus gene capable of generating multiple 
transcripts through a processes known as RNA editing and ribosomal stuttering, 
which is described in greater detail below. The proteins generated from the non-
templated transcripts are often referred to as accessory proteins, and this term 
can suggest that they are non-essential. However, viruses lacking them often 
exhibit attenuated growth (Chattopadhyay et al., 2011). The faithful (unedited) 
copy of the V/P transcript comes from the V gene in rubulaviruses and from the 
P gene in respiro-, morbilli-, henipa- and avula-viruses. The additional proteins 
are transcribed by the addition of non-templated G residues in a tract of G 
residues to create a transcriptional frameshift. In rubulaviruses, the addition of 
one or two G residues generates the I (sometimes referred to as W) and P 
transcripts, respectively. In respiro-, morbilli-, henipa- and avula-viruses, the V 
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and W/D transcripts are generated by the addition of one or two G residues, 
respectively. The P protein can also transcribe a C protein through an additional 
open reading frame by ribosomal stuttering. The functions of the accessory 
proteins are described below.  
 
The phosphoprotein 
 
The P protein is a major component of the RNA polymerase and is essential for 
viral RNA synthesis. It interacts with the L and NP proteins to perform critical 
roles in viral transcription and replication (Karron and Collins 2013; Lamb and 
Parks, 2013). The N terminus of P interacts with NP0 to form a soluble complex, 
and prevents NP from interacting with cellular RNA (Curran et al., 1995; De et 
al., 2000; Horikami et al., 1992; Zhao and Banerjee, 1995). The P protein is 
also a non-catalytic subunit of the RNA polymerase. It is widely believed that 
the P subunit acts as a tether to the genomic template for L, which is the 
catalytic subunit of the RNA polymerase (Hamaguchi et al., 1983). The P 
protein becomes heavily phosphorylated by cellular kinases at specific serine 
and threonine residues, principally in the N terminus. The role of 
phosphorylation of the P protein during RNA synthesis has obtained some 
contradictory results, reviewed in Fuentes et al., (2010). Studies using SeV 
using a minigenome systems have reported that up to 90% reduction in the 
phosphorylation of the P protein exhibits no negative effect on viral RNA 
synthesis or virus growth (Byrappa et al., 1996; Hu and Gupta, 2000; Hu et al., 
1999). However, several of these phosphorylated residues have been shown to 
have a significant impact on viral RNA synthesis. For example, PKC-mediated 
phosphorylation has been shown to play a regulatory role for human PIV3, but 
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not for Sendai virus (SeV) (De et al., 1995; Hu et al., 1999; Hu and Gupta, 
2000). Polo-like kinase 1 (PLK1), which is involved in regulating the cell cycle, 
has been shown to phosphorylate a serine at position 157 of the PIV5 P protein, 
resulting in inhibition of RNA synthesis (Sun et al., 2009; Timani et al., 2008).  
 
The V protein 
 
This is a multifunctional protein with essential roles as an IFN antagonist and as 
a regulator of viral RNA synthesis. Its role as an IFN antagonist is discussed 
further at (section 1.4). The V and P proteins share a common N terminus that 
allows the protein to possibly interact with the NP and L proteins; this is possibly 
the mechanism by which it inhibits viral RNA synthesis, as mutations in V can 
result in increased viral RNA synthesis (Dalenda et al., 1997; Durbin et al., 
1999; He et al., 2002; Horikami et al., 1996; Huang et al., 2000; Kato et al., 
1997b; Lin et al., 1997; Nishio et al., 2008;, Precious et al., 1998).  
 
The C protein 
 
A number of paramyxoviruses generate the C protein from an alternative open 
reading frame present in the V/P gene. Human PIV3 produces only one C 
protein, whereas human PIV1 and SeV produce four (C’, C, Y1 and Y2) by two 
mechanisms, namely leaky ribosomal scanning and ribosomal shunting (Lamb 
and Parks, 2013; Latorre et al., 1998). The C protein has a role in the regulation 
of viral RNA synthesis and also serves as an IFN antagonist (Kurotani et al 
1998). It does not seem to be essential for viral transcription and replication, but 
viruses lacking the C gene have shown decreased virus growth (Chattopadhyay 
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et al., 2011). It has been hypothesized that the C protein interacts with L, but at 
a different site from that of P, resulting in decreased RNA synthesis (Horikami et 
al., 1997; Grogan and Moyer, 2001; Smallwood and Moyer, 2004). It has also 
been suggested that C can interact with the promoter to regulate RNA synthesis 
(Cadd et al., 1996; Tapparel et al., 1997).   
 
The D, W and I proteins 
 
These proteins are generated via RNA editing and the insertion of 2 G residues 
(D generated by the respiroviruses) or 1 G residue (I or W for rubulaviruses) at 
RNA editing site present in the V (rubulavirus) or P genes (respirovirus). The 
proteins are produced at relatively low abundances during viral infection, and 
their functions are largely unknown. A study by Horikami et al., (1996) 
suggested that the W protein, due to its shared N-terminal with P, could interact 
with free NP0 proteins and thereby inhibit viral RNA synthesis.  
 
The matrix protein  
 
Matrix (M) proteins are the major structural components of the virus particle and 
lie beneath the envelope. They interact with the glycoproteins present on the 
surface of the envelope and the nucleocapsid complex (see the descriptions 
below) to form the viral particle. The M protein plays an essential role in viral 
assembly, budding and morphogenesis (Sanderson et al., 1995; Stricker et al., 
1994; Takimoto and Portner, 2004; Terrier et al., 2009). 
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The fusion protein  
 
The fusion (F) protein plays a role in the fusion of the viral envelope to the host 
cell membrane, allowing the nucleocapsid to be internalized. Initially, the F 
protein is translated as an inactive precursor, and is cleaved by host cell 
proteases to form the F1 and F2 polypeptides linked by a disulphide bond. At 
late times post infection (p.i.) it is widely believed that the newly synthesized F 
proteins facilitate cytopathic cell-to-cell fusion, forming syncytia (Chattophraya 
et al., 2011). These syncytia may play an important role in the cell-to-cell 
transmission of some paramyxoviruses.  
 
The haemagglutinin-neuraminidase glycoprotein 
 
The haemagglutinin-neuraminidase (HN) proteins protrude from the viral 
envelope. The HN protein is involved in the attachment of the viral particle to 
host cell membranes by interacting with sialic acid residues (Lamb and Parks, 
2013). Additionally, it is thought to interact with the F protein and assist in fusion 
to host cell membranes. The HN protein plays an essential role in the egress of 
viral particles from the infected cell through its neuraminidase activity (Mascona, 
2005; Porotto et al., 2005).  
 
The large protein 
 
The L protein is a subunit of the viral RNA polymerase, and specifies an 
enzyme activity that is crucial for the various stages of viral RNA synthesis, 
including mRNA capping, methylation and polyadenylation (Banerjee, 1987; 
Banerjee et al., 1991; Karron and Collins, 2013). L interacts with P to form the 
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RNA polymerase complex. The L proteins of negative-sense, non-segmented 
(NNS) RNA viruses virus are believed to possess common conserved regions 
conferring specific functions. Region III is thought to act as a polymerase 
module because mutations in this region can result in the complete inhibition of 
viral RNA synthesis (Sleat and Banerjee, 1993; Malur et al., 2002 a,b). Region 
V carries a specific conserved histidine-arginine nucleotides at position 1227-
1228 respectively known as the HR motif that is required for capping of nascent 
viral mRNAs (Li et al., 2008; Ogino and Banerjee, 2007, 2010; Ogino et al., 
2010). However, the functions of some regions remain elusive, even though 
mutational analyses of SeV L protein regions I, II and IV have shown 
detrimental effects on viral transcription or replication (Chandrika et al., 1995; 
Feller et al., 2000; Smallwood et al., 1999, 2002). 
 
 
 
1.2 Virus particle 
The viral particle of paramyxoviruses is usually spherical and 150-350 nm in 
diameter. It contains a lipid bilayer envelope that is derived from the host cell 
membrane during viral particle egress from the infected cell. A schematic of a 
typical paramyxovirus particle is shown in Fig 1.1. The major component of the 
viral particle is the M protein, which acts as the principal structural protein in a 
layer underlying the envelope. The HN and F proteins protrude from the 
envelope to facilitate viral entry and egress and viral particle fusion with the host 
cell membrane, respectively. Some paramyxoviruses generate a small 
hydrophobic (SH) protein, which has been associated with the envelope but is 
of unknown function.  Contained within the viral envelope is the nucleocapsid, 
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which is also known as the 
ribonucleoprotein (RNP). 
This complex is comprised 
of the NP in a helical 
structure in which the viral 
genome is tightly 
encapsidated. Each NP 
subunit is bound to its 
immediate neighbours by 
N-terminal (N-ter) and C-
terminal (C-ter) arms, 
independent of binding to 
the RNA (Ruigrok et el., 
2011). Each subunit is also 
associated with 6 
nucleotides of the viral RNA 
genome. As such typically 
paramyxoviruses favour a genome length consisting of a multiple of 6 nts for 
effective replication, commonly known as “the rule of six” (Calain and Roux, 
1993). The PIV5 nucleocapsid is thought to be comprised of 14 NP subunits per 
turn, although this may differ amongst paramyxoviruses as SeV is believed to 
have only 13 NP subunits per turn (Egelman et al., 1989; Lamb and Parks, 
2013). Studies have shown that the structure of the nucleocapsid is critical to a 
functional promoter to initiate virus replication and transcription (reviewed in 
Fearns and Plemper, 2017).  
 
Fig 1.1. A schematic of a parainfluenza virus 5 particle. 
Nucleocapsid (RNP) is shown inside the virus particle 
comprised of the negative strand RNA genome 
encapsidated by NP and associated with L and P 
proteins. The lipid bilayer and matrix proteins are 
represented by concentric circles. The HN, F and SH 
proteins are inserted into the virus membrane. Taken 
from Lamb and Parks (2013). 
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The mechanism by which the RNA 
polymerase recognizes the 
promoter to initiate RNA synthesis 
is not fully understood. It is widely 
accepted that paramyxovirus 
genomes contain bipartite 
promoters. The first component is a 
string of a minimum of 12 
conserved nucleotides, known as 
the internal promoter element 
(IPE), present at the 3’ end of the 
viral genome. The second 
component is the presence of 
tandem repeats in the untranslated 
region (UTR) of the NP gene 
between positions 77 and 96, the 
precise position varies amongst 
paramyxoviruses. These two 
promoter elements must be on the 
correct phase in relation to the 
encapsidating NP, this is often 
referred to as hexamer phasing 
(Cordey and Roux, 2007). A schematic of the two promoter components in 
relation to the encapsidating NP is provided in Fig 1.2. In rubulaviruses, the 
second component is a CG at positions five and six of hexamers (NP) 13, 14 
and 15 (3’-XXXXCG-5’). In respiroviruses such as SeV and PIV3, it is a C at 
Fig 1.2. A schematic depicting the hexamer 
phasing of the promoter components for 
rubula-and respiro-viruses. The NP proteins 
are shown as blue rectangles, 13 per turn of 
the nucleocapsid. The internal elements of 
the promoter, the first is a string of 12 
conserved nucleotides at the 3’-end of the 
virus genome and the second element is 
repetitive tandem repeats present in the 
UTR of the NP protein. Rubulavirus second 
promoter component shown in blue, the 
respirovirus shown in yellow. Taken from 
Kolakofsky (2016). 
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position 1 of hexamers 14, 15 and 16 (3’-CXXXXX-5’) (Hoffman and Banerjee, 
2000; Murphy and Parks, 1999; Tapparel et al., 1998). The positions of the 
promoter components on the hexamers place them on the same vertical face as 
the nucleocapsid helix. Hexamer positions 1, 5 and 6, which seem to be the 
most important for the second component of the promoter, face away from the 
RNA-binding groove, whereas positions 2, 3 and 4 face towards the RNA 
binding grove (Iseni et al., 2002; Gutsche et al., 2015; Alayyoubi et al., 2015). 
The hexamer phasing of the promoter elements suggests that the RNA 
polymerase simultaneously interacts with these during the initial stages of 
promoter recognition for RNA synthesis. The viral genome must then be 
internalised within the active cavity of the polymerase to initiate RNA synthesis, 
which would require separation of NP subunits from the viral genome (Maclellan 
et al., 2007; Tawar et al., 2009). The RNA-dependent RNA polymerase is 
comprised of one L subunit and four P subunits. The P subunits are non-
catalytic and act as a tether for the catalytic L subunit, and P interacts with the 
C-terminal arm of the NP subunits of the nucleocapsid (Hamaguchi et al., 1983; 
Horikami et al., 1992). Small amounts of L and P are associated with the 
nucleocapsid complex present in the virus particle in order to enable viral 
transcription to occur immediately upon viral entry into the cell. NP subunits that 
have dissociated from the nucleocapsid in order to allow the viral genome to be 
internalized into the RNA polymerase cavity are then believed to cross over the 
surface of the L subunit of the RNA polymerase to reform the helical 
nucleocapsid structure by associating with the template RNA as it exits the 
cavity (Liang et al., 2015).  
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1.3 Paramyxovirus transcription and replication 
 
Paramyxoviruses possess single-stranded, non-segmented, negative-sense 
RNA genomes. Typically, these are 15000-19000 nucleotides (nt) in length. 
Different paramyxoviruses possess comparable but not identical cohorts of 
genes that exhibit analogous functions. A schematic of the genome of prototype 
virus parainfluenza virus 5 (PIV5) in shown in Fig 1.3. The 3’ end of the viral 
genome contains an extracistronic region of 55-70 nt, which makes up the 
leader (Le) region and contains the Le promoter elements required for the 
generation of viral mRNAs and antigenomes. There is also a 5’ extracistronic 
region of 50-161 nt that is known as the trailer (Tr) region that contains the 
antigenome promoter (TrC) required for generation of antigenomes. Viral 
mRNAs are transcribed through a stop-start process that is directed by cis-
acting elements in the viral genome. Cis-acting elements include the gene start 
(Gs) and gene end (Ge) sites, which flank the individual genes. The Ge is 
followed by a U-tract of variable length, which is the site of viral mRNA 
polyadenylation. Between each gene pair there is an additional cis-acting 
element known as the intergenic region (Ig) which is composed of a short 
sequence that is not generally transcribed into mRNA. The Igs vary in sequence 
and length between the paramyxovirus genera. The respirovirus and 
morbillivirus contain conserved cis-acting elements, for parainfluenza virus 3 
(PIV3) this includes a Gs and Ge sequences of 3’-AGGANNAAAG-5’ and 3’-
ANTANNA5-5’ respectively and a 3’-GAA-5’ trinucleotide Ig sequence. Whilst, 
rubulaviruses including PIV2, MuV and PIV5 possess variable cis-acting 
elements, both in length and sequence. The Igs can be between 1 and 56 nts in 
length.  
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The processes of transcription (generation of viral mRNAs) and replication 
(generation of antigenomes and newly synthesized viral genome) are common 
among NNS RNA viruses, and have been reviewed extensively in Banerjee and 
Barik (1992). As such studies using different NNS RNA viruses, such as the 
rabies virus (rhabdoviridae), are used to inform the proposed mechanisms by 
which paramyxoviruses control transcription and replication. A schematic of 
virus transcription and replication is provided in Fig 1.3. Upon entry into the cell, 
the virus commences transcription. The small amounts of L and P associated 
with the nucleocapsid form the RNA polymerase complex, which initiates 
primary transcription of viral mRNAs. It is believed that viral replication can 
occur only after sufficient amounts of soluble NP0 (required for encapsidation of 
newly synthesized antigenomes and viral genomes) have been produced in the 
cytoplasm (Curran and Kolakofsky 1999; Howard and Wertz 1989; Patton et al., 
1984). The new viral genomes then act as templates for further transcription 
and replication known as secondary transcription. The precise mechanism by 
which the virus controls the switch between transcription and replication from a 
single promoter is yet to be elucidated.  
 
There are two models that have been hypothesized to explain the switch 
between viral transcription and replication from a single promoter reviewed by 
Noton and Fearns (2015). The first model suggests that there is a single pool of 
RNA polymerase that initiates transcription and replication by an identical 
method at position 1 of the viral genome. The polymerase transcribes a Le 
transcript, which is then released. After this, the RNA polymerase scans the 
viral genome further downstream until it finds the Gs signal for the NP gene, 
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where it initiates and commits to transcription. If a sufficient amount of NP0 is 
present in the cytoplasm, the Le transcript would be immediately encapsidated 
after initiation, which may stabilise the RNA polymerase and commit it to 
replication (Blumberg et al., 1981; Kolakofsky et al., 2004 Vidal and Kolakofsky, 
1989). However, this model is not supported by the observation that increasing 
the amount of NP0 did not necessarily increase the level of replication 
compared to that of transcription (Fearns et al., 1997). Recent studies using a 
mini-genome system for infections with respiratory syncytial virus (RSV) (family 
Orthopneumovirus) have suggested that the Le promoter contains three distinct 
regions. The first region, a string of 12 conserved nucleotides, was discussed 
above as an important element in promoter recognition and is sufficient to 
initiate transcription and replication, suggesting that it forms the core promoter. 
Nucleotides at positions 3, 5, 8, 9, 10 and 11 in this element have been shown 
to be particularly significant, as their mutation led to a reduction of RNA 
synthesis (Fearns et al., 2002). The second region is comprised of nucleotides 
16-34, which are essential for replication but not transcription. The third region 
corresponds to nucleotides 36-43 at the 5’ end of the Le region. It is U-rich and 
plays a role in transcription efficiency but does not appear to be critical for 
replication initiation (McGivern et al., 2005). RSV was observed producing short 
Le transcripts, of approximately 20-25 nts, from position 3 (Tremaglio et al., 
2013). Recent studies with VSV have shown that initiation of transcription 
occurs at position 1 of the genome in the Le and TrC promoters, independent of 
NP (Morin et al., 2012; Noton et al., 2012). Paramyxoviruses and 
orthopneumoviruses (RSV) whilst possessing many similarities in the 
mechanisms of viral RNA synthesis could initiate transcription and replication 
differently, with paramyxoviruses initiating RNA synthesis from position 1 and 
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orthomyxoviruses initiating transcription from position 3 of the genome. For 
paramyxoviruses the RNA polymerase initiates at position 1 of the genome, if 
insufficient amounts of NP0 are available encapsidation does not occur and the 
virus transcribes a short Le transcript, which is then released. The RNA 
polymerase scans the genome aided by the U-rich region 3 for the downstream 
NP Gs site to initiate transcription.  
 
Alternatively, the switch between transcription and replication could be 
controlled by two types of RNA polymerase, transcriptases and replicases. 
These are composed of the L and P subunits in association with other proteins, 
and initiate viral transcription and replication, respectively (Banerjee, 2008; 
Qanungo et al., 2004; Whelan, 2008). Studies of vesicular stomatis virus (VSV) 
(family rhabdoviridae) have demonstrated the presence of a transcriptase 
composed of L, P, NP, cellular elongation factor-1-alpha, heat-shock protein 60 
and guanylyltransferase (initiating transcription from the N GS site), and a 
replicase complex composed only L, P and NP (initiating replication from 
position 1 of the Le region (Keene et al., 1981; Qanungo et al., 2004; Whelan 
and Wertz, 1999, 2002). However, structural studies have shown that initiation 
of transcription from an internal site is unlikely because of genome 
encapsidation by NP (Albertini et al., 2006 a, b; Green et al., 2006).  
 
1.3.1 Virus Transcription 
 
Current evidence suggests that scanning by the RNA polymerase to locate the 
NP Gs site is important for the initiation of transcription. The RNA polymerase 
complex then transcribes the gene until it reaches the NP Ge site. 
	 29	
Polyadenylation occurs by stuttering of the polymerase complex over 4-7 U 
residues following the Ge site. A 5’-capped, 3’-polyadenylated mRNA is then 
released. The Gs site is thought to contain the signal for the RNA polymerase to 
carry out capping and cap methylation (Ogino et al., 2005; Stillman and Whitt, 
1999; Wang et al., 2007). Studies with RSV show that, if capping is prevented, 
the RNA polymerase terminates transcription (Liuzzi et al., 2005). Following 
polyadenylation and release of viral mRNA, the RNA polymerase complex 
either disengages from the genome or traverses the Ig to reinitiate transcription 
at the Gs site of the sequential downstream gene. If the RNA polymerase 
complex disengages from the genome, it can participate in further transcription 
only by re-attaching to the Le promoter. This transcription mechanism, known 
as stop-start transcription, produces a transcriptional gradient, with greater 
quantities of mRNA produced from genes nearer the 3’ end of the genome. 
Thus, the amount of mRNA produced is inversely proportional to the distance of 
the gene from the 3’ end of the genome (Fig 1.3) (Abraham and Banerjee 1976; 
Ball and White 1976; Collins and Wertz 1983; Huang and Wertz 1982, 1983). 
The viral mRNAs produced are translated by the host-cell machinery to produce 
viral proteins.  
 
1.3.2 Read-through mRNAs 
 
During transcription, the RNA polymerase may fail to terminate at the Ge signal. 
In this circumstance, the RNA polymerase transcribes the Ig and the 
downstream gene(s), producing a polycistronic mRNA that is also known as a 
read-through mRNA. The polymerase produces a faithful copy of the genes and 
the connecting Ig, and there is no evidence of stuttering at the U-tract in 
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polyadenylation site of the first gene transcript (Gupta and Kingsbury 1985, 
Wong and Hirano 1986).  Polycistronic mRNAs have been found in numerous 
paramyxo-, rhabdo- and orthopneumoviruses, including RSV, Newcastle 
disease virus (NDV), measles virus (MeV) and PIV5 (Collins and Wertz, 1983, 
Hiebert et al., 1985; Paterson et al., 1984; Rozenblatt et al., 1982; Wilde and 
Morrison, 1984). Much of our knowledge of the generation of read-through 
mRNAs has been conducted using VSV and RSV, which are rhabdo- and 
orthopneumoviruses, respectively, and are thought to share common 
transcription control mechanisms with the paramyxoviruses. Previous studies 
have suggested that the generation of read-through mRNAs may confer an 
additional gene expression control mechanism, beyond the generation of the 
transcription gradient. This mechanism may operate by increasing the access of 
RNA polymerase to downstream genes or by inhibiting the generation of 
downstream transcripts of polycistronic mRNAs. Wong and Hirano (1986) 
showed that generation of P-M transcripts down-regulated the expression of M 
in MeV. This may indicate that the downstream transcripts are not translated 
and therefore are a control mechanism for inhibiting the expression of viral 
proteins. Alternatively, a higher rate of read-through at a specific gene junction 
may increase RNA polymerase access to downstream genes. In the case of 
PIV5, the downstream genes included SH, HN and L. Rassa and Parks (1999, 
2001) showed that mutations that increased read-through at the M-F gene 
junction also decreased RNA synthesis. Additionally, as HN has a short half-life 
on the cell surface, increasing polymerase access to HN gene may be an 
important factor in maintaining sufficient levels of HN (Leser et al 1996; Rassa 
and Parks, 1999, 2001). Furthermore, maintaining access to the downstream L 
gene may be critical to viral replication. Previous studies have shown that an 
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over- or under-abundance of the L protein can have an inhibitory effect on viral 
protein synthesis (Finke et al., 2000; He and Lamb 1999; Kato et al., 1999; 
Parks et al., 2001). It is possible that the control of viral gene expression 
conferred by the production of polycistronic mRNAs is critical at various stages 
of the infection. Rassa and Parks (1998) demonstrated a higher generation of 
read-through transcription early in infection compared to late times post 
infection. In summary, the generation of read-through mRNAs may have a 
crucial role in the regulation of viral gene expression, but the exact mechanisms 
by which the paramyxoviruses maintain this control are unclear.  
 
The generation of polycistronic mRNAs is thought to be directed by cis-acting 
elements Ge and Ig (Barr et al., 1997 a,b; Kato et al., 1999; Rassa and Park, 
1998; Stillman and Whitt, 1997). Previous studies have shown a lack of 
consensus among viruses in regard to the mechanisms that they use to 
generate read-through mRNAs. This could be due to the diversity of the cis-
acting elements of paramyxoviruses, including the highly conserved elements of 
the respiroviruses and morbilliviruses, and the high variability of the length and 
sequence of these elements of the rubulaviruses. Despite this lack of 
consensus, numerous viruses produce a greater relative abundance of read-
through mRNAs at the M-F gene junction. This includes PIV5, PIV1, MeV and 
PIV3, which synthesize a ~42-80% of M and F transcripts in dicistronic form, 
indicating that they may have a critical, universal role in efficient virus infection 
(Bousse et al., 1997; Cattaneo et al., 1987a, b; Rassa and Parks, 1998; Spriggs 
et al., 1987).  
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Several studies have demonstrated a crucial role of the Ge sequence in the 
generation of read-through mRNAs by PIV5, RSV and VSV (Barr et al., 1997b; 
Hwang et al., 1998; Kuo et al., 1997; Spriggs and Collins, 1986; Rassa and 
Parks, 1998; Tsurudome et al., 1991). A study by Rassa and Parks (1998) 
showed that the level of PIV5 M-F read-through mRNAs was decreased to the 
level of the SH-HN read-through mRNAs by replacing the Ge sequence (10 nt) 
prior to the U-tract of M with that of the SH Ge sequence. A comparison of the 
M and SH Ge sequences showed changes in three nucleotides: a G to A at 
position 5, a U to A at position 8, and a C to U at position 9. Only the change at 
position 5 was proved to be important in the generation of dicistronic M-F 
transcripts. Furthermore, a comparison of PIV5 Ge sequences showed that the 
M Ge is unique and contains a G instead of the collective A at position 5. In the 
majority of paramyxoviruses the Ge site displays a high level of conservation, 
suggesting an critical role in paramyxovirus infection (Collins et al.,1996; 
Kolakofsky et al., 1998).  
 
The polyadenylation site U-tract has also been implicated as a critical factor in 
determining transcription termination. A minimum length of 7 nt for the U-tract 
was found to be important in VSV, in which the cis-acting elements are highly 
conserved, and removing a single U residue decreased the level of transcription 
termination and thereby generated a higher proportion of read-through mRNAs 
(Barr et al., 1997b; Hwang et al., 1998). Interestingly, the F Ge of mumps virus 
(MuV) strain Enders contains a mutation, U to C, which reduces the U-tract from 
7 to 4 Us. With this comes a 100% read-through rate and the generation of no 
detectable SH monocistronic mRNAs (Takeuchi et al., 1991). Combined, these 
studies suggest that U-tract length is an important factor in polycistronic mRNA 
	 33	
generation for viruses with highly conserved cis-acting elements (VSV), and 
also those with variable cis-acting elements (MuV). However, a study by Rassa 
and Parks (1998) showed that, although M in PIV5 (a rubulavirus with variable 
cis-acting elements) possesses the shortest polyadenylation site, with 4 U 
residues, increasing this to 6 or 8 Us did not appear to affect the rate of 
transcript termination (Rassa and Parks, 1998). 
 
The cis-acting element Ig has also been implicated as an essential factor in 
efficient transcription termination. A study by Bousse et al (2002) using PIV1 
and SeV (both respiroviruses with highly conserved cis-acting elements) 
showed that replacing the SeV M-F Ig with the PIV1 M-F Ig, which produce a 
low and high proportion of dicistronic mRNAs, respectively, the generation of M-
F read-through mRNAs by SeV increased to a level comparable to that 
observed for PIV1. However, previous studies using SeV and VSV suggested 
that differences in Igs did not necessarily correlate with changes in transcription 
termination. Gupta and Kingsbury (1984) showed that the SeV Igs contain a tri-
nucleotide sequence of 3’-GAA-5’, with the exception of HN-L, which contains 
3’-GGG-5’. This mutation did not affect transcription termination at the HN-L Ge 
site. Studies investigating the importance of Ig in VSV, in which the 3’-GA-5’ 
dinucleotide is present in all Igs with the exception of the NS-M Ig (which 
contains a G to C mutation), have shown this site to be critical for effective 
transcription termination (Barr et al., 1997a; Stillman and Whitt, 1997). 
However, the altered NS-M Ig did not confer an increased proportion of read-
through mRNAs (Iverson and Rose, 1981).  
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A study by Rassa and Parks (1999) suggested that PIV5 cis-acting elements Ig 
and Ge may work in tandem. A G residue located immediately after the M gene 
U-tract that contains 4 U residues was found to confer efficient transcription 
termination for a short U-tract. The rate of transcription termination was 
comparable to the M gene when the U-tract was increased to contained 6 U 
residue polyadenylation site and possessed an A residue at position 1 of the Ig. 
This suggests that the Ig and Ge could function in tandem as a control 
mechanism for transcription termination. This study also demonstrated, by 
introducing insertions into the M-F Ig, that the length of Ig may not play a critical 
role in transcription termination. However, the lengths of insertions were 
multiples of 6 and thus maintained the hexamer phasing that is essential for 
effective paramyxovirus RNA synthesis (Rassa and Parks, 1999). Therefore, it 
is not possible to conclude whether disrupting the position of cis-acting 
elements in relation to hexamer phasing and the “rule of six” is crucial in 
transcription termination, as suggested by Kolakofsky et al (1998, 2016). 
Furthermore, Rassa et al (2000) showed that the spacing between the last 
residue of the SH gene U-tract and the first residue of the HN gene must be a 
minimum of 6 nt for effective transcription termination and reinitiation. This 
suggests that maintaining the spacing between cis-acting elements and their 
relative positions in relation to hexamer phasing and the “rule of six”, and 
possibly indicate a crucial role efficient in viral transcription.  
 
The cis-acting elements Ge and Ig and the U-tract polyadenylation site have 
been implicated in the control of effective transcription termination and the 
generation of read-through mRNAs. It is hypothesized that the generation of 
read-through mRNAs plays a critical role in the control of viral gene expression 
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either by inhibiting the production of monocistronic mRNAs or by increasing 
access to downstream genes. The lack of consensus over the control 
mechanisms of transcription termination among the paramyxovirus is possibly 
not surprising. The differences between the cis-acting elements are diverse, 
from those of the highly conserved respiroviruses to those of the highly variable 
rubulaviruses, and it is possible that the individual viruses may exert both 
common and unique transcription termination controls.  
 
It is not known whether viral proteins are also a factor in transcription 
termination. A study by Hardy and Wertz (1998) suggested that the M2 ORF1 
protein is crucial in increasing the rate of read-through mRNA production by 
RSV. However, Rassa and Parks (1998) showed that PIV5 proteins N, P and L 
have no effect on transcription termination, but that other PIV5 viral proteins 
may be a factor in the generation of polycistronic mRNAs.  
 
1.3.3 RNA editing and the generation of accessory proteins 
 
Paramyxoviruses share the common feature of allowing multiple mRNAs to be 
transcribed from a single gene through a process known as RNA editing. This 
occurs in the V (rubularvirus) or P (respiro-, morbilli-, henipa- and avula-viruses) 
genes, where G residues are inserted at a specific genome position in a 
proportion of mRNA transcripts, resulting in a transcriptional frameshift. This is 
thought to occur by slippage of the viral polymerase within a short run of G 
residues by a similar mechanism as that of polyadenylation (Hausmann et al., 
1999a, b; Thomas et al., 1988; Vidal et al., 1990). In rubulaviruses, the V/P 
gene produces three transcripts: V, which is a faithful copy of the gene; P, 
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which is generated by insertion of two G residues at position 2338 of the P 
transcript; and I, which is produced by a single G insertion. As a result, the V, P 
and I proteins share the same N-terminal sequence but differ in their C-terminal 
sequences. The proteins produced due to RNA editing differ among viruses in 
the various paramyxovirus genera. The rubulaviruses, including PIV5, PIV2 and 
MuV, produce P, V and I transcripts, whereas the respiro-, morbilli-, henipa- and 
avula-viruses, such as PIV3, generate transcripts for P, V and D through RNA 
editing. The cis-acting elements that direct RNA editing are conserved and 
positioned immediately upstream of the RNA editing site. The rubulavirus RNA 
editing site sequence is 3’-AAAUUCUCCCC-5’, whereas in respiroviruses the 
sequence is 3’-UUUUUUCCC-5’. A study by Thomas et al., (1988) 
demonstrated that RNA editing, and the insertion of G residues in PIV5, occurs 
at a 1:1 ratio.  Kolakofsky (2016) suggested that conserved hexamer phasing, 
as is found in the rubula- and morbilliviruses, may control the ratio of 2 and 1 G 
residue inserts, respectively. However, the lack of conserved hexamer phasing 
among the respiroviruses, such as SeV and PIV3, results in non-conserved G 
insertions as SeV inserts 1 G at high frequency, whereas PIV3 inserts between 
1 to 6 G residues occur at equal frequency (Hausmann et al., 1999b; 
Kolakofsky, 2016; Kolakofsky et al., 2005; Iseni et al., 2002).  
 
1.3.4 Viral Replication 
 
Genome replication occurs after initial viral transcription and translation. The 
RNA polymerase complex attaches to the Le region promoter at the 3’ end of 
the genome, as described above. However, the RNA polymerase complex 
transcribes the entire length of the genome, ignoring all Gs and Ge sites. This 
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produces a full-length, faithful, positive-sense copy of the genome known as the 
antigenome. The antigenome then acts as a template for the production of viral 
genomes. The 3’ end of the antigenome is the complement of the Le region and 
contains at its end 13 nt that are identical to those at the 3’ end of the genome. 
These are a crucial promoter element for recognition of the RNA polymerase 
and subsequent RNA synthesis. The newly synthesized genomes and 
antigenomes are encapsidated by NP0 to form the nucleocapsid structure. It is 
thought that simultaneous encapsidation allows the polymerase to ignore Ge 
signals, thus producing a full-length copy of the template RNA (McGivern et al., 
2005; Vidal and Kolakofsky, 1989).  
 
Viral genomes are required at significantly higher levels than antigenomes, as 
the newly synthesized genomes are assembled into new virus particles. Based 
on studies by Keller et al (2001, 2003) using mutational analysis and 
minigenome replicons for PIV5, the TrC promoter on the antigenome is stronger 
than the Le promoter on the genome and produces a greater number of new 
viral genomes (Keller et al., 2001; Keller and Parks 2003; Whelan and Wertz 
1999). This difference in strength was shown to be the results of 3’ cis-acting 
elements in both promoters (Keller et al., 2001; Keller and Parks, 2003). 
However, a study by Fearns et al (2000) demonstrated that for RSV the 
strengths of the Le and TrC promoter are similar.  
 
The replication process of RNA viruses can be erroneous, often producing viral 
products, such as naked RNA or defective interfering particles (DIs), that can 
activate the first line in anti-viral defence of the host immune system, the 
interferon (IFN) response.  
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1.4 Evasion of the Host Immune Response 
 
One of the most important determinants of viral pathogenesis is the ability of 
viruses to circumvent the host immune response. The most effective innate anti-
Fig 1.3. A schematic of the PIV5 genome (shown as antisense RNA) 
indicating the seven genes. The Gs (green) and Ge (red) sites are shown 
flanking each gene. Genes are represented as blue boxes containing the 
name of the gene. The replication process and production of the antigenome 
(shown as sense RNA, red rectangle) are indicated. Transcription is also 
illustrated, producing 5’-capped, 3’-polyadenylated mRNAs (short blue lines). 
The transcription gradient displays the abundance of mRNAs produced. The 
additional P transcript generated via RNA editing and the insertion of two G 
residues is shown as a yellow bow outlined in blue containing two Gs.  
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viral response is the type I IFN system, which can inhibit viral replication and 
cell-to-cell spread. The type I IFN response can be divided into two phases 
(induction and signalling), and is extensively reviewed in Stetson and Medzhitov 
(2006) and Schneider et al., (2014). A schematic overview of the type I IFN 
induction and signalling pathways is provided in Fig 1.4.   
 
1.4.1 Induction of the Type I IFN Response 
 
The type I IFN response is induced by recognition of pathogen-associated 
molecular patterns (PAMPS) by host pattern recognition receptors (PRRs). 
Recognition of PAMPs often occurs through the identification of non-host 
nucleic acid structures, including viral products generated during (defective) 
RNA synthesis, such as double-stranded RNA (dsRNA) or uncapped, single-
stranded 5’ triphosphate RNAs (uncapped ssRNA). Recognition can occur 
through PRRs such as protein kinase R (PKR) and Toll-like receptors (TLRs), 
which recognize viral nucleic acid through endocytosis or autophagy. For 
example, TLR3 and PKR recognize dsRNA, and TLR7 recognizes uncapped 
ssRNA. Alternatively, viral nucleic acid can be detected in the cytoplasm by 
RNA helicases such as retinoic acid inducible gene-I (RIG-I) and melanoma 
differentiation-associated gene 5 (mda-5) (Andrejeva et al., 2004; Yoneyama et 
al., 2004). The former is believed to associate with short dsRNA (Cui et al., 
2004; Hornung et al., 2006; Pichlmair et al., 2006; Takahasi et al., 2008), and 
the latter interacts with longer dsRNAs (Kato et al., 2008). The activation of 
RIG-I or mda-5 (or both) leads to the recruitment of mitochondrial anti-viral 
signalling protein (MAVS) or IFN-β promoter stimulator 1 (IPS-1) (Kawai et al., 
2005). The recruitment of these cellular factors leads to the activation of 
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cytoplasmic kinases such as TANK-binding kinase-1 (TBK-1) and inhibitor of κB 
kinase ε (IKKε). This then leads to the subsequent phosphorylation and 
dimerization of interferon regulatory factors (IRFs) and the activation NF-κB, 
which translocate to the nucleus and activate cellular promoters. This results in 
the transcription of proinflammatory cytokine genes, including IFN-β (Lamb and 
Parks, 2013; Randall and Goodbourn, 2008).  
 
 1.4.2 Type I IFN Signalling 
 
Upon induction of the type I IFN response, IFN is produced and secreted from 
the cell. The IFN then binds to its receptor on the cell surface of the infected cell 
or neighbouring uninfected cells. This results in the phosphorylation of 
transcription factors STAT1 and STAT2 by Janus kinases (JAK) Tyk2 and 
JAK1. STAT1 and STAT2 then heterodimerize and associate with IRF-9, 
forming the transcription factor ISGF3, which translocates to the nucleus and 
binds to the interferon-stimulated response elements (ISRE) in the promoter 
region of IFN-inducible genes (Blaszczyk et al., 2016; Horvarth 2000a, b; 
Raftery and Stevenson, 2017). 
 
1.4.3 Genes induced by IFN 
 
Activation of ISGs results in the expression of numerous anti-viral genes 
including the production of cytokines to create an anti-viral state (Kotwal et al., 
2012). These proteins include the IFN-inducible transmembrane family (IFITM) 
found principally in late endosomes and lysosomes, most likely affecting virus 
entry by inhibiting virus fusion with the endosomal membrane (Huang et al., 
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2011; Li et al., 2013) and TRIM proteins the functions of which are diverse and 
range from protein ubiquitination to SUMOylation and ISGylation (Chu and 
Yang, 2011; Ozato et al., 2008).  ISG56, which encodes P56 is the most 
strongly induced of the ISGs. It interacts with the P48 subunit of the 
translocation initiation factor (eLF)-3 and specifically targets virus transcription 
and protein synthesis (Andrejeva et al., 2013; Guo and Sen, 2000). 
Other important ISGs responsible for producing an anti-viral state include the 
multifunctional pro-inflammatory cytokines IL-6 and TNF-α (Cantaert et al., 
2010; Ishihara and Hirano, 2002).  
1.4.3 Paramyxoviruses and the IFN system 
 
Paramyxoviruses are capable of encoding IFN antagonists that allow them to 
circumvent host IFN induction and signalling; this has been reviewed 
extensively by Audsley and Moseley (2013) and Parks and Alexander-Miller 
(2013). The rubula-, respiro-, morbilli-, henipa- and avulaviruses encode the V 
protein, which is templated by RNA editing and the insertion of a single G 
residue.  In contrast, the V protein is the faithful copy of the templated gene In 
the rubulaviruses (He et al., 2002; Komatsu et al., 2004; Poole et al., 2002). An 
additional protein is generated by respiroviruses and allows the virus to evade 
the IFN response. The C protein is encoded by alternative read frames in the 
V/P gene (Komatsu et al., 2004).  
 
Paramyxoviruses produce encapsidated genomes, antigenomes and 5’-capped 
mRNAs during replication and transcription, and these are not recognised by 
host cell PRRs. However, numerous studies have shown that paramyxoviruses 
are strong activators of the IFN system, primarily through the induction of RIG-I 
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and the production of short dsRNAs (Habjan et al., 2008; Kato et al., 2006; 
Plumet et al., 2007; Strahle et al., 2007). Paramyxoviruses have also been 
shown to be inducers of mda-5 (Andrejeva et al., 2004; Berghall et al., 2006; 
Melchjorsen et al., 2005; Yoneyama et al., 2004, 2005). The precise 
mechanism by which paramyxoviruses induce type I IFN is yet to be fully 
elucidated. The activation of PRRs may be due to the generation of some 
uncharacterised viral products during typical virus transcription and replication. 
Alternatively, PRRs may be induced by viral products that are generated as a 
result of defective transcription and replication processes. These products may 
include defective interfering genomes (DIs), which exist in two types: internal 
deletion DIs contain the Le and Tr promoter region but lack internal regions of 
the genome, and copyback DIs are generated when the RNA polymerase 
switches to the nascent strand during replication, generating a pan-handle 
dsRNA structure. Copyback DIs have been shown to activate IFN induction in 
PIV5, SeV and a vaccine strain of MeV (Johnson, 1981; Killip et al., 2013; 
Poole et al., 2002; Shingai et al., 2007; Strahle et al., 2007).     
 
The V protein of numerous paramyxoviruses, including PIV5, PIV2 and MuV, 
have been shown to interact with mda-5, thereby inhibiting the type I IFN 
response (Andrejeva et al., 2004; Childs et al., 2007). The interaction between 
V protein and mda-5 occurs via the conserved cysteine-rich C terminus of the V 
protein, which binds to several sites on mda-5 and prevents dsRNA from 
binding to sites on either the C terminus or the helicase recruitment domain of 
IRF-3, thereby inhibiting IFNβ production (Childs et al., 2009; Komatsu et al., 
2004).  
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Several studies have suggested that the V protein can block RIG-I induction of 
type I IFN by acting as a ‘decoy substrate’, blocking TBK and IKK-ε 
(rubulaviruses) or IKKα (MeV) and preventing phosphorylation of transcription 
factors IRF-3 and IRF-7, respectively (Lu et al., 2008; Pfaller and Conzelmann, 
2008). A study by Manuse and Parks (2009) suggested that PIV5 was 
incapable of inhibiting RIG-I induction. However, Childs et al. (2012) 
demonstrated that RIG-I induction can be inhibited by the V protein interacting 
with LGP2 (laboratory of genetics and physiology 2), which inhibits induction by 
RIG-I ligands. Additionally, it has been shown that PIV5 may not be able to 
block activation of TLR3 and TLR4 (Arimilli et al., 2006).  
 
Studies using mini replicon systems have suggested that the V protein may 
indirectly inhibit type I IFN induction by down-regulating RNA synthesis (Curran 
et al.,1991, 1995; Horikami et al., 1997; Lin et al., 2005; Nishio et al., 2008; 
Parks et al., 2006; Witko et al., 2006). Numerous studies have shown that 
recombinant viruses with mutations in this protein often display increased viral 
RNA synthesis (Baron and Barrett, 2000; Delenda et al., 1997; Durbin et al., 
1999; Gainey et al., 2008; Kato et al., 1997a, b; Kawano et al., 2001; Schneider 
et al., 1997; Tober et al., 1998). The control of RNA synthesis may be a 
mechanism by which the virus decreases the generation of virus products, such 
as DIs or other, as yet uncharacterised RNA structures, which could induce the 
IFN response. One proposed mechanism of RNA synthesis control may be the 
binding of V to NP0 required for encapsidation of viral genomes and 
antigenomes (Curran et al., 1995; Precious et al., 1995; Tober et al., 1998). 
There is some evidence to suggest that PIV5 V protein also binds to Akt1 and 
inhibits its ability to phosphorylate viral P protein, which has been shown to play 
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a critical role in the regulation of viral RNA synthesis (Sun et al., 2008; Timani et 
al., 2008). Furthermore, PIV2 V protein inhibits replication by binding to the L 
subunit (Nishio et al., 2008).  
 
A number of paramyxoviruses can encode a C protein that acts as an IFN 
antagonist. Studies using SeV, PIV1 and MeV (which lack the C protein) show 
an increased induction of type I IFN (Boonyaratanakornkit et al., 2011; Komatsu 
et al., 2004; Nakatsu et al., 2006; Strahle et al., 2003, 2006). The C protein may 
function to inhibit RIG-I induction (Strahle et al., 2007).  Several studies have 
suggested that the MeV, SeV and PIV3 C proteins may act as a regulator of the 
RNA polymerase, thereby limiting the production of dsRNA and indirectly 
inhibiting IFN induction (Bankamp et al., 2005; Boonyaratanakornkit et al., 
2011; Curran et al., 1991, 1992; Cadd et al., 1996; Horikami et al., 1997; Malur 
et al., 2004; Reutter et al., 2001). Additionally, the C protein may also limit the 
production of DIs, which have been shown to be potent activators of the IFN 
induction (Killip et al., 2013; Sanchez-Aparicio et al., 2017). The exact functions 
of the C protein remain unclear, although PIV1 and PIV3 have been shown to 
inhibit activation of IRF-3 and the production of IFN-α and IFN-β (Komatsu et 
al., 2007; Van Cleve et al., 2006).  
 
It has been shown that PIV5 and MuV block IFN signalling by targeting STAT1 
for proteosome-mediated degradation, which blocks type I IFN signalling 
(Didcock et al., 1999a, b; He et al., 2002; Poole et al., 2002; Wansley and Parks 
2002; Young et al., 2000). However, PIV2 targets STAT2 for degradation. 
Targeting STAT for degradation requires the assembly of a cytoplasmic 
ubiquitin ligase complex. For PIV5 this is composed of the V protein, STAT1, 
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STAT2, the ultraviolet (UV)-DNA damage repair binding protein DDB1 and a 
member of the Cullin family of ubiquitin ligase subunits (Lin et al., 1998; 
Precious et al., 2005, 2007; Ulane et al., 2005).  
 
Alternatively, some paramyxoviruses can inhibit IFN signalling by binding of the 
V protein to other proteins involved in the phosphorylation or translocation of 
STAT to the nucleus. The V protein of Hendra and Nipah viruses binds to 
STAT1, STAT2 and IRF-9, and forms a high molecular weight complex that 
cannot function, whereas MeV blocks translocation of STATs to the nucleus 
(Palosari et al., 2003). Interestingly, MeV P protein can also bind STAT1 to 
prevent phosphorylation (Devaux et al., 2013).  
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Fig 1.4. A schematic showing the IFN induction and signalling pathways and 
the paramyxovirus proteins that inhibit the IFN response. Upon entry into the 
cell the virus produces dsRNA or 5’-triphosphate during virus replication 
triggering IFN induction through PKR, TLRs, mda-5 and RIG-I. The 
paramyxovirus V and C proteins inhibit induction of IFN by inhibiting RIG-I 
and mda-5. Induction of IFN results in a signalling cascade of MAVS and 
subsequently IRF3 and NFκB resulting in the transcription of IFN-β. The V 
protein targets TBK-1to inhibit this cascade. Following transcription of IFN-β 
genes, IFN activates signalling through the JAK-STAT pathway at the cell 
surface. The paramyxovirus C and V protein target STAT1 and STAT2 for 
degradation inhibiting stimulation of ISGs.  
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1.5 Persistent Infections 
 
When a virus infects a host, this typically results in the symptoms of acute 
disease. During this time, the virus replicates and is shed into the environment. 
In an acute infection, it would be expected that all virally infected cells would be 
cleared from the host by the innate and adaptive immune responses 
approximately within a few weeks of initial infection. An infection that lasts 
longer is considered to be persistent. This does not necessarily lead to life-long 
infections like those caused by hepatitis C virus (HCV), but can last a few 
weeks, months or perhaps years longer than expected; reviewed in Randall and 
Griffin (2017) and in some cases allow the virus to be transmitted to a new host 
such as in Ebola (Harrower et al., 2016). Some viruses, including those that 
generate defective genomes, can spread from cell to cell and thus are capable 
of persisting in the host without the production of infectious viral particles.  
 
Many paramyxoviruses are capable of establishing a persistent infection in the 
host. For example, MeV can establish persistent infections in the human brain 
that can lead to subacute sclerosing panencephalitis (SSPE) many years after 
the initial infection (Garg, 2002; Kristensson and Norrby, 1986). It has been 
suggested that persistent MeV infection can lead to life-long immunity for the 
host, thus conferring a potentially great benefit (Griffin et al., 2012; Lin et al., 
2012). The mechanisms by which paramyxoviruses establish persistence 
remain unknown, but it is known that the virus must accomplish two objectives: 
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1. The virus must evade the host immune system.  
2. The virus must maintain its genome in at least some infected cells while not 
killing them.  
  
A large abundance of viral genomes may either kill the cell directly by creating a 
toxic environment including viral RNAs and proteins, or may kill the cell 
indirectly as a consequence of activating cytotoxic T cells through presentation 
of viral products by MHC class II molecules. Viral avoidance of killing infected 
cells may be achieved by low-level replication or cell-to-cell spread (Randall and 
Griffin, 2017). For viruses that kill cells during infection to establish a persistent 
infection, the virus must repress virus replication or select viral variants that 
elicit reduced cytopathogenic activity, such as temperature-sensitive (ts) 
mutants (Randall and Griffin, 2017).  
 
The generation of DIs has been proposed as a method by which viruses 
establish persistence and repress virus replication (Johnson, 1981; Roux et al., 
1991; Sidhu et al., 1994). DIs contain either TrC or Le and TrC promoter 
elements, copyback DIs and internal deletion DIs respectively, and therefore 
can out-compete non-defective genomes and antigenomes for RNA polymerase 
activity (Roux et al., 1991). Copyback DIs have been shown to induce the host 
IFN response, thus inhibiting RNA synthesis (Killip et al., 2013). DIs were 
isolated from brain biopsies of SSPE patients suggesting a causative role in 
establishing viral persistence (Sidhu et al., 1994). Additionally, studies have 
shown a correlation between the presence of DIs and the ability of Ebola to 
establish a persistent infection (Calain et al., 2016; Calain et al., 1999). 
Alternatively, the virus may be maintained in infected cells with no viral 
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replication, such as is the case with Blue Tongue Virus (BTV, orbivirus of the 
reoviridae family) in erythrocytes (MacLachlan et al., 1994; Schwartz-Cornil et 
al., 2008; Randall and Griffin, 2017; Whetter et al., 1989).  
 
The majority of studies investigating paramyxovirus persistence were 
conducted using SeV, and the clinical relevance of these infections, if any, has 
not been demonstrated. Two potentially important factors have been identified 
that may allow SeV to establish a persistent infection: 
 
1. The presence of DIs. 
2. The production of ts mutant viruses.  
 
Studies with SeV have shown that persistent infections can be established by 
the presence of DIs and/or the selection of ts mutants. Studies by Roux and 
Holland (1979, 1980) showed that SeV was able to establish persistence 
through infection with non-defective SeV virus containing DIs. Their presence 
may confer protection from lytic infection allowing the initial establishment of 
persistence, with non-defective virus genomes and DIs surviving in a balanced 
state. If the balance leans towards the non-defective genomes, the cells would 
enter crisis.  
 
SeV mutants have also often been isolated from persistently infected cells, and 
the mutations have been found to be ts, enabling the virus to grow well at 33°C 
but not at 38°C. These mutants were able to establish a persistent infection 
(Kimura et al., 1975; Nagata et al.,1972). During persistent infection, ts mutants 
are produced that interfere with the replication of wild-type (WT) non-defective 
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genomes, resulting in their replacement (Kiyotani et al., 1990; Nagai and 
Yoshida, 1984; Yoshida et al., 1982). Several mutations have been identified in 
the ts mutants, in the M, HN and L genes, which are thought to be essential for 
the establishment of persistence. Additionally, two mutations in the Le were 
found to confer increased interference capacity (Inoue et al., 2003; Kondo et al., 
1993; Nishio et al., 2004; Shimazu et al., 2008).  Yoshida et al (1982) observed 
that cells persistently infected with a stock of SeV that had undergone 
numerous serial passages in cell culture could enter crisis and cause a high 
proportion of cell death. The presence of DIs and ts mutants in these 
persistently infected cell lines was established. Furthermore, the ts mutants 
were able to establish a persistent infection in the absence of DIs and did not 
provoke a crisis state.  
 
1.6 High-throughput sequencing 
 
High-throughput sequencing (HTS) is revolutionising biomolecular research, 
including research on viruses. The advancement of rapid and cost-effective 
sequencing has allowed the assembly of millions of viral gene sequences and is 
transforming investigations into the dynamics of viral infections, including areas 
such as transcriptomics and genomic research (Radford et al., 2012). Advances 
in HTS technologies have led to the generation of large and complex data sets, 
with a single sequencing run able to produce millions of short reads. Longer 
read technologies are available. However, they remain expensive and therefore 
are not yet widely applied in biomedical research. This study employs short-
read sequencing using the Illumina platform, and represents a unique 
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opportunity to achieve a comprehensive overview of the infection dynamics of 
paramyxoviruses. There are three steps involved in HTS: the generation of 
template molecules for sequencing (a process known as library preparation), 
sequencing and bioinformatic analysis. 
 
1.6.1 Library preparation 
 
The library preparation workflow is illustrated in Figure 1.5. The ability to 
produce high quality libraries is a crucial step in the generation of HTS data. 
This process involves the generation of template molecules that are 
subsequently subjected to sequencing. The numerous library preparation 
methods reflect the wide range of areas to which HTS methods can be 
employed, including whole transcriptome sequencing, targeted RNA 
sequencing and whole genome sequencing. This project employed RNA 
sequencing using Illumina library preparation kits; namely, total RNA 
sequencing with nuclear and mitochondrial ribosomal RNA (rRNA) reduction 
(TruSeq stranded total RNA with Ribo-Zero gold) and targeted mRNA 
sequencing by polyA selection (TruSeq stranded mRNA library prep kit). These 
library preparation methods differ in their RNA purification steps (Fig 1.5B) due 
to their respective target RNA, however subsequent steps are identical.  
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Fig 1.5 A schematic of the workflow of library preparation for HTS. (A) The 
total RNA present in the sample including host and viral RNAs, different 
species of RNA are represented as different coloured arrows. (B) RNA is 
purified either by selecting for target RNA such as in polyA selection or 
depleting unwanted RNA as in total RNA with ribosomal RNA reduction. The 
purified RNA is then fragmented. (C) The first strand cDNA is transcribed 
from the fragmented RNA. (D) The second strand cDNA is transcribed from 
the first strand cDNA incorporating dUTPs in the place of dTTP thereby 
retaining strand specificity. (E) Adapters are ligated to the ends of the ds 
cDNA. (F) The ds cDNA fragments are enriched by PCR amplification.  
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1.6.1.1 Purification and fragmentation of extracted RNA 
Purification of extracted RNA differs dependent on the method of library 
preparation and the target molecule. This project used both reduction and 
selection methods to purify the target RNA (Fig 5B).  The TruSeq stranded 
total RNA with Ribo-Zero gold kit depletes nuclear and mitochondrial rRNA. 
Over 90% of the total RNA in the sample may be composed of these 
molecules, and removing them allows the remaining RNA (including host 
mRNA and viral genome and antigenome RNAs and mRNAs) to be enriched. 
The TruSeq Stranded mRNA Library Prep Kit selects host and viral poly A 
mRNA using oligo d(T) beads. With both kits, the remaining RNA is 
fragmented after the RNA purification stage using divalent cations under 
elevated temperature, and primed for cDNA synthesis.  
 
The fragmented RNA is primed with hexameric oligonucleotides with random 
sequences and reverse transcribed using reverse transcriptase into first strand 
cDNA (Fig 5C). The second strand cDNA is generated using the first strand 
cDNA as a template. Strand specificity is retained during second strand cDNA 
synthesis by incorporating dUTP in place of dTTP (Fig 5D). This process 
generates blunt-ended, double-stranded cDNA. The initial template RNA is 
removed during this procedure. 
 
A single A residue is then incorporated at the 3’ ends of the blunt-ended cDNA to 
prevent the fragments from ligating to one another during subsequent steps. 
After this, indexed, double-stranded oligonucleotide adapters are ligated to the 
ends of the cDNA fragments, a T residue at the 3’ end of the adapter providing 
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complementarity to the added A residue incorporated at the 3’ ends of the blunt 
ended cDNA (Fig 5E). This process prepares the cDNA for hybridization to the 
flow cell used on the Illumina sequencing platform, as discussed in greater detail 
below.  
 
1.6.1.2 DNA fragment enrichment 
 
The adapter-ligated, double stranded (ds) cDNA is then amplified by PCR using 
oligonucleotide primers that enrich only the molecules that have adapters at 
both ends (Fig 5F) by annealing to the ends of the adapters. The number of 
cycles of PCR amplification is minimized to 15 in order to avoid skewing the 
representation of sequencing in the library. PCR biases can result in regions 
with extreme nucleotide compositions being underrepresented in the library, 
which results in a reduction of read coverage in these regions (Aird et al., 2011; 
Baskaran et al., 1996; Benita et al., 2003; Dohm et al., 2008; Kozarewa et al., 
2009; Oyola et al., 2012).  
 
The library then undergoes quality control and quantification. This is essential for 
ensuring optimal cluster densities on the flow cell, which are needed in order to 
generate high quality reads.  
 
1.6.2 DNA Sequencing 
 
There are two approaches to short-read HTS: sequencing by synthesis and 
sequencing by ligation. This project utilized Illumina sequencing platforms, 
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which are in the first category. An overview is provided in Figure 1.6 and a 
video by Illumina can be viewed at 
https://m.youtube.com/watch?v=fCd6B5HRaZ8. Illumina sequencing is 
reviewed extensively in Radford et al., (2012).  
 
Illumina technology use a flow cell for carrying out sequencing. The flow cell has 
multiple channels, which are coated in a layer of oligonucleotide primers that are 
complementary to the adapters ligated to the ds cDNA fragments in the library. 
The fragments are first denatured, producing single-stranded (ss) cDNA that is 
passed through the channels of the flow cell. The ss cDNA anneals to the 
primers attached to the surface of the channel in the flow cell. This process is 
repeated until there are millions of cDNA molecules attached to the surface of 
the flow cell. Thus, the annealed cDNA molecules are immobilized, creating a 
stable environment for subsequent steps.  
 
Unlabelled nucleotide triphosphates and oligonucleotide primers are added to 
the flow cell to initiate solid-phase bridge amplification, which can create up to 
1000 copies of each individual input cDNA molecule. To determine the sequence 
of the cDNA fragments, four labelled reversible terminators corresponding to a 
specific nucleotide (A, T, C and G), primer(s) and DNA polymerase are added to 
the flow cell. Either single-end or paired-end reads can be generated by using a 
single or two primers, respectively. A single primer (the forward or F primer) will 
transcribe the cDNA molecule from the 5’ end, producing single-end reads. 
Paired-end reads require the use of two primers (the F and the reverse or R 
primers), which sequentially copy the cDNA molecules from both the 5’ and 3’ 
ends, respectively. The labelled terminators attach at the relevant cycles and 
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emit a fluorescent signal unique to each nucleotide after laser excitation. The 
fluorescence from each cDNA cluster is captured by a CCD camera each time a 
labelled terminator attaches to a downstream nucleotide. This process is 
repeated until the sequence of the whole strand of every cDNA molecule has 
been determined. The number of cycles determines the length of the reads. The 
data captured from the fluorescent imaging are processed into text files in fastq 
format, which contain a quality value for each nucleotide. To generate single-end 
reads only a using a single primer (F) is used producing a single fastq file (R1). 
Two cycles of sequencing are required for the generation of paired-end reads. 
The first cycle uses the F primer to produce the R1 fastq file, and then the 
second cycle uses the R primer to produce the R2 fastq file. The R1 file 
produces reads that are antisense to the RNA from which they originated, the R2 
files produces reads in the same sense as the transcript. The analysis conducted 
during this study utilized reads that were either 75 or 150 nts in length.  
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1.6.3 Bioinformatic analysis 
 
The ability to analyse HTS data to best effect requires the use and concurrent 
development of bioinformatic program designed to operate with large, complex 
data sets. Sets of bioinformatic programs that work in sequence to produce the 
desired output are known as bioinformatic pipelines and can differ greatly, 
depending on the aims of the analysis. However, there are several initial steps 
that are common to accurate bioinformatic analysis, namely read quality control 
and mapping reviewed by Orton et al., 2016.  
 
Fig 1.6 Overview of Sequencing by Synthesis used by Illumina sequencing 
platforms. (1-2) ds cDNA produced during library preparation is denatured and 
passed through the flow cell attaching to primers complementary to the 
adapters ligated during library preparation that coat the flow cell surface. (3-6) 
Unlabelled nucleotide triphosphates and oligonucleotide primers are added to 
the flow cell to copy the immobilised cDNA fragments. (7) Four labelled 
reversible terminators corresponding to a specific nucleotide (A, T, C and G) 
are added to the flow cell, attaching to the nucleotides of the cDNA fragments 
and emitting fluorescence when excited by a laser that is captured by a CCD 
camera allowing the sequence of nucleotides of the fragment cDNA to be 
identified.  
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1.6.3.1 Read Quality Control 
 
Typically, the first step in HTS analysis is quality control, which is essential for 
accurate downstream analysis. The millions of short reads that are generated 
by HTS typically vary in quality since they may contain sequencing errors and 
artefacts. Each single nucleotide of a read is allocated a quality score, as well 
as the read as a whole. Nucleotides or reads with low quality scores are 
removed by trimming and filtering processes. Quality usually decreases over 
the length of a read, with the 3’ end containing a higher proportion of low quality 
bases. These bases, along with the adapter sequences attached to the ends of 
cDNA fragments during library preparation, are trimmed from the reads.  The 
reads also undergo filtering to remove those with a low average quality score, 
reads which are short in length or any containing uncalled (ambiguous) 
nucleotides.  
1.6.3.2 Mapping 
 
Accurate mapping of reads to a reference genome sequence is a crucial step in 
many bioinformatic pipelines. The use of short-read mapping tools has been 
reviewed extensively by Hatem et al (2013). The aligning of a read to its correct 
position in a genome sequence indicates the origin of the read. The majority of 
mapping programs use hash-based tools or the Burrows-Wheeler 
Transformation (BWT) to map reads accurately to the reference. Hash-based 
programmes use have high computational demands but are more sensitive 
using them to align diverse reads to distantly related references. In contrast, 
BWT-based programs are rapid and use less computational resource. Since the 
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paramyxoviruses analysed throughout this project have closely related 
reference genomes, a BWT-based program was used (Li and Durbin, 2009).  
 
The most commonly used BWT-based alignment software packages are BWA 
and Bowtie, which were adapted from the Ferragina and Manzini matching 
algorithm to incorporate an full-text in minute space (FM-index) (Li and Durbin, 
2009; Langmead et al., 2009).  This transforms the reference genome 
sequence into an FM-index, which compresses the reference genome 
sequence and allows the rapid identification of patterns of nucleotides that 
match those found in the reads. Other alignment programs also utilise the FM-
index of the reads, but this has been shown to be less effective than indexing 
the reference sequence. BWA and Bowtie are the alignment programs that 
were employed during this project. They differ in their method of mapping. BWA 
aligns a read by counting the number of matches or mismatches between the 
read and the corresponding genome position. This is conducted by employing 
the Bayesian posterior probability to identify the genome position that is most 
likely to be the correct match. BWA included an additional algorithm that 
accommodates the mapping of a read with inexact matches to the reference 
genome position, thus allowing reads containing SNPs, deletions or repeats to 
be aligned. Bowtie and its successor Bowtie2, which can process reads longer 
than 50 nt, use a quality threshold (i.e. alignment score) to identify the correct 
genome position of the read. In general, BWA is the more stringent of the two 
programs, and therefore was employed throughout this project in cases where 
the reference genome was closely related to the sequenced sample. However, 
in cases where several SNPs were present, or in which duplications or deletions 
were anticipated, Bowtie2 was employed. Accurate mapping is essential in 
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downstream bioinformatic pipelines, including those involving transcriptomics, 
which was a principle area of investigation in the analyses described in this 
report.  
 
1.6.4 Transcriptomics 
 
The ability to quantify a complete set of transcripts promised to provide powerful 
insights into paramyxovirus gene expression. Gene expression analyses have 
been conducted previously using microarrays or quantitative PCR. However, 
HTS provides an alternative method for investigating viral transcription that is 
known as transcriptomics or RNA-seq analysis (Zhang et al., 2016; Wilhelm and 
Landry, 2009). This newer technology provides increased specificity and 
sensitivity and the ability to detect novel transcripts, gene fusions and gene 
variants, which previous technologies could not do (Zhao et al., 2014). 
However, to identify transcription products, the reads must be mapped to a 
reference sequence, and those that span splice junctions will fail to map 
(Trapnell et al., 2009). Bioinformatic tools are available for detecting reads that 
map across exon junctions, including alignment software such as TopHat. Such 
programs are less stringent in mapping reads to a reference genome, 
compared to BWT alignment tools, and thus allow the mapping of reads that 
can be matched to two genome positions. However, the reduction in stringency 
is a potential disadvantage to the accuracy of such analyses. As 
paramyxoviruses are not believed to use splicing to generate mRNAs, this 
analysis is not required for transcriptome analysis.   
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RNA-seq data can also be used to estimate the overall abundance of viral 
transcripts in order to investigate the kinetics of viral transcription. The data can 
also be employed to estimate the abundance of the individual viral mRNAs, 
which effectively allows the quantification of the paramyxovirus transcription 
gradient and provide an indication of the features of gene expression (Anders 
and Huber, 2010; Robinson et al., 2010). To analyse the abundance of viral 
mRNAs, the read counts need to be normalized in order to obtain accurate 
expression estimates across the genome. There are two features that must be 
normalized to allow comparisons between genes: gene size and the number of 
reads mapping to the gene. Firstly, longer genes will generate more reads than 
shorter genes. The transcripts that are generated are fragmented to a similar 
size during library preparation, and thus longer transcripts will produce more 
fragments than shorter transcripts. The fragments are then transcribed into 
cDNA from which the read data are generated, resulting in a greater number of 
reads produced by longer genes. Secondly, the cluster density of each sample 
causes fluctuations in the number of reads generated between samples. These 
are normalized using values known as FPKM or RPKM (Fragments or Reads 
Per Kilobase of transcript per Million mapped reads) (Mortazavi et al., 2008). 
The term mappable read or fragment can be used interchangeably, but the 
program used to obtained the values throughout the study used fragments, as 
FPKM. These values represent the relative mRNA abundances. Transcriptomic 
analysis is accurate when the mRNAs have relatively equal representation, 
which is usually approached by random priming or RNA ligation during library 
preparation. The library preparation methods utilized during this study used 
random priming. However, random priming does result in some coverage 
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fluctuation over the length of the genome, and this often due to variations in 
genome composition (Khrameeva and Gelfrand, 2012; Tilak et al., 2018).  
 
1.6.5 Detection of defective interfering genomes 
 
Total RNA sequencing allows the analysis of all aspects of the transcription and 
replication of negative strand viruses simultaneously, as previously discussed. 
These methods can also be used to analyse other viral RNA products, such as 
DIs. Some reads generated from a DI would contain a discontinuity or 
breakpoint corresponding to the location where the RNA polymerase jumped 
along the template (internal deletion DI) or switched to the nascent strand 
(copyback DI) (Fig 1.7). The use of software developed to identify reads that 
contain a breakpoint causing two regions of the read to map to two different 
genome positions. In this study, the ViReMa (Virus Recombination Mapper) 
program was used to identify internal deletion and copyback DIs.  
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Fig 1.7. A schematic of the generation of internal deletion and copyback DIs, 
indicating the genome positions to which the components map on the virus 
genome. The blue boxes represent the antigenome and the reference 
genome as indicated. RNA polymerase molecules are represented by the red 
circles, the solid grey lines indicate newly synthesized RNA genomes, and the 
dotted lines indicate where replication ceased and to which genome position 
the RNA polymerase jumped. The polymerase jumps along the antigenome in 
the generation of internal deletion DIs, these therefore contain the 3’ and 5’ 
end of the virus genome. During the generation of copyback DIs, the 
polymerase leaves the antigenome template and attaches to the nascent 
strand producing a breakpoint, with reads on either side mapping to different 
regions of the antigenome/genome.  The solid black (negative sense) and 
hatched boxes (positive sense) depict the two regions of the read generated 
from the DIs and where on the reference genome the reads would map.  
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1.7 Thesis Objectives 
 
The principal objective of this thesis is the analysis of the dynamics of 
paramyxovirus infection using HTS. This study developed a pipeline using 
directional analysis of HTS data to simultaneously analyse virus transcription 
and replication. This pipeline offers a unique opportunity to investigate the 
overall infection dynamics of paramyxoviruses and could be applied to the study 
of other negative sense RNA viruses.  
 
Additionally, the pipeline was employed to analyse a number of characteristics 
of paramyxovirus transcription including the generation of a transcription 
gradient, RNA editing and the production of read-through mRNAs showing the 
versatility and scope of the developed pipeline in transcriptome analysis.  
 
These developed methods of virus transcription and replication analysis were 
employed to investigate the kinetics of acute and persistent infections as well as 
possible mechanisms by which the paramyxoviruses can establish a persistent 
infection.  
 
 
 
 
 
 
 
 
	 65	
 
 
 
	Chapter	two	
Materials and Methods 
 
  
08 Fall	
	 66	
2.1 Infection and treatment of cells 
 
Cells were typically maintained in 25cm2 and 75cm2 tissue culture flasks 
(Greiner, U.K.) in DMEM (Dulbecco’s modified Eagles’s medium; Invitrogen, 
U.K.) supplemented with 10% (v/v) heat-inactivated FBS (foetal bovine serum, 
Biowest) and incubated at 37°C/5% CO2. Either A549 cells (ATCC CRL-1739) 
or human skin fibroblast (HSF) cells were used during this study. Cells were 
routinely trypsinised (Trypsin, EDTA; Becton Dickson Ltd., U.K.), and diluted 
every 4-7 days as appropriate. To stimulate IFN-responsive promoters cells 
were treated with media supplemented with 103 units/ml human IFNα (PBL 
Biomedical Labs) and incubated overnight. Monolayers of cells were washed 
with PBS prior to infection to remove traces of serum. Monolayers were infected 
with virus diluted in DMEM at an appropriate multiplicity (MOI). Virus stocks, for 
PIV5 strain W3, PIV5 strain CPI+, PIV2, MuV Enders strain and PIV3, were 
kindly maintained and provided as required by Mr. Dan Young (University of St 
Andrews, U.K.). The infected monolayers were placed on a rocker for 1-2 hr to 
allow adsorption of the virus after which the virus inoculum was removed and 
replaced with DMEM supplemented with 10% (v/v) heat-inactivated FBS and 
incubated at 37°C/5% CO2 until harvested.  
 
2.2 Extraction of RNA 
 
Cells were harvested by scraping. The cells were pelleted by centrifugation at 
4700 rpm for 5 mins. The supernatant was removed and discarded. The pellet 
was resuspended in 1 ml of Trizol. An equal volume of ethanol was added. The 
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RNA was extracted using the Direct-zol RNA miniprep kit (Zymo) as per 
manufacturers instruction. The sample was directly added to the Zymo-Spin IC 
column. The sample undergoes several cycles of centrifugation at 13000rpm for 
30 secs and washing and eluted in RNase free water.   
2.3 Library preparation and high-throughput sequencing 
 
Purification and Selection of RNA 
 
Two methods of library preparation were employed during this study, polyA 
selection and total RNA with nuclear and mitochondrial rRNA reduction. These 
methods have different purification/selection of RNA steps described below. 
Subsequent library preparation steps are identical.  
 
Poly-A selection 
The extracted RNA was directionally sequenced using TruSeq Stranded mRNA 
library Preparation Kit LS protocol (Illumina, U.K.) as per manufacturers 
instructions. Total RNA was diluted with nuclease-free water to 4µg in a final 
volume of 50µl. PolyA RNA was selected, adding 50µl oligo-dT magnetic beads 
to the total RNA and incubated at 65°C for 5 minutes to denature the RNA and 
5 minutes at room temperature to allow binding of the polyA RNA to the beads. 
The sample was then placed on a magnetic stand for 5 minutes selecting the 
polyA RNA bound beads. The supernatant was discarded. The beads were 
washed, adding 200µl of Bead Washing buffer. The sample was placed on a 
magnetic stand for 5 minutes after which the supernatant containing unbound 
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RNA was discarded (non mRNA). The polyA RNA bound beads were 
resuspended in 50µl of Elution buffer and incubated at 80°C for 2 minutes to 
elute mRNA from the beads. The mRNA was rebound to the beads, adding 50µl 
of Bead Binding Buffer and incubating at room temperature for 5 minutes, to 
increase specificity and reduce the amount of rRNA that non-specifically binds. 
The sample was placed on a magnetic stand for 5 minutes at room temperature 
after which the supernatant was removed and discarded. The beads were 
resuspended in 200µl of Bead Washing buffer and placed on a magnetic stand 
for 5 minutes. The supernatant, containing rRNA, was removed and discarded.  
 
Total RNA with rRNA reduction 
 
Total RNA was diluted with nuclease-free water up to 1µg in a final volume of 
10µl. To bind the rRNA, 5µl of rRNA binding buffer and RNA removal mix was 
added to the diluted RNA and incubate at 68°C for 5 mins following which 35µl 
rRNA removal beads were added and incubate at room temperature for 1 mins 
then place on magnet for a further 5 mins. The supernatant was transferred to a 
fresh tube. The RNA was purified by adding 99µl RNAClean XP Beads to the 
sample and incubating at room temperature for 15 mins. The supernatant was 
removed and the beads with bound RNA washed twice with 200µl of 70% 
ethanol. The bead bound RNA was resuspend in 11µl elution solution and 
incubated at room temperature for 1 mins and transferred to magnet for a 
further 5 mins. The supernatant containing the rRNA depleted RNA was 
transferred to a fresh tube.  
 
First Strand cDNA synthesis 
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The mRNA was eluted, fragmented and randomly primed, adding 19.5µl of 
Frag, Prime, Finish Mix which contains random hexamers for RT priming to the 
polyA RNA bound beads and incubated at 94°C for 8 minutes. The beads were 
placed on a magnetic stand for 5 minutes, after which the supernatant was 
transferred to a fresh tube. The fragmented RNA was then reverse transcribed 
using reverse transcriptase and random primers, the First Strand Synthesis Act 
D Mix and SuperScript II (Invitrogen, U.K.) was mixed at a ratio of 9:1µl, 8µl of 
which was added to the fragmented mRNA. Actinomycin D is included in the 
First Strand Synthesis Act D Mix to prevent spurious DNA-dependent synthesis 
but allows RNA-dependent synthesis improving strand specificity. The sample 
was incubated at 25°C for 10 minutes, 42°C for 15 minutes and 70°C for 15 
minutes.  
 
Synthesis of Second Strand cDNA 
 
The RNA template was removed and a second strand cDNA replacement 
strand generated, adding 20µl of Second Strand marking Master Mix to the 
sample and incubate at 16°C for 1 hour. Blunt ended dsDNA was generated 
incorporating dUTP in place of dTTP to quench the second strand during 
amplification as the polymerase cannot incorporate past this nucleotide.   
 
AMPure XP beads were used to separate the ds cDNA from the Second Strand 
Marking Master Mix. AMPure XP beads was added to the sample and 
incubated at room temperature for 15 minutes and then placed on a magnetic 
stand for 5 minutes. The supernatant was removed and discarded. The beads 
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were washed twice with 200µl of 80% ethanol and the supernatant was 
discarded. The beads were air dried at room temperature for 10 minutes. The 
beads were eluted in 17.5µl Resuspension Buffer, incubated at room 
temperature for 2 minutes and placed on the magnetic strand for 5 minutes. 
The supernatant containing the RNA was transferred to a fresh tube.  
 
Ligating Adapters 
 
An ‘A’ nucleotide was added to the 3’ end of the blunt cDNA fragments, adding 
12.5µl of A-Tailing Mix to the sample, to prevent them from ligating to one 
another during adapter ligation reaction and providing a complementary 
overhang to the ‘T’ nucleotide present on the 3’ end of the adapter for ligation. 
The sample was incubated at 37°C for 30 minutes and 70°C for 5 minutes. The 
Ligation mix, RNA Adapter Index and resuspension buffer were added at a 
volume of 2.5µl to the sample. The sample was then incubated at 30°C for 10 
mins after which 5µl of Stop Ligation Buffer was added. A further AMPure XP 
bead clean up was conducted as previously described, using 42µl of Ampure 
XP beads. The sample was resuspended in 52.5µl of resuspension buffer.  
 
An additional clean up step was conducted by adding 52.5µl of SPRI to the 
resuspended sample and incubated at room temperature for 5 mins and then 
placed on a magnetic stand for 5 mins. The supernatant was removed and 
discarded. The beads were washed twice using 200µl of 80% ethanol, incubate 
at room temperature for 30 seconds. The supernatant was discarded. The 
beads were allowed to air dry at room temperature for 10 minutes. The beads 
were resuspended in in 22.5µl Resuspension Buffer, incubated at room 
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temperature for 2 minutes and placed on the magnetic strand for 5 minutes. 
The supernatant containing the cDNA was transferred to a fresh tube.  
 
Enrich DNA Fragments 
 
The DNA fragments containing the adapter molecules on both end are 
selectively enriched by PCR. The PCR Primer Cocktail and PCR Master Mix are 
added at 5µl and 25µl respectively to the sample. The sample is incubated at 
98°C for 30 seconds (secs). The samples then undergo 15 cycles of 98°C for 
10 secs, 60°C for 30 secs and 72°C for 30 secs. The samples are then held at 
72°C for 5 mins. The number of PCR cycles is kept to a minimum to avoid 
skewing the library representation. This is followed by an Ampure XP clean up, 
as previously described, using 50µl of Ampure XP beads and resuspending in 
15µl of resuspension buffer.  
 
Validate Library 
 
Quality control and quantification of the DNA library must then be performed. To 
achieve high quality data optimal cluster densities must be reached which 
requires accurate quantification conducted using the dsDNA HS Assay Kit with 
the Qubit Fluorometer as per manufacturers instructions. The Qubit buffer 
containing, 198µl of Qubit dsDNA HS Buffer and 1µl of Qubit dsDNA HS 
Reagent per sample, is prepared. To individual assay tubes 199µl of the Qubit 
buffer solution and 1µl of each sample is mixed thoroughly by vortexing for 2-3 
secs (for the standards add 190µl of Qubit buffer to 10µl of standard 1 and 
standard 2). The samples were then incubate at room temperature for 2 mins. 
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The standards were firstly read by the fluorometer (Thermo Fischer Scientific 
UK) to provide accurate markers for the sample quantification. The individual 
dsDNA library samples were then quantified.  
 
The quality of the samples was analysed using the Agilent Technologies 2100 
Bioanalyzer using a DNA-specific chips Agilent DNA 1000 or 5000. Loading 1µl 
of buffer to 1µl of sample. The size and purity of the library can be observed. A 
pure library should display a single peak representing a fragment size of 
approximately 260bp.  
 
Normalize and Pool Libraries 
 
The individual dsDNA library samples are normalized to 10 nM and pooled in 
equal volumes to prepare them for cluster generation (see section Introduction 
1.6.1 for description of cluster generation during Illumina sequencing). The 
samples were then run on the MiSeq or Next-Seq platforms (Illumina).  
 
 
2.4 Bioinformatic Analysis 
 
The sequencing data was demultiplexed. The reads were trimmed to remove 
adapter sequences and filtered to remove low quality reads using trim_galore 
software. The read quality was ensured to have a quality (Q score) of 30, 1 
nucleotide sequencing error in 1000, using fastqc analysis.  
 
	 73	
2.4.1 Bioinformatic analysis of virus transcription and replication 
 
A bioinformatic pipeline was developed for the analysis of virus transcription 
and replication. The reads contained in the R1 and R2 files generated from the 
HTS described above were independently mapped to a reference genome 
using BWA alignment software. The reference genomes for PIV5 strain W3, 
PIV5 strain CPI+, PIV2 and MuV are available from GenBank, accession 
numbers are JQ743318.1, JQ743321.1, NC_003443.1 and GU980052.1. A 
consensus sequence was constructed for PIV3 and used as a reference 
genome as the available PIV3 reference genomes did not provide sufficient 
read coverage across all of the genome of the strain used due to the presence 
of several mutations. The aligned reads were split based on directionality using 
the flag field of the sam file that indicates read orientation. The viral 
mRNA/antigenome reads from the R1 and R2 files were concatenated, 
producing a file that contained reads generated exclusively from viral 
mRNAs/antigenomes. A similar process was carried out for viral genome reads. 
The viral genome and mRNA/antigenome reads were then mapped separately 
to the respective reference sequence using BWA software. The number of viral 
mRNA/antigenome and viral reads was ascertained from these alignments. The 
alignments were visualized using Tablet (Milne et al., 2013). The viral mRNA 
and antigenome reads are of the same orientation and therefore cannot be 
separated by directional analysis. The contribution of antigenomes to the viral 
mRNA cannot be more than the average coverage of reads of the L mRNA. The 
contribution of antigenome reads to the transcription gradient was not 
significant and therefore would not interfere with downstream bioinformatic 
analysis. As the antigenome reads did not significantly contribute to the positive 
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sense reads, these were referred to as only viral mRNA reads in subsequent 
analysis. The remaining nuclear and mitochondrial ribosomal RNA (rRNA) 
reads were removed from the total cellular reads by aligning the reads 
contained in the R1 and R2 files to reference genomes for 18S, 28S, 5S, 5.8S 
and mitochondrial rRNA (Accession numbers NR_003286.2, NR_003287, 
X51545, J01866, NC_012920). The unaligned reads were quantified and 
referred to as total cellular reads in downstream analysis. To calculate the 
abundance of viral mRNAs and genomes the number of viral mRNAs and 
genome reads was compared to the total cellular reads.  
 
2.4.2 Analysis of virus transcription 
 
The abundances of viral mRNAs was calculated using FPKM values obtained 
by RSEM software (Li and Dewey 2011). The coordinates of the genes required 
for the program was provided by manually creating gtf files. This method cannot 
distinguish between the transcripts generated via RNA editing and the insertion 
of G residues at the RNA editing site. To ascertain the ratio of G inserts the 
reads overlapping the RNA editing site were identified using a 10 nt search 
string upstream and downstream of the RNA editing site. The number of reads 
overlapping the RNA editing site containing 1-12 G insertions were quantified 
and compared to the total number of reads overlapping the RNA editing site.  
 
To quantify the number of reads that cross the Ig sub alignments were 
extracted from the previously described viral mRNA alignment generated using 
BWA software. The average coverage of the genes was ascertained by aligning 
reads to the viral genes using BWA software that was subsequently visualized 
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in Tablet, from which the average coverage of the genes could be determined. 
The generation of read-through mRNAs was calculated by quantifying the 
number of reads that cross the Ig and comparing this to the average coverage 
of the gene immediately upstream.  
 
The antigenome reads were identified by quantifying the reads that crossing the 
Le region into the NP gene. A sub-alignment was extracted from genome 
positions 44-54 nts from the genome and mRNA/antigenome read BWA 
alignments. The sum of the reads present at these positions was quantified and 
the ratio of genome and antigenomes reads was determined. 
 
2.4.3 Establishing the presence of defective interfering genomes 
 
The presence of DIs was established using ViReMa (Virus Recombination 
Mapper) software (Routh and Johnson 2013). The software was run on the R1 
and R2 files separately. ViReMa detects recombination events by identifying 
reads with a breakpoint, therefore, the read would map to two different areas of 
the genome. The identification of reads containing different breakpoints allowed 
the identification and quantification of different DI populations.  
 
2.5 Immunofluorescence 
 
Cells were grown in monolayers on 10mm coverslips. The cells were fixed in 
5% formaldehyde, 2% sucrose in PBS for 10 mins, before permeabilisation with 
0.5% NP-40, 10% sucrose in PBS. The cells underwent repeated washes with 
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1% FBS in PBS. The cells were incubated with the appropriate diluted primary 
antibody for 1 h. The cells underwent repeated washes again, following which 
the cells ere incubated for 1 h with a secondary antibody of Texas Red or FITC 
conjugated secondary antibody (Oxford Biotechnology Ltd., U.K.) with the DNA-
binding flurochrome 4’, 6-diamidino-2-phenylindole (DAPI; 0.5µg/ml; Sigma-
Aldrich Ltd., U.K.). All reactions were conducted at room temperature in a 
humidified chamber. The coverslips were washed in PBS and mounted on 
slides using Citifluor AF-1 mounting solution (Citifluor Ltd., U.K.). 
Immunofluorescence was visualised using a Nikon Microphot-FXA microscope.  
 
2.6 35S-methionine labelling of proteins 
Cells were grown in 25cm2 flasks and infected with the appropriate virus at an 
MOI of 10. The cells were metabolically labelled at specified times for 1 h on a 
rocking platform with 35S-methionine (25µCi/25cm2 flask; Amersham 
International Ltd., U.K.). The cells were washed in PBS, following which 
disruption buffer was added to the cells which were then sonicated and heated 
to 100° for 3 mins. The polypeptides present in total cell extracts were 
separated by SDS-PAGE through a 4-12% polyacrylamide gel, and the labeled 
polypeptides were visualized using a phosphoimager 
 
2.7 Immunoblots of proteins 
Cells were grown in 25cm2 flasks and infected with the appropriate virus at an 
MOI of 10. The cells were washed in PBS, following which disruption buffer was 
added to the cells which were then sonicated and heated to 100° for 3 mins. 
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The polypeptides present in total cell extracts were separated by SDS-PAGE 
through a 4-12% polyacrylamide gel. The proteins were transferred to PVDF 
(polyvinylidene difluoride) membrane, which had been activated with methanol 
for 1 min. The membrane was blocked for 1hr at room temperature in blocking 
buffer. The membrane underwent several washes using washing buffer. The 
membrane was incubated with the appropriate diluted primary antibody for 1 h. 
The membrane underwent repeated washes again, following which the 
membrane was incubated for 1 h with an appropriate secondary antibody (Li-
Cor). The antibody-bound proteins were then visualised using Odyssey Clx 
imager (Li-Cor).  
 
2.8 Nucleocapsid Purification  
Cells were grown in 300cm2 flasks and infected with the appropriate virus at an 
MOI of 10. Infected cells were harvested and washed with PBS. The cells were 
then scrapped into 10 mls of PBS and pelleted at 700 rpm for 10 min. The pellet 
was resuspended in ice-cold lysis buffer (150 mM NaCl, 50 mM Tris-HCl, 0.6% 
NP-40), incubated on ice for 5 mins and centrifuged at 4,200 rpm for 5 min at 
4°C. The supernatant was transferred to a fresh tube and incubated on ice. 
EDTA was added at a concentration of 6 mM. Linear 25 to 35% cesium chloride 
gradients were prepared. The lysed cells were overlaid on the gradients which 
were centrifuged overnight at 175,000 rpm at 12°C. Nucleocapsid bands were 
harvested and the RNA extracted using TRIzol (Invitrogen) according to the 
manufacturer’s instructions.  
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Previous research has demonstrated that paramyxoviruses control viral gene 
expression by stop-start transcription and the generation of a transcription 
gradient, with genes located at the 3’ end of the viral genome producing the 
most abundant mRNAs and genes positioned at the 5’ end producing the least 
abundant mRNAs. PIV5 strain W3 transcription was investigated using HTS to 
analyse the generation of viral mRNAs and the transcription gradient. Using this 
analysis, a bioinformatic pipeline was established that could be employed to 
analyse the transcriptome of additional paramyxoviruses as well as other 
negative strand RNA viruses.  
 
3.0 Pipeline for analysing virus transcription 
 
Human skin fibroblast (HSF) cells were infected with PIV5 strain W3 at an MOI 
of 50 pfu/cell. RNA was extracted at 18 hours post-infection (h p.i.). The 
extracted RNA was subjected to library preparation using TruSeq stranded 
mRNA library preparation kit (Illumina) which isolates mRNAs by polyA 
selection using oligo(dT) beads. This library preparation method generates 
directional sequencing data, which retain information on the strand orientation 
of the selected RNA. Paramyxoviruses have single-stranded, negative sense 
RNA genomes, from which positive sense viral mRNAs and antigenomes are 
transcribed or replicated. Directional sequencing allows the reads generated by 
HTS to be separated based on their directionality, thus allowing the origin of the 
read from viral genomes (-ssRNA) or viral mRNAs (+ssRNA) and antigenomes 
(+ssRNA) to be established. The reads generated from viral mRNAs and 
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antigenomes cannot be distinguished from each other, as these are of the same 
positive sense orientation. Directional analysis of the sequencing data is only 
required if the orientation of the reads must be determined for downstream 
bioinformatic analysis. As polyA selection should have only selected mRNAs, 
the orientation of the reads would not have to be determined in this experiment, 
and consequently the data were not initially subjected to directional analysis.  
 
Sequencing was conducted on a MiSeq (illumina) platform using two primers, 
an antisense (forward) primer and a sense (reverse) primer, from which two 
files (R1 and R2, respectively) were produced (see Introduction section 1.6). 
These files were concatenated and contained 6,523,498 reads. The reads 
present in the R1 and R2 files were generated from all of the mRNAs present in 
the cell at the time of RNA extraction, including both host and viral mRNAs; 
these are referred to as total cellular reads.  The total cellular reads were 
mapped to the PIV5 strain W3 reference sequence (Accession number 
JQ743318.1) by alignment using the BWA software, and the alignment was 
visualised using the Tablet software.  A screen shot of the alignment visualized 
in Tablet is provided in Fig 3.1. 
 
The reads that map to the PIV5 strain W3 reference genome are of viral origin 
and account for 4.7% of the total cellular reads. A greater number of aligned 
reads mapped to genes transcribed from the 3’-end of the genome, NP and 
V/P, acquire a greater number of aligned reads, suggesting a greater 
abundance of the mRNAs from these genes. However, genes downstream of M 
display an approximately equal coverage of reads, implying that a similar 
abundance of mRNAs was generated. This flat transcription gradient for genes 
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downstream of M does not correlate with the previously reported decreasing 
gradient from the 3’ to the 5’ end of the genome.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
One possible explanation for this finding is the presence of contaminating viral 
reads that were generated from the viral genome. It is possible that during RNA 
extraction and polyA selection, viral mRNAs hybridised to complementary viral 
genomes. Thus, the subsequent analysis of viral mRNAs would incorporate 
reads from hybridised viral genomes. Reads that are of viral genome origin 
would also align to the reference genome, thereby increasing the read coverage 
at that genome position, interfering with the analysis of the abundances of viral 
mRNAs, and distorting the transcription profile of PIV5 strain W3.  
       NP V/P M F HN L 
Fig 3.1. BWA alignment of the PIV5 strain W3 transcriptome in HSF cells at 
18 h p.i. visualized in Tablet, using the reads from the concatenated R1 and 
R2 files. The RNA was subjected to polyA selection prior to library 
preparation followed by sequencing using the MiSeq platform (Illumina). 
Coloured boxes indicate approximate gene positions and contain the names 
of the genes. The individual coloured vertical bars represent the coverage 
(number of reads) aligned to each nucleotide of the reference sequence. 
Each nucleotide is represented by a different colour, G is red, A is green, T is 
blue and C is yellow. The overall coverage of a gene indicates the 
abundance of viral mRNA produced from that gene. The black arrow 
indicates the boundary between the M and F genes. 
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To investigate whether viral genome sequences were present in the polyA 
selected RNA samples, directional analysis was conducted to distinguish reads 
originating from viral genomes from those originating from viral 
mRNAs/antigenomes. The use of the antisense and sense primers to generate 
the R1 and R2 files allows the orientation of the RNA molecule from which each 
read originated to be determined. Splitting the reads based on directionality 
separates the reads generated from viral genomes from those generated from 
viral mRNAs/antigenomes. The R1 and R2 files were individually mapped to the 
PIV5 strain W3 reference sequence by alignment using the BWA software. The 
aligned reads were then split based on directionality (as summarised in Fig 
3.2A), using the flag field of the SAM alignment file that indicates read 
orientation. The viral mRNA/antigenome reads from the R1 and R2 files were 
concatenated, producing a file that contained reads generated exclusively from 
viral mRNAs/antigenomes. A similar process was carried out for viral genome 
reads. A schematic of the bioinformatic process, which separates the reads 
based on directionality, is provided in Fig 3.2B. The viral genome and 
mRNA/antigenome reads were then mapped separately to the PIV5 strain W3 
reference sequence by alignment using the BWA software, and visualised in 
Tablet. A screen shot of the alignments are provided in Fig 3.3.  
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Fig 3.2. Schematics depicting the sorting of reads into those originating from 
viral genomes and those originating from viral mRNA/antigenomes. (A) The 
directionality of reads relative to the negative sense viral genome (grey 
rectangles) and positive sense viral mRNA and antigenome (blue 
rectangles) generated during library prep and subsequent sequencing. The 
arrows showing the 5’ to 3’ direction in the centre of the rectangles indicate 
read orientation. The directionality of the adapters used during sequencing 
to generate the R1 (forward primer) and R2 (reverse primer) files are shown 
at the ends of the rectangles, with the 3’ primer represented by a solid grey 
rectangle and the 5’ primer by a hatched rectangle. (B) Directional splitting 
of the forward and reverse reads from the R1 and R2 files. The viral 
mRNA/antigenome reads were concatenated into a single file, and similarly 
the viral genome reads. 
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The alignment produced using directional analysis of the viral genome reads 
(Fig 3.3B) revealed that approximately 2.5% of total cellular reads aligned to the 
PIV5 strain W3 reference sequence. This indicates the presence of a significant 
amount of viral genomes present in the sample. The viral mRNA/antigenome 
reads were 2.2% of total cellular reads. The alignment of viral 
mRNA/antigenome reads (Fig 3.3C) reveals a decreasing transcription gradient, 
with the greater coverage of reads aligning to the genes at the 3’ end of the 
genome (NP and V/P) and a lesser coverage of reads mapping to the L gene at 
Fig 3.3. BWA alignments of the PIV5 strain W3 transcriptome in HFS cells at 
18 h p.i. visualised in Tablet, using reads sorted directionally. The individual 
coloured vertical bars represent the coverage (number of reads) aligned to 
each nucleotide of the reference sequence. Each nucleotide is represented 
by a different colour, G is red, A is green, T is blue and C is yellow. The 
percentage of reads present in the alignments compared to total cellular 
reads is provided. Coloured boxes indicate approximate gene positions and 
contain the names of the genes. (A) Aligned reads from the concatenated R1 
and R2 files (non-directional analysis). (B) Viral genome reads generated 
from directional splitting of the R1 and R2 files (directional analysis). (C) Viral 
mRNA/antigenome reads generated from directional splitting of the R1 and 
R2 files (directional analysis).  
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the 5’ end. The data confirm that a significant number of viral genomes had co-
purified with the viral mRNAs during library preparation, despite the use of poly 
A selection. This was most likely due to hybridisation of viral genomic RNA to 
viral mRNAs during RNA extraction and polyA selection, as previously 
discussed.  
 
Although directional analysis demonstrated the presence of viral genomes and 
permitted it to be quantified, it did not establish the potential presence of viral 
antigenome, as this has the same polarity as viral mRNAs. If a proportion of the 
mRNAs selected by oligo(dT) beads had hybridised to viral genomes, it is 
possible that subsequently the viral  genomes had hybridised to antigenomes. If 
a significant proportion of reads were of antigenome origin, this could have 
compromised the accuracy of the PIV5 strain W3 transcription analysis. The 
antigenome is a full length complementary copy of the genome, and therefore 
should be present at a relatively constant coverage level in an alignment of the 
mRNA/antigenome reads against the PIV5 strain W3 reference sequence. The 
coverage of the antigenome can be estimated from the coverage of reads in the 
Le region, which should not contain any mRNA reads as it is located outwith the 
gene boundaries. Some models for paramyxovirus transcription suggest that 
the Le region produces a short transcript. However, due to fragment size 
selection during library preparation and the length of reads generated from 
sequencing (in this analysis, read length was approximately 300 nt), these short 
transcripts would not have been represented in the data. Additionally, the reads 
originating in the Le region cross the NP gene boundary, ensuring that they are 
of antigenome origin. The Tr region could not be used to estimate the 
antigenome reads, as coverage is reduced at the 5’ end of the genome due to 
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the requirement for random priming and a minimum fragment size during library 
preparation and sequencing. Therefore, the average coverage of 10 nt at the 5’ 
end of Le (positions 45-54) was calculated, in order to reduce this effect. The 
average coverage at positions 45-54 was calculated as 15.6 reads. A 
rearranged Lander/Waterman equation (Lander and Waterman 1988) [coverage 
= (length of read x number of reads)/length of genome] was used to estimate 
the number of reads attributed to viral antigenome throughout the full length of 
the alignment. The average length of a read was extracted from the alignment 
and calculated as 300 nt, and the length of the PIV5 strain W3 single-stranded 
genome is 15246 nt. Therefore, the number of reads attributed to the 
antigenome was 792.8, which comprises 0.01% of the total cellular reads. 
Furthermore, the coverage of antigenome reads cannot have exceeded that of 
the L gene (Fig 3.3C) extended over the whole genome, calculated as 3794 
read contributing 0.06% of total cellular reads.  In conclusion, it is unlikely that 
these low numbers of antigenome reads would have compromised the 
transcriptome analysis.  
 
These results demonstrate that directional analysis is essential for accurate 
paramyxovirus transcriptome research using HTS data, and led to the 
establishment of a general bioinformatic pipeline for analysing negative strand 
virus transcription and gene expression analysis. After removing viral genome 
reads from the PIV5 strain W3 transcription profile and showing that 
antigenomes make a negligible contribution to viral mRNA/antigenome reads, a 
decreasing gradient of mRNAs from the 3’ end of the genome was revealed 
(Fig 3.3C).  
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3.1.1 Optimisation of library preparation  
 
Although viral genome sequences were shown to be present in the above 
analysis, the method used to select mRNAs was not appropriate for quantifying 
viral genomes. As an alternative, it would be possible to use the TruSeq 
stranded total RNA with Ribo-Zero human/mouse/rat library preparation kit 
(Illumina), which depletes cytoplasmic-coded ribosomal RNA (rRNA), rather 
than polyA selection. This method could be used together with directional 
sequencing to quantify both viral mRNAs and viral genomes. Furthermore, this 
procedure could be used to detect the presence of defective interfering viral 
genomes, which are discussed in chapter 6. The ability to analyse viral 
transcription and replication from the same data offers a unique opportunity to 
achieve a complete overview of the dynamics of viral infection.  
 
To determine whether rRNA depletion of total RNA preparations could be used 
for the accurate analysis of viral mRNAs, which can be at low levels in the cell, 
a study was conducted to compare two library preparation kits: the TruSeq 
stranded mRNA Library preparation kit (involving polyA selection, as previously 
described) and the TruSeq stranded total RNA library preparation kit (involving 
rRNA depletion). Library preparation was conducted on the same samples to 
exclude sampling bias. RNA was extracted from A549 cells infected with PIV5 
strain W3 at an MOI of 10 pfu/cell at 6, 12 and 18 h p.i. Following sequencing, 
the data were directionally analysed as previously described. Furthermore, 
since the selection or depletion of target RNA is not completely efficient during 
library preparation, any remaining rRNA reads were removed from the total 
cellular reads by alignment using the BWA software, for improved accuracy 
when calculating the abundances of viral RNAs. Additionally, the percentage of 
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mitochondrial rRNA reads present in each sample was also calculated, and 
these were removed from the total cellular reads. Table 3.1 shows the 
percentages of cytoplasmic and mitochondrial rRNA reads compared to total 
cellular reads, and the percentages of viral mRNA reads before and after 
removal of cytoplasmic and mitochondrial rRNA reads. These results indicate 
that the cytoplasmic and mitochondrial rRNA reads can have a significant effect 
of the quantification of viral mRNA abundance. The samples subjected to polyA 
selection showed significant proportions of cytoplasmic and mitochondrial rRNA 
reads (up to 3.04 and 8.5%, respectively). The rRNA depleted samples also 
showed significant proportions of cytoplasmic and mitochondrial rRNA reads 
(up to 1.88 and 13.2%, respectively). The impact on the accurate quantification 
of the abundance of viral mRNAs due to the presence of cytoplasmic and 
mitochondrial rRNA reads can be seen especially for the samples isolated at 12 
and 18 h p.i. After removal of cytoplasmic and mitochondrial rRNA reads, the 
apparent abundance of viral mRNAs increased as much as 1%. The abundance 
of mitochondrial RNA reads is particularly apparent in the rRNA reduction 
approach, and indicates that a method that reduces both cytoplasmic and 
mitochondrial rRNA would be more effective. 
 
When cytoplasmic and mitochondrial rRNA reads were eliminated from the 
analysis, the abundance of viral mRNAs compared to total cellular RNA reads 
(with the cytoplasmic and mitochondrial rRNA reads removed) was calculated 
for each library preparation method (Fig 3.4A). To ensure that the coverage of 
reads when aligned to the PIV5 strain W3 reference genome was sufficient, 
which is critical for downstream analysis, the viral mRNA reads were aligned to 
the reference genome (Fig 3.4B). There was very little difference between the 
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library preparation methods in the relative abundance of viral mRNAs (Fig 
3.4A), although rRNA depletion generated slightly less viral mRNA at each time 
point, compared to polyA selection. However, this decrease is not sufficient 
enough to compromise analysis of the abundance of viral mRNAs, as can be 
seen in Fig 3.4B. Alignments of viral mRNA reads to the reference PIV5 strain 
W3 genome showed little difference between the methods. For example, the 
mRNA profile at 6 h p.i. for polyA selected RNA is essentially indistinguishable 
from that for rRNA depleted RNA (Fig 4B).  
 
Table 3.1. Percentages of viral mRNA reads compared to total cellular reads 
before and after cytoplasmic and mitochondrial rRNA reads were removed from 
total cellular reads from the data obtained using polyA selection or rRNA 
depletion library preparation methods.  
 
  
Viral reads before 
removal of 
cytoplasmic and 
mitochondrial 
rRNA reads 
 
Percentage of cytoplasmic and 
mitochondrial rRNA reads compared 
to total cellular reads 
 
Viral reads after 
removal of 
cytoplasmic and 
mitochondrial rRNA 
reads 
 
  
Viral mRNA reads 
 
Cytoplasmic rRNA 
 
Mitochondrial 
rRNA  
Viral mRNA reads 
h p.i. 
 
PolyA 
selection 
rRNA 
depletion  
PolyA 
selection 
rRNA 
depletion  
PolyA 
selection 
rRNA 
depletion  
PolyA 
selection 
rRNA 
depletion 
6 
 
1.46 1.02 
 
1.62 0.36 
 
8.5 3.8 
 
1.62 1.07 
12 
 
8.27 7.22 
 
1.55 0.23 
 
6.1 11.8 
 
8.96 8.21 
18 
 
5.35 4.78 
 
3.04 1.88 
 
7.3 13.2 
 
5.97 5.63 
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Fig 3.4. A comparison of the abundance of viral mRNAs using polyA 
selection or total RNA with rRNA reduction library preparation methods. (A) 
Abundance of PIV5 strain W3 mRNA compared to total cellular reads as 
obtained using polyA selection or rRNA reduction. RNA was extracted from 
infected A549 cells at 6, 12 and 18 h p.i. and subjected to library preparation 
and subsequent sequencing and directional analysis. (B) Screen shots of 
BWA alignments for data obtained at 6 h p.i. visualised in Tablet.  
 
	 91	
The advantage of using rRNA reduction rather than polyA selection is that it 
facilitates the quantification of the abundance of virus genome reads (Fig 3.5). 
The abundance of viral genome reads gradually increased between 6 and 18 h 
p.i. from 0.09 to 1.42% of total cellular reads. Additionally, the proportion of 
antigenomes was estimated by counting the coverage of reads at positions 45-
54 and using the Lander-Waterman equation as previously described. The 
proportion of antigenomes present at 6, 12 and 18 h p.i. was estimated as 0.07, 
0.21 and 0.16%, respectively, of total cellular reads. Antigenome read coverage 
accounted for a very low proportion of total cellular reads, and, in any case, 
could not exceed mRNA/antigenome coverage of the L gene, and therefore did 
not significantly affect the observed transcription gradient (Fig 3.4B). 
Consequently, the numbers of mRNA/antigenome reads calculated in later 
experiments are referred to solely as mRNA reads. 
 
In conclusion, using rRNA reduction instead of polyA selection offers a powerful 
opportunity to analyse viral transcription and replication in parallel during 
infection.  
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3.1.2 Optimised pipeline for analysing transcription and replication 
 
The analysis above used the TruSeq Stranded Total RNA Ribo-zero 
human/mouse/rat library preparation kit, which depletes human/mouse/rat 
cytoplasmic rRNA. However, as shown in Table 3.1, a significant proportion of 
total cellular reads were of mitochondrial rRNA origin, which could impact the 
accuracy of the analysis. Therefore, all subsequent experiments were 
conducted using the TruSeq Stranded Total RNA Ribo-Zero Gold library 
preparation kit, which also depletes mitochondrial rRNA. In addition, following 
library preparation, samples were sequenced using the Illumina NextSeq 
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Fig 3.5. Abundance of viral genome reads compared to total cellular reads 
after remaining cytoplasmic and mitochondrial rRNA reads had been 
removed. The data were directionally analysed using the bioinformatic 
pipeline established previously. 
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platform, which generates more reads (up to 260 million) per run. Following 
sequencing, the most essential step for accurate analysis of viral transcription 
and replication was directional analysis using the estabished bioinformatic 
pipeline, which allows reads derived from mRNA to be separated from those 
generated from genomic RNA.  
 
3.1.3 Establishing the presence of defective interfering genomes 
 
The repression of viral RNA synthesis and the subsequent establishment of 
persistent infections by paramyxoviruses, as well as the induction of IFN, has 
been associated with the generation of copyback DIs (see Introduction section 
1.5). To determine whether the established workflow described above using 
total RNA with rRNA reduction could be employed to reliably detect the 
presence of DIs in RNA extracted from infected cells without the need for 
nucleocapsid purification, a comparative study was conducted. A549 cells were 
infected with a DI rich virus stock of PIV5 strain VΔC, at an MOI of 10 pfu/cell. 
At 24h p.i. either total cellular RNA was extracted by Trizol,  or viral 
nucleocapsids were first purified on a CsCl gradient prior to RNA extraction. 
The extracted RNA was subjected to cytoplasmic and mitochondrial rRNA 
reduction library preparation followed by sequencing. The data was then 
subjected to analysis by ViReMa (Virus Recombination Mapper) software that 
identifies recombination events also known as breakpoints where the RNA 
polymerase during virus replication has jumped along the template to produce 
an internal deletion DI or alternatively switched to the nascent strand to 
generate a copyback DI. Reads generated from these DIs would contain two 
regions that map to different positions of the genome. ViReMa identifies reads 
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that contain breakpoints, thereby identifying internal deletions and copyback DIs 
(see Introduction Figure 1.7 for information regarding the generation of 
copyback and internal deletion DIs). The software identifies the position of the 
recombination event and quantifies the number of reads containing the 
recombination. This allows the identification and quantification of distinct DI 
populations. There were no significant internal DIs identified from the 
nucleocapsid purified or not nucleocapsid purified samples. Several populations 
of copyback DIs were identified (Table 3.2).  
 
Table 3.2. The identification of distinct copyback DIs populations, the genome 
and antigenome position of the breakpoint, the number of reads which are 
generated from the DIs and the proportions of the populations 
 
There was no significant difference between the results obtained from total RNA 
extracted from infected cells and RNA isolated from purified nucleocapsids. 
ViReMa identified 4 identical DIs populations present in both samples (Table 
3.2). Furthermore, the proportion of DIs to genomes in the two samples was 
nearly identical. Two of the four identified DI, with junctions at positions 14827-
15157 and 14873-15153, matched within +/- 4 nts those determined by Killip et 
al (2013), who used a similar, but not identical, preparation of PIV5 strain VΔC 
to identify DI populations. These results demonstrate that ViReMa software can 
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be employed to determine the presence of DIs in samples that have not 
undergone nucleocapsid purification and can therefore be utilized on HTS data 
generated using the pipeline for the analysis of virus transcription and 
replication described above.   
3.2 Analysis of Parainfluenza Virus 5 replication and transcription 
 
The bioinformatic pipeline established above was used to investigate PIV5 
strain W3 transcription and replication during the course of infection. A549 cells 
were infected with PIV5 strain W3 at an MOI of 10 pfu/cell, and total cellular 
RNA was extracted at 0, 6, 12, 18 and 24 h p.i. The RNA was subjected to 
cytoplasmic and mitochondrial rRNA reduction, and libraries were made and 
sequenced. The data were then directionally analysed as previously described. 
As the efficiency of cytoplasmic and mitochondrial rRNA depletion during library 
preparation can vary between samples, the remaining reads generated from 
cytoplasmic and mitochondrial rRNA were removed from the total cellular reads. 
To estimate the relative abundance of viral genomes and viral mRNAs in 
infected cells, the numbers of relevant reads, obtained from aligning the reads 
to the PIV5 strain W3 reference genome using the BWA software, were 
compared to the numbers of total cellular reads (Fig 3.6). This was conducted in 
triplicate, from which the standard deviation was calculated and depicted as 
error bars. A Table of the number of total cellular, viral genome and viral mRNA 
reads at each time point is provided in Appendix I. 
 
There was an initial surge of transcriptional activity during the initial stages of 
infection, as the rate of transcript production between 6 and 12 h p.i. increased 
	 96	
nine-fold (Fig. 3.6). This activity peaked between 12 and 18 h p.i. at 4.59 and 
4.34% of total cellular reads, respectively, after which the abundance of viral 
mRNAs decreased to 2.31%. As this analysis reports the overall abundance of 
transcripts and not the active rate of mRNA production, it is likely that the rate of 
viral transcription decreases after 12 h p.i.  
 
The abundance of viral genome reads gradually increased between 6 and 24 h 
p.i. from 0.03 to 1.82%, suggesting a gradual increase in the rate of viral 
genome production over the initial 24 h of infection. At the earlier time point of 6 
h, the abundance of viral genome reads had increased from the input virus at 0 
h p.i. suggesting a low rate of new viral genome production. The generation of 
new viral genomes would require the prior production of antigenomes and viral 
protein NP for encapsidation. A more detailed investigation of viral replication 
during the initial stages of infection is presented in section 3.2.2.  
 
These results demonstrate that, during the first 18 h of infection, transcription is 
the principal viral process, with an initial surge in activity between 6 and 12 h 
p.i. This correlates with the widely accepted model of paramyxovirus infection, 
in which the virus commences transcription immediately upon entering the cell. 
By 24 h p.i., the abundance of viral genome production is comparable to that of 
mRNAs, suggesting a change in virus RNA polymerase activity in which 
transcription is no longer the primary process and the RNA polymerase has 
been in a replicative mode. To gain further insight into how the virus controls 
the switch between transcription and replication, the abundance of individual 
viral mRNAs was analysed, in order to identify changes in viral transcription 
	 97	
(indicating protein expression) that might play a role. All bioinformatic analyses 
were conducted using the data set described above.  
 
 
 
 
 
 
 
 
3.2.1 Analysis of viral transcription 
 
The abundance of viral mRNAs was investigated in order to identify changes 
that might account for the switch in viral transcription and replication during 
PIV5 strain W3 infection. This was done by analysing the abundance of viral 
mRNAs using FPKM values (fragments per kilobase of transcript per million 
mapped reads). FPKM values normalise the abundance of transcripts 
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Fig 3.6. Abundance of PIV5 strain W3 viral genome and mRNA reads at 0, 
6, 12, 18 and 24 h p.i. compared to the number of total cellular reads after 
removal of cytoplasmic and mitochondrial rRNA reads. The data were 
directionally analysed using the established bioinformatic pipeline. The bars 
show standard deviation values based on three independent experiments. 
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generated from individual genes to account for differences in gene length, thus 
allowing the transcription of different genes to be compared (see Introduction 
section 1.6). The abundances of viral mRNAs were calculated using RSEM 
software (Fig 3.7).  
 
 
 
 
 
 
 
While the earlier time points of 6, 12 and 18 h p.i. exhibited little difference in 
the abundance of viral mRNA transcripts, all displayed a transcriptional gradient 
Fig 3.7. Transcription of PIV5 strain W3 genes at 6, 12, 18 and 24 h pi.. The 
data were directionally analysed using the established bioinformatic pipeline. 
The FPKM values on the y-axes were obtained using the RSEM software. 
The bars show standard deviation values based on three independent 
experiments.  
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with higher abundance of mRNA from genes at the 3’ end compared to the 5’ 
end of the genome. There was a plateauing of the abundance of viral V/P, M, F, 
SH and HN mRNAs at 24h p.i. However, this could be due to the stability of 
transcripts rather than changes in virus gene expression. This suggests that 
there are no differences in virus gene expression that could account for the 
switch between transcription and replication.  
 
RNA editing and generation of the V, I and P mRNAs 
 
The V and P mRNA transcripts, which are generated differentially via RNA 
editing in a tract of 4 G residues at position 2340 in the PIV5 strain W3 genome, 
cannot be distinguished using the method describe above. The abundance of 
these transcripts was estimated by identifying reads that overlap the RNA 
editing site. The reads were identified in the R1 and R2 data files by using a 10 
nt search string upstream and downstream of the editing site, upstream string 
3’-TTAAGAGGG-5’ and downstream string 3’-GCAGGGATC-5’, and reads 
containing up to 7 additional G residues were counted. Their abundance was 
expressed as a mean percentage of the total number of reads overlapping the 
RNA editing site in three replicate experiments (Table 3.3). To estimate the 
abundance of the V and P transcripts, reads containing 0 and 0+3 G inserts 
(generating V mRNAs) and 2 and 2+3 G inserts (generating P mRNAs) were 
identified. Additionally, a third transcript encoding a third potential protein (I), the 
function of which has not been defined, was estimated by counting reads 
containing 1 and 1+3 G inserts. These numbers were compared to the total 
number of reads overlapping the RNA editing site (Fig 3.8). 
 
	 100	
The proportions of G insertions made by the RNA polymerase remain stable 
throughout infection (Table 3.3). The number of reads containing either 0 (V 
mRNA) or 2 G inserts (P mRNA) were the most abundant, contributing >93% of 
total reads, with the ratio of V to P mRNAs being approximately  2:1 (Fig 3.8). 
Only  1-2% of reads had an insertion of  1 G residue (I mRNA), and insertions of 
more than 3 G inserts were also rare (<3%). These data demonstrate the 
precision and stability of the RNA editing mechanism employed by PIV5 strain 
W3 in generating the V, P and I transcripts. 
 
Collectively, these results demonstrate a consistent mechanism of transcription 
throughout infection. There were no obvious changes in the abundance of viral 
mRNAs, including those generated by RNA editing. Furthermore, the stability of 
viral mRNA generation suggests a consistency to the RNA polymerase 
processivity.   
 
Table 3.3 Mean percentages of G inserts compared with the total number of 
reads overlapping the V/P RNA editing site. 
	 Percentage	of	G	inserts		
	 0	 1	 2	 3	 4	 5	 6	 7	6	 61.3	 1.3	 33.2	 2.1	 1.7	 0.5	 0	 0	
12	 61.2	 1.6	 33.1	 1.9	 1.6	 0.5	 0.03	 0	
18	 60.2	 1.2	 34.6	 2.3	 1.2	 0.5	 0.01	 0	
24	 63.1	 0.9	 32.6	 1.8	 1.2	 0.4	 0.02	 0	
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Generation of read-through mRNAs 
 
In order to investigate the efficiency of transcription termination and re-initiation 
at the gene junctions, which is an additional method of control for viral gene 
expression, the generation of read-through mRNAs was analysed. Read-
through mRNAs are generated when the RNA polymerase fails to terminate 
transcription at the Ge sequence (cis-acting transcription termination signal) and 
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Fig 3.8. Abundance of V, P and I mRNAs generated by PIV5 strain W3 during 
infection. The number of reads that were generated from the V, P and I 
mRNAs were calculated: 0 and 0+3 G inserts (V), 2 and 2+3 G inserts (P) and 
1 and 1+3 G inserts (I) from the R1 and R2 files using a 10 nt search string 
upstream and downstream of the RNA editing site. The bars show standard 
deviation values based on three experiments. 
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continues to transcribe the Ig (cis-acting element located between Ge and Gs) 
and the subsequent downstream gene(s), producing a bi- or polycistronic 
mRNA. To investigate the generation of read-through mRNAs, the reads 
overlapping the Igs, from the Ge of the upstream gene to the Gs of the 
downstream gene, were calculated by extracting a sub-alignment from the 
mRNA read alignment previously generated using the established bioinformatic 
pipeline. This was compared to the average coverage of the gene immediately 
upstream of the Ig (Fig 3.9). There was a greater proportion of read-through 
mRNAs produced at 6 h p.i. However, some of these reads could be of 
antigenome origin. Such reads would affect the intergenic region at a constant 
level across the genome and therefore not bias the overall pattern of read-
through mRNA generation, but they could account for the overall increase in the 
abundance of read-though mRNAs at 6 h p.i. The differences in the overall 
abundance of read-through mRNAs could also be influenced by their turn-over 
rate and stability. The overall pattern of read-through mRNA generation 
remained stable throughout the infection. The M-F Ig always produced a higher 
proportion of read-through mRNAs. The NP-V/P and V/P-M Igs produced 
greater proportions of read-through mRNAs compared to the downstream SH-
HN and HN-L Igs.  
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3.2.2 Analysis of viral replication 
 
As previously demonstrated, the abundance of viral genomes gradually 
increases during infection (Fig 3.6). New virus genomes are synthesized via the 
generation of the viral antigenome, which is a faithful positive sense copy of the 
negative sense viral genome produced by the RNA polymerase. The RNA 
polymerase then binds to the TrC promoter at the 3’ end of the viral antigenome 
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Fig 3.9. Analysis of the generation of read-through mRNAs of PIV5 strain W3. 
The average coverage of reads present in the intergenic regions was 
compared to the average coverage of reads of the gene immediately 
upstream. The bars show standard deviation values based on three 
independent experiments.   
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to synthesize new viral genomes. The TrC promoter is widely accepted as being 
a stronger promoter to promote the production of new virus genomes.  
 
In general, viral mRNA and antigenome reads cannot be distinguished by the 
established bioinformatics pipeline. The production of viral antigenome was 
estimated by calculating the reads generated from the Le region, which lies 
outwith the PIV5 strain W3 gene boundaries and should not generate reads 
from viral mRNA (Fig 3.10A). As mentioned earlier, there is evidence that some 
paramyxoviruses generate a short Le transcript which has the potential of 
interfering with the estimation of viral antigenome production. To summarise, 
the method of library preparation and sequencing would not generate reads 
from short RNAs (the Le transcripts have been estimated to be 1-55 nts in 
length), and, in addition, all of the reads included in the quantification of viral 
antigenomes cross the NP gene junction and therefore must be of viral 
antigenome origin. A search string of 10 nt in the 3’ Le region (positions 44-54) 
was used to calculate the number of reads generated from this location, which 
must be of viral antigenome origin. Using the Lander/Waterman equation, the 
number of viral antigenome reads was estimated at each time point and 
compared to the number of total cellular reads (Fig 3.10B).  
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Fig 3.10. Ratio of PIV5 strain W3 virus genomes to antigenomes (A) A 
schematic of the PIV5 strain W3 genome, depicting the positions of the 
genes (blue rectangles containing names of genes, not to scale) and Gs and 
Ge sequences (green and red rectangles, respectively. The Le region from 
which the abundance of antigenomes was estimated, position 44-54 is 
indicated, as is the NP gene boundary shown as a double red line and 10 nt 
downstream of the boundary, the sequence and position of nucleotides is 
indicated.  (B) The abundance of viral antigenome reads calculated from Le 
positions 44-54, compared to total cellular reads from which cytoplasmic and 
mitochondrial rRNA reads had been removed. The reads were directionally 
analysed as previously described and aligned to the PIV5 strain W3 
reference sequence by BWA alignment software.  The bars show standard 
deviation values based on three experiments. 
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The abundance of viral antigenomes increased between 0 and 12 h p.i. to 
0.12% of total cellular reads. After this there was a slight and gradual decrease 
to 24 h p.i. This suggests the abundance of viral antigenomes remains at very 
low levels throughout the 24 h infection. However, the use of random primers 
during library preparation (which do not prime truly randomly), and the 
dependence on reads in a short region of the genome that is not represented in 
mRNAs, can only lead to an approximation of the proportion of viral 
antigenomes. Interestingly, the increase in the abundance of viral antigenomes 
between 0 and 6 h p.i. mirrors that of the abundance of viral mRNAs (Fig 3.6), 
which also peaks at 12 h p.i. This analysis suggests that a small proportion of 
antigenomes, and therefore potentially newly synthesized viral genomes, is 
being generated at very early times p.i.  
 
The generation of viral antigenomes and newly synthesized viral genomes was 
investigated by ascertaining the ratio of genome to antigenome reads 
calculated at Le positions 44-54 (Fig 3.11). At the point of infection, 0 h p.i., viral 
genomes far outnumbered viral antigenomes at a ratio of 9 to 1, but by 6 h p.i. 
this had been reversed. Thereafter, the abundance of viral genome increased 
and that of the antigenome decreased. These results suggest that in the first 6 
h of infection the virus is engaged in viral antigenome generation.  It is 
commonly thought that the TrC promoter must be stronger than that of the Le 
promoter in order to facilitate the production of more viral genomes than 
antigenomes. These results suggest three mechanisms. Firstly, that the RNA 
polymerase undergoes modification to allow a switch between viral antigenome 
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production earlier in infection and viral genome generation later in infection. 
Secondly, there are other viral or host cell proteins that act to change the 
strength of the promoter. Lastly, there could be several RNA polymerase 
molecules copying a single viral genome at the same time, producing several 
viral antigenome molecules from a single template, which could account for the 
antigenome generation at early times p.i. and the switch in the proportion of 
genome to antigenomes. In addition, the generation of viral antigenomes and 
new viral genomes requires the production of the viral NP protein for RNA 
encapsidation. Previous research has indicated that viral replication cannot 
occur until a sufficient level of NP has been reached in the cytoplasm to allow 
encapsidation, suggesting that NP may have a critical role to play in the switch 
between transcription and replication. The abundance of viral mRNAs at 6 h is 
low (0.41% of total cellular reads; Fig 3.6), indicating that the level of NP in the 
cytoplasm available for encapsidating antigenomes and new viral genomes may 
also be low.  
 
To investigate the synthesis and relative abundance of NP, A549 cells were 
infected at an MOI of 10 pfu/cell with PIV5 strain W3 and metabolically labelled 
with 35S-methionine at 3, 6, 9, 12 and 18 h p.i. (Fig 3.12A). In agreement with 
NGS data on the relative abundance of viral mRNAs (Fig 3.6), maximum rates 
of NP synthesis were observed at 12-18 h p.i.. However, low levels of NP 
synthesis were also be observed at 6 h p.i. These results were supported by 
immunoblot analysis showing that relatively low levels of NP accumulated by 6 
h p.i. (Fig 3.12B). These results were unexpected, in that viral antigenome 
synthesis (which requires encapsidation) had started by 6 h p.i., and yet 
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maximum rates of mRNA production and NP synthesis were not reached until 
12 h p.i., and viral genome synthesis increased until 24 h p.i..  
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Fig 3.11. Proportions of viral genome and viral antigenome reads in 
positions 45-54 of the Le region, expressed as a percentage of the total. 
The data was directionally analysed using the bioinformatic pipeline 
previously described. The viral genome and mRNA/antigenome reads 
were then aligned to the PIV5 strain W3 reference sequence by BWA 
software. The bars show standard deviation values based on three 
independent experiments. 
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A B 
Fig 3.12. Production of viral NP at early time points during infection. (A) A549 
cells were infected with PIV5 strain W3 at an MOI of 10 pfu/cell. The infected 
cells were metabolically labelled for 1 h using 35S-methionine. The 
polypeptides present in the total cell extracts were separated by SDS-PAGE 
on a 4-12% polyacrylamide gel, and the labelled polypeptides were detected 
using a phosphoimager. (B) A549 cells were infected with PIV5 strain W3 at 
an MOI of 10 pfu/cell. The polypeptides present in the total cell extracts were 
separated by SDS-PAGE on a 4-12% polyacrylamide gel. Anti-NP and anti-
actin antibodies were used to detect the polypeptides and imaged using 
LiCor software. 
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The analysis described above showed that there was an increase in the levels 
of viral genome and antigenomes early in infection, and that by 6 h p.i. the 
amount of viral antigenomes exceeded that of genomes. It was also clear that 
viral replication had begun by 6 h p.i., at a time when there were only very low 
levels of NP in infected cells. As a result, it was hypothesised that it was the 
local concentrations of NP surrounding viral genomes, rather than overall levels 
in the cytoplasm, that controlled the switch from transcription to replication. 
Local foci of virus replication, also known as inclusion or Negri bodies, have 
been shown to form in some Mononegavirales virus infections such as Rabies 
(Nikolic et al 2017). To investigate whether the formation of these foci plays a 
role in PIV5 strain W3 viral RNA synthesis, A549 cells were infected with PIV5 
strain W3 at an MOI of 1 pfu/cell, and infected cells were fixed for 
immunostaining at 3, 6, 9, 12 and 24 h p.i. An anti-NP antibody was used to 
detect the presence of the viral NP protein in the cytoplasm by 
immunofluorescence (Fig 3.13). At early times in infection (3 and 6 h p.i.), NP 
was detected at a restricted number of cytoplasmic foci within infected cells (Fig 
3.13B). By 9 h p.i., viral NP and the foci had significantly increased in number 
and were dispersed throughout the cell. By 24h p.i., the foci had aggregated to 
form larger inclusion bodies. These results suggest that the virus forms local 
foci as centres of virus transcription and replication, where the level of NP may 
have a critical role to play in the control of RNA synthesis. During the initial 
stages of infection, viral transcription and replication are localised at these sites. 
At later time points, by 9 h p.i., the foci had grown in number and dispersed 
throughout the cytoplasm. This expansion correlates with the significant 
increase in viral mRNA levels between 6 and 12 h p.i. (Fig 3.6). Finally, by 24 h 
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p.i. the foci had aggregated to form larger foci, the formation of which may play 
a role in the establishment of persistence, creating stable environments for the 
maintenance of viral genomes that require little or no viral transcription (see 
Chapter 6 for further information on persistent infections).  
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Fig 3.13. Immunofluorescence staining of viral NP in the cytoplasm of A549 
cells infected with PIV5 strain W3. A) A549 cells were grown on coverslips 
and infected with PIV5 W3 at an MOI of 1 pfu/cell. The cells were fixed and 
immunostained using anti-NP  antibodies and DAPI (not included in panel A) 
at 3, 6, 9, 12 and 24 h p.i. and visualized using an Evos microscope. (B) 
Images taken from those described above in panel A of time points 3, 9 and 
24 h p.i.  by zooming in and including DAPI staining nucleic acid  
A 
B 
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Chapter	four	
Analysis of the transcription and 
replication of PIV2, MuV and PIV3 
 
  
08 Fall	
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There are numerous clinically important paramyxoviruses, many of which can 
infect humans, including PIV2 and MuV (rubulaviruses) and PIV3 (respirovirus), 
which can cause anything from mild respiratory infections to more serious 
illnesses, including bronchitis and mumps. Understanding the infection 
dynamics that underlie the diseases caused by these pathogens is important for 
the identification of new therapeutic targets.   
 
As discussed in the Introduction (section 1.3), virus transcription and replication 
is widely accepted to be directed by cis-acting elements, namely the Gs, Ig and 
Ge. The cis-acting elements in the rubulaviruses and respiroviruses differ 
significantly. Rubulaviruses (PIV5, PIV2 and MuV) contain cis-acting elements 
that vary in sequence and length, whereas the respiroviruses contain conserved 
elements that, in the case of PIV3, include Gs and Ge sequences of 3’-
AGGANNAAAG-5’ and 3’-ANTANNA5-5’ respectively and a 3’-GAA-5’ 
trinucleotide Ig sequence. 
 
 The methods developed to study the transcription and replication of the 
prototypic virus PIV5 strain W3 (see chapter 3) were employed to investigate 
human isolates of the two rubulaviruses PIV2 strain GREER (Accession number 
AF533012.1) and MuV strain Enders (Accession number GU980052) and the 
respirovirus PIV3 (reference genome obtained by de novo assembly). A549 
cells were infected with PIV2, MuV or PIV3 at an MOI of 10 pfu/cell. Total 
cellular RNA was extracted at 6, 12, 18 and 24 h p.i. and subjected to rRNA 
reduction and library preparation followed by Illumina sequencing. As the 
efficiency of cytoplasmic and mitochondrial rRNA reduction can vary among 
samples, the remaining cytoplasmic and mitochondrial rRNA reads were  
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removed from the total cellular reads by Bowtie2 alignment. The data were then 
directionally analysed using the established bioinformatic pipeline, as previously 
described (chapter 3). This analysis was conducted as three independent 
biological experiments, from which the standard deviations were calculated and 
are represented as error bars where appropriate. The exception is PIV3 6 h p.i. 
for which due to the time constraints of this project, a single sample was 
obtained but replicates are currently being generated to ensure a more 
representative result.   The results were compared to those obtained from the 
analysis of PIV5 strain W3 transcription and replication (chapter 3.2). All 
subsequent analyses were conducted on the data sets described above.  
 
4.0 Analysis of PIV2 and MuV (Rubulavirus) and PIV3 (Respirovirus) 
transcription and replication 
 
To estimate the kinetics of PIV2, MuV and PIV3 viral genome and mRNA 
production, the numbers of viral genome and mRNA reads, obtained by aligning 
the total cellular reads to the appropriate reference sequence using the BWA 
alignment software, were compared to the number of total cellular reads (Fig 
4.1). A table showing the numbers of total cellular, viral genome and mRNA 
reads for each virus is provided in Appendix I. 
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Abundance of genome or mRNA reads 
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The paramyxoviruses display diverse transcriptional profiles. As previously 
discussed, the abundance of PIV5 strain W3 (rubulavirus) mRNAs increased 
greatly in the first 12 h of infection, peaking at 12 h p.i. when it comprised 
4.59% of total cellular reads. After this, the abundance of viral mRNAs 
decreased until 24 h p.i. when it had halved to 2.3% of total cellular reads. 
Interestingly, PIV2 and MuV (also rubulaviruses) displayed a significant 
increase in mRNA generation between 6 and 12 h p.i., from 0.4 and 0.5% of 
total cellular reads to 8 and 9.8%, respectively. In comparison, PIV3 exhibited a 
greater abundance of mRNAs by 6 h, when 9% of total cellular reads were of 
viral mRNA origin, suggesting a significant increase in transcriptional activity 
than that observed with the rubulaviruses.  
 
The abundance of mRNAs for PIV2 and MuV peaked at 24 and 18 h, 
respectively, generating 18.96% of total cellular reads for PIV2 and 16.9% for 
MuV. This reflects an almost four-fold difference in peak mRNA abundance 
between PIV5 strain W3 and PIV2 and MuV, and is perhaps a cause of the 
cytopathogenicity of the infection. PIV2 and MuV are known to kill almost 100% 
of infected cells by 48 h p.i. (observational data). Conversely, PIV5 strain W3 
establishes a persistent infection in cells, with the majority surviving up to 96 h 
p.i. (see chapter 5 for more information). There was a slight decrease in the 
abundance of MuV mRNAs between the peak at 18 h p.i. and 6 h later at 24 h 
p.i. A decrease in the abundance of viral mRNAs was also observed for PIV3 
(respirovirus) with the peak of 17.4% at 12 h p.i. declining to 11.5% at 24 h p.i. 
Interestingly, cells infected with PIV3 also die by 48 h p.i. (observational data), 
again suggesting a possible correlation between high levels of viral mRNA 
generation and cytopathogenicity.  
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The abundance of viral genomes displayed the same pattern in PIV5 strain W3, 
PIV2, MuV and PIV3, with a gradual increase in the abundance of viral 
genomes between 6 and 24 h p.i. The abundance of viral genomes at the early 
time point of 6 h p.i. may indicate the generation of newly synthesised genomes 
or, alternatively, the presence of input genomes. Unfortunately, a 0 h p.i. time 
point was not included for PIV2, MuV and PIV3 as it was for PIV5 strain W3 
where there was a clear increase in the abundance of virus genomes from the 
input virus at 0 h p.i. to 6 h pi. (chapter 3 Fig 3.6). As was previously discussed 
for PIV5 strain W3 (chapter 3) if new viral genomes were being generated at 
early time points, this would require the production of the viral antigenome and 
sufficient levels of NP in the cytoplasm to allow encapsidation. A more detailed 
analysis of viral replication is available in section 4.3. 
 
4.1 Analysis of PIV2, MuV and PIV3 Transcription 
 
 
As described for PIV5 strain W3, the abundance of viral mRNAs was analysed 
to ascertain any changes in the transcriptional gradient indicating a change in 
viral gene expression that occurs over time. This analysis was conducted using 
FPKM values, which normalize the abundance of mRNAs generated from 
different samples and from genes of different lengths (see Introduction section 
1.6.4). FPKM values were obtained using the RSEM software (Fig 4.2). 
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The relative abundance of individual viral mRNAs remained relatively stable 
throughout infection.  The transcription profile depicts the transcription gradient 
displayed by the individual viruses, which generally has a negative slope from 
the 3’ to the 5’ end of the genome. However, there are differences between the 
viruses in transcription profile. PIV2 demonstrated a sharp decrease in 
expression between NP and V/P, and the genes downstream of V/P showed a 
less sharp decrease and therefore a shallower transcription gradient. In 
contrast, MuV displayed a more equal level of expression between NP and V/P 
at 6 and 12 h p.i., with the abundance of V/P more obviously greater than that 
of NP at the later time points of 18 and 24 h p.i. This was most likely due to 
differences in mRNA stability rather than to changes in RNA polymerase 
processivity. The genes downstream displayed a clearly negative gradient. 
PIV3 displays a flatter transcription gradient between the P/D/C, M, F and HN. 
Interestingly, all four viruses show a significant decrease in the abundance of 
the HN and L mRNAs, more obviously observed for PIV5 strain W3 and PIV3 
that exhibit decreases of more than eight-fold and 14-fold in the abundance of 
HN to L mRNAs, respectively, compared to less than a two-fold decrease in the 
abundances of mRNAs from upstream genes. The significance of any changes 
observed over time was analysed using a two-way anova test, all P values were 
shown to be not significant.  
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Analysis of RNA editing and the generation of accessory protein 
transcripts 
 
The analysis described above did not allow the mRNAs generated via RNA 
editing to be distinguished from each other. This involves the mRNAs encoding 
accessory proteins transcribed by insertion of additional G residues into a tract 
of G residues specified by the viral genome at the RNA editing site. This site 
was analysed to ascertain the proportions of G inserts encoding accessory 
proteins, which are named P and I for PIV5, PIV2 and MuV (rubulaviruses) and 
D and V for PIV3 (respirovirus), as these ratios cannot be estimated using the 
RSEM software. An additional accessory protein C is produced by 
respiroviruses, but this is generated via an additional open reading frame and 
not via RNA editing, and therefore could not be included in the analysis. The 
rubulaviruses produce a faithful copy of the gene (0 or 0+3 G inserts), 
generating the V mRNA, and insertion of 1 or 1+3 and 2 or 2+3 residues 
generates frameshifts that produce the I and P mRNAs, respectively. PIV3 
(respirovirus) transcribes a faithful copy of the gene (0 or 0+3 G inserts) to 
produce the P mRNA. The insertion of 1 or 1+3 G residues generates a 
frameshift that produce the V mRNA. Similarly the addition of 2 or 2+3 G inserts 
produces the D mRNA. The reads overlapping the RNA editing site were 
identified from the relevant R1 and R2 read files by using a 10 nt search string 
upstream and downstream of the RNA editing site, and the number of reads 
containing up to 15 G inserts was calculated. As with PIV5 strain W3 7 G inserts 
was identified as the upper limit for these data sets. The mean number of G 
inserts produced from each replicate is shown in Table 4.1.  
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The pattern of G insertions is remarkably different among PIV2, MuV and PIV3. 
The pattern for PIV2 (rubulavirus) was similar to that of PIV5 strain W3, and 
displayed a ratio of 2:1 for 0 or 0+3 and 2 or 2+3 G inserts, which generate the 
V and P mRNAs, respectively, and together accounted for approximately 98% 
reads overlapping the RNA editing site. The I mRNA is generated by 1 or 1+3 G 
inserts and accounted for  less than 2% of reads. In contrast, MuV (rubulavirus), 
displayed an approximately equivalent number of mRNAs with either 0 and 2 G 
inserts, the former being only 5% greater than the latter. Additionally, the 
proportion of 1 or 1+3 G inserts generating the I mRNA was 5%, compared to 
<2% in PIV2. MuV (rubulavirus) transcripts also produced a greater number of 3 
and 4 G inserts, amounting to approximately 8-9% of reads overlapping the 
RNA editing site and generating the V and I transcripts, respectively.  PIV3 
(respirovirus) produced 0, 1 and 2 or G inserts at a ratio of approximately 5:3:1, 
generating the P, V and D mRNAs, respectively. These account for 96-99% of 
reads overlapping the RNA editing site.  
 
Table 4.1. Total reads containing G inserts present in reads overlapping the 
RNA editing site in PIV2, MuV and PIV3 
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The viruses displayed different proportions of G inserts. However, these 
proportions remained stable throughout infection for each virus. To quantify the 
relative abundance of accessory protein transcripts, reads containing 0 or 0+3, 
1 or 1+3 and 2 or 2+3 G inserts were counted and compared to the total 
number of reads overlapping the RNA editing site (Fig 4.3).  
 
The generation of accessory transcripts remains stable throughout the infection. 
The viruses display different rates of generation for transcripts produced via 
RNA editing.  PIV5, PIV2 and MuV (rubulaviruses) generated mRNAs at a ratio 
for P:V of 2:1, 3:1 and 1.5:1, respectively. The I mRNA  (1 or 1+3 G inserts) was 
generated at levels of less than 1% for PIV5 and PIV2. However, approximately 
10% of MuV transcripts overlapping the RNA editing site originated from the I 
mRNA, suggesting that this mRNA may have a function. PIV3 generated 
transcripts at a ratio of approximately 5:3:1 for the P (0 or 0+3 Gs), V (1 or 1+3 
Gs) and D (2 or 2+3 Gs) mRNAs, respectively. The significance of any changes 
observed over time was analysed using a two-way anova test that showed no 
significant differences over time.  
 
 
These results demonstrate that the pattern of G insertions and the generation of 
accessory protein transcripts remains stable throughout infection for each virus 
but differs between viruses. This suggests that each viral RNA polymerase 
operates a precision in inserting G residues at the RNA editing site. 
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h p.i. 
Fig 4.3 Percentage abundances of accessory proteins generated by PIV2 
and MuV (rubulaviruses; V, P and I mRNAs) and PIV3 (respirovirus; P, V and 
D mRNAs) at 6, 12, 18 and 24 h p.i. The number of reads generated from the 
RNA editing site was calculated using a 10 nt search string immediately 
upstream and downstream of the site. The number of G inserts present in the 
reads overlapping the RNA editing site which generated the V, P and I 
mRNA transcripts was calculated, 0 and 0+3 G inserts (V or P for 
rubulaviruses and respiroviruses respectively), 2 and 2+3 G inserts (P or D 
for rubulaviruses and respiroviruses respectively) and 1 and 1+3 G inserts (I 
or V for rubulaviruses or respiroviruses respectively). 
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Generation of read-through mRNAs 
 
The generation of read-through mRNAs has been proposed as a secondary 
mechanism by which paramyxoviruses can control virus gene expression. 
Read-through mRNAs are generated when the RNA polymerase fails to 
terminate transcription at the Ge sequence and continues transcribing the Ig 
and subsequent gene(s), producing a polycistronic mRNA. The generation of 
read-through mRNAs was analysed by counting the reads overlapping the Ig 
regions by extracting sub-alignments from the previously discussed mRNA read 
BWA alignment and comparing these to the average coverage of the gene 
immediately upstream (Fig 4.4).  Overall read-through mRNA abundance can 
be influenced by the presence of viral antigenomes, as reads from mRNAs and 
antigenomes cannot be separated. However, viral antigenomes were calculated 
as being present at a very low abundance (see chapter 3.1), which would not 
significantly affect read-through analysis. Furthermore, viral antigenome reads 
would display a relatively consistent coverage throughout the alignment and 
therefore should affect the quantification of read-through mRNAs at an 
equivalent level at each time point. The overall pattern of read-through mRNA 
generation remained relatively stable throughout the various infections (Fig 4.4).  
PIV2 and PIV3 displayed a pattern of transcription termination and reinitiation 
similar to that of PIV5 strain W3, with the M-F Ig consistently generating a 
greater proportion of read-through mRNAs. However, the abundance of read-
though mRNAs generation is different, approximately 20-36% in PIV5 W3 
indicating that over two-thirds of transcripts are terminated at the Ge signal. 
Whilst approximately >97% of M-F transcripts are read-throughs in PIV3 and 
PIV2 infections, displaying a transcription termination rate <3%. The generation 
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of M-F read-through mRNAs increased slightly during PIV3 infection, from 73% 
at 6 h p.i. to 100% at 18 and 24 h p.i. This observed increase in read-through 
production at the M-F Ig is supported by numerous studies (see Introduction 
1.3.1). The generation of read-through mRNAs at the NP-P and P-M Igs of 
PIV5, PIV2 and MuV (rubulaviruses) and PIV3 (respirovirus) showed 
transcription termination rates of >88%. The transcription termination rate at the 
PIV2 F-HN Ig was lower, with over a third of transcripts being read-through. 
There was also a slightly higher rate of read-through mRNA generation at the 
SH-HN Ig in PIV5 strain W3 infection.   
 
MuV demonstrates a different pattern of read-through mRNA generation, with 
the highest proportion of read-through detected at the F-SH Ig, where 100% of 
transcripts are dicistronic. Indeed, previous studies have demonstrated that 
there are no monocistronic SH mRNAs produced by MuV Enders strain 
(Takeuchi et al., 1991). The rate of transcription termination at the MuV M-F Ig 
is similar to that of PIV5 strain W3, where approximately two-thirds of transcripts 
are terminated. MuV also showed a greater abundance of read-through mRNAs 
at the SH-HN Ig, where a third of transcripts are read-through.  
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 4.1 Analysis of the Kinetics of Viral Replication 
 
As demonstrated previously, the abundance of PIV5 strain W3, PIV2, MuV and 
PIV3 viral genomes increased during infection (Fig 4.1). It is notable that a 
three-fold increase in the abundance of viral genome occurred between 6 and 
12 h p.i. for PIV2, MuV and PIV3, whereas PIV5 strain W3 displayed a ten-fold 
increase between 6 and 12 h p.i. This suggests that viral replication occurs at 
early times during infection, concurrent with significant increases in mRNA 
abundance, which occurred between 6 and 12 h p.i. for PIV5 strain W3, PIV2 
and MuV. Therefore, there is not a sharp demarcation in timing between viral 
transcription and replication. Although the amount of viral genomes at 6 h p.i. 
suggests that viral replication may have occurred between 0 and 6 h p.i., this 
was not confirmed directly as a 0 h p.i. for PIV2, MuV and PIV3 was not 
obtained.  Replication was shown to occur between 0 and 6 h p.i. for PIV5 
strain W3 (chapter 3).  
 
As discussed previously, the viral mRNA and antigenome reads cannot be 
distinguished from each other by the established bioinformatics pipeline as they 
are both positive-sense. The production of antigenome was estimated for PIV5 
strain W3 (see chapter 3.0) by calculating read coverage in the Le region, which 
is not transcribed into mRNA. However, coverage of genome and antigenome 
reads in this region of the PIV2, MuV and PIV3 genome was low at early time 
points and therefore introduced too much variation to allow confident estimates 
of the abundance of antigenome or the ratio of genomes to antigenomes. 
Despite the lack of coverage at the 3’ end of the genome, reads were detected 
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that cross the Le region, the gene boundary and the NP gene, indicating the 
presence of antigenomes at early times p.i.   
 
If viral replication does occur at very early times p.i., it would require sufficient 
amounts of NP to encapsidate the newly synthesized genomes and 
antigenomes, prior to maximum rates of viral mRNA synthesis. To investigate 
the generation of NP at early times, 35S-methionine labelling was conducted. 
A549 cells were infected with PIV5 strain W3, PIV2, MuV or PIV3 at an MOI of 
10 pfu/cell were metabolically labelled for 1 h with 35S-methionine at 3, 6, 12, 18 
and 24 h p.i. (Fig 4.5). The production of NP was observed at 12 h p.i. for PIV2, 
MuV and PIV3. NP was detected at low levels earlier during infection with PIV5 
strain W3, with a band visible at 6 h p.i.. It should be noted that the sensitivity of 
the assay may not allow a detection of very low levels of proteins including NP 
therefore the absence of a band at early times p.i. does not correlate with 
absence of the protein.   
 
The widely accepted model for paramyxovirus replication requires NP to be 
present at sufficient levels to allow encapsidation of the antigenome and new 
viral genomes, and the level of NP in the cytoplasm is thought to be a 
determining factor in the switch between viral transcription and replication. 
However, peak transcription and translation of NP did not occur until 12 – 24h 
p.i. during PIV strain W3, PIV2, MuV and PIV3 infection (Fig 4.1). Despite this, 
there was a clear increase in the abundance of viral genomes between 6 and 
12 h p.i. (Fig 1). Therefore, either the overall cellular concentration of NP 
required for viral replication is be relatively low (much less than that observed at 
later times p.i.), or NP may localise in areas of viral replication. To investigate 
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the cytoplasmic distribution of NP during infection, A549 cells were infected with 
PIV3 and MuV at an MOI of 5 pfu/cell. The cells then were fixed and 
immunostained using anti-NP antibodies at 3, 6, 12 and 24 h p.i. (Fig 4.6). 
Unfortunately, similar studies could not be undertaken with PIV2, as there was 
no antibodies against NP available. 
 
 
These preliminary results suggest that the distribution of NP during MuV and 
PIV3 infections is significantly different. NP displayed a distribution during MuV 
infection similar to that observed during PIV5 strain W3 infection (see chapter 3 
Fig 3.13), with localisation into small cytoplasmic foci that may correspond to 
areas of viral transcription and replication. By 6 and 12 h p.i., these foci had 
Fig 4.5. Investigating the production of viral NP at early time points during 
infection. (A) A549 cell monolayers were infected at an MOI of 10 with PIV5 
strain W3, PIV2, MuV or PIV3. The infected cells were labelled with 35S-
methionine for 1 h at 3, 6, 12, 18 and 24 h p.i. The polypeptides present in 
the total cell extracts were separated by SDS-PAGE through a 4-12% gel, 
and visualized using a phosphoimager.  
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dispersed relatively equally throughout the cytoplasm, and larger inclusion 
bodies were clearly visible by 24 h p.i. During PIV3 infection, the foci were 
restricted to one area of the cell up to 6 h p.i., and by 12 h had dispersed, 
displaying a restricted grouping of foci into clear regions of the cytoplasm. By 24 
h p.i., the foci were more equally dispersed throughout the cell, but, unlike the 
situation with PIV5 strain W3 and MuV, there was no evidence of the formation 
of inclusion bodies.  
 
Collectively, these results indicate that, similar to PIV5 strain W3, viral 
replication is occurring at early times p.i.. The formation of foci during MuV and 
PIV3 infections suggest that it is the level of NP surrounding the viral genomes 
at these local sites of virus transcription and replication that dictates the RNA 
polymerase ability to enter a transcriptive or replicative mode. Interestingly, the 
viruses belonging to different genera exhibit distinctive patterns of distribution 
around the infected cell possibly indicating genera specific mechanisms of 
dispersal.  
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Fig 4.6. Immunofluorescence analysis of the localization of NP during infection. 
A549 cells monolayers were infected with PIV3 and MuV at an MOI of 2. The cells 
were fixed and immunostained using an anti-NP antibody at the times specified. The 
white arrows indicate the nucleus.  
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Chapter	five	
Analysis of persistence of PIV5 
infected A549 cells 
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Many paramyxoviruses are capable of establishing persistent infections in vitro 
and in vivo.  MeV infections can cause SSP in patients several years after the 
acute infection has been eliminated by the immune response. Defective MeV 
genomes have been isolated from brain lesions of people who have gone on to 
develop SSPE (Garg 2002, Kristensson and Norrby 1986, Randall and Griffin 
2017). SeV have been well documented as being able to establish persistent 
infections in vitro (see Introduction section 1.6 for full details). These infections 
can cause chronic or reactivated diseases that can have serious clinical 
outcomes. However, the mechanisms by which paramyxoviruses are capable of 
establishing persistence are not well understood. A PIV5 model was used to 
investigate possible mechanisms. 
 
5.0 Analysis of persistent infection of A549 cells by PIV5 
 
Previous observations in Professor Randall’s laboratory had shown that, 
following infection of A549 cells with the W3 strain of PIV5, the majority of cells 
survived the infection and became persistently infected. This was confirmed by 
phase contrast microscopy of A549 cells infected with PIV5 at an MOI of 10 
pfu/cell at 24 and 96 h p.i. (Fig 5.1A). Immunostaining of the cells using anti-NP 
and anti-HN antibodies revealed that the majority of cells were positive for NP 
and HN at 24 h p.i. (Fig 5.1B). By 96 h p.i., the majority of cells were positive for 
NP but <50% were positive for HN. Since the half-life of HN is only 2-4h 
compared to the half life of NP which is >24h (Leser et al., 1996), this 
suggested that viral protein synthesis may be repressed in the majority of 
infected cells at late times p.i.   
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To assess the kinetics of viral protein synthesis during infection, A549 cells 
were infected with PIV5 strain W3 at an MOI of 10 pfu/cell and metabolically 
labelled with 35S-methionine at various times p.i. (Fig 5.2). Viral NP and M were 
clearly detected at 24 h p.i., indicating active translation of the respective 
mRNAs. At 48 h p.i., the production of NP and M had significantly decreased, 
and NP and M were no longer detected at 72 and 96 h p.i., demonstrating that 
viral protein synthesis is repressed at late times p.i.  
 
 
 
 
Fig 5.2. Radioactive labelling of PIV5 strain W3 infected A549 cells at 24, 48, 
72 and 96 h p.i.. Monolayers of A549 cells were grown in T25 flasks and 
were mock-infected or infected with PIV5 strain W3 at an MOI of 10 pfu/cell. 
At 24, 48, 72 and 96 h p.i., the cells were metabolically labelled for 1 h using 
35S-methionine. The polypeptides present in total cell extracts were 
separated by SDS-PAGE through a 4-12% polyacrylamide gel, and the 
labelled polypeptides were visualized using a phosphoimager. 
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To determine whether the repression of viral protein synthesis observed at late 
times p.i. is reflected in the abundance of viral mRNAs, or whether translation of 
viral mRNAs is specifically repressed, A549 cells were infected with PIV5 strain 
W3 at an MOI of 10 pfu/cell and total RNA was extracted at 6, 12, 18, 24, 48 
and 96 h p.i. and subjected to cytooplasmic and mitochondrial rRNA reduction. 
Sequencing libraries were then prepared and analysed on the Illumina platform. 
Directional data were obtained using the bioinformatic pipeline described 
previously (see chapter 3.0). The abundances of viral mRNA and genome 
reads were then compared to total cellular reads (Fig 5.3), having removed 
remaining nuclear and mitochondrial rRNA reads. The time points 6, 12, 18 and 
24 h p.i. had also been analysed previously as part of an investigation into the 
acute paramyxovirus infections (see chapter 3).  
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As previously described (chapter 3.0), there was an initial significant increase in 
viral mRNA production between 6 and 12 h p.i. the abundance of viral mRNAs 
increasing 4-fold and peaking at 4.59% of total cellular reads. Subsequently, 
there was a significant decrease in the abundance of viral mRNAs to 0.18% of 
total cellular reads at 96 h p.i. In contrast, the abundance of viral genomes 
gradually increased to 48 h p.i., at which point they constituted 2.9% of total 
cellular reads. Thereafter, the level of viral genomes decreased slightly to 2% at 
96 h p.i.. These results demonstrates that shut-off of viral protein synthesis at 
Fig 5.3. The abundance of PIV5 strain W3 viral mRNAs and viral genomes 
over time. The data was directionally analysed using the established 
bioinformatic pipeline. The number of viral mRNA and viral genome reads 
was compared to total cellular reads from which the remaining cytoplasmic 
and mitochondrial rRNA were removed at each time point. The error bars are 
based on three independent experiments. 
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late times p.i. occurred because viral transcription was repressed, and not 
because of loss of viral genomes or because of specific inhibition of the 
translation of viral mRNAs.  
 
Viral transcription was analysed further in order to identify changes that might 
account for the repression of viral transcription. This utilised the data set 
described above in which A549 cells had been infected with PIV5 W3 at an MOI 
of 10 pfu/cell. Total RNA was extracted at 6, 12, 18, 24, 48 and 96 h p.i. and 
subjected to cytoplasmic and mitochondrial rRNA reduction and directional 
sequencing as described above. As the time points up to 24 h p.i. were 
analysed in chapter 3.0, the following analysis considers only the later time 
points between 24 and 96 h p.i., during which viral protein synthesis was 
repressed and the virus established a persistent infection. 
 
 
5.0.2 Transcription and replication of PIV5 strain W3 during establishment of 
persistent infection 
 
To identify whether changes in the transcription profile of PIV5 strain W3 could 
be responsible for the subsequent repression of viral transcription, the relative 
abundance of individual viral mRNAs was determined. The abundance of viral  
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mRNAs was calculated using FPKM values (fragments per kilobase of transcript 
per million mapped reads). FPKM values normalise the abundance of 
transcripts generated from individual genes in order to account for differences in 
gene length and number of reads generated due to clustering during 
sequencing, thus allowing the transcription of different genes to be compared. 
The abundances of viral mRNAs were calculated by using RSEM software (Fig 
5.4).  
 
As described previously (see chapter 3.1 Fig 3.6) PIV5 strain W3 exhibits a 
decreasing transcription gradient at early times p.i., with the gene at the 3’ end 
of the genome (NP) producing the most abundant mRNA and the gene at the 5’ 
end of the genome (L) producing the least abundant mRNA. The levels of the 
V/P, M, F and HN mRNAs exhibit a slight plateaued gradient at 24 and 48 h p.i. 
However, this analysis was conducted on the overall abundance of mRNAs and 
could reflect the stability of the transcripts and not necessarily changes in viral 
Fig 5.4. The abundances of PIV5 strain W3 mRNAs at 24, 48 and 96 h p.i. 
The abundances of viral mRNAs was quantified using FPKM values obtained 
using RSEM software. Standard deviation values are based on three 
independent experiments.  
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transcription, especially as a plateauing of these mRNAs was not observed at 
96 h p.i., at which point a decreasing gradient, similar to that observed at 6, 12 
and 18 h p.i., was observed. A slight increase observed in the abundance of the 
SH mRNA, compared with the upstream F mRNA at 48 and 96 h p.i., could also 
reflect mRNA stability. The relative stability of paramyxovirus viral mRNAs is not 
well documented and is an area of research which requires future research. 
Overall, the transcription profile of PIV5 strain W3 did not change significantly 
between early and late times p.i. suggesting that changes on the relative 
abundance of viral mRNAs is not responsible for the establishment of 
persistence. An two-way anova was conducted to test the significance of any 
observed changed, no significance was identified.  
  
RNA editing and production of V, P and I transcripts 
 
The analysis described above could not distinguish among the V, P and I 
mRNAs, which are generated via RNA editing and the insertion of 2 or 1 non-
templated G nucleotides, respectively, in a tract of 4 G residues in the V/P gene 
(position 2340 in the genome). As previously described for early times p.i. 
(chapter 3.2), the abundance of these transcripts was estimated by identifying 
reads that overlap the RNA editing site, by counting reads containing up to 7 
additional G residues. The abundance of each type of read was expressed as a 
mean percentage of the total number of reads overlapping the RNA editing site 
in three replicate experiments (Table 5.1). The numbers of reads in the 
individual replicates is provided in Appendix II. To estimate the abundance of 
the V, P and I transcripts, reads were identified containing 0 and 0+3 G inserts 
(generating V mRNAs), 1 and 1+3 G inserts (generating I mRNAs) and 2 and 
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2+3 G inserts (generating P mRNAs). These numbers were compared to the 
total number of reads overlapping the RNA editing site (Fig 5.5). 
 
The proportions of G insertions made by the RNA polymerase remained stable 
throughout infection (Table 5.1). Reads containing either 0 (V mRNA) or 2 G 
inserts (P mRNA) were the most abundant, contributing >97% of total reads.  
Less than 2% of reads contained a single G residue (I mRNA). Reads 
containing more than 3 G inserts contributed to <3.2% of reads. These results 
are the same as those observed at the earlier time points. These data 
demonstrate stability of the RNA editing mechanism employed by PIV5 strain 
W3 throughout the infection, suggesting that there are no changes in the 
abundance of accessory protein transcripts that could account for the 
transcriptional “shut off”. To ensure there were no significant differences 
between 24 and 96 h p.i. a two-way anova with post-hoc tests was conducted 
generating a p value of no significance suggesting there were no significant 
differences to account for the establishment of persistence.  
 
Table 5.1 Abundance of Reads Containing G Inserts that Overlap the RNA 
Editing Site 
 
Number of G inserts 
h p.i. 0 1 2 3 4 5 6 7 
24 63.1% 0.9% 32.6% 1.8% 1.2% 0.4% 0.0% 0.0% 
48 67.4% 0.9% 29.0% 1.9% 0.9% 0.1% 0.0% 0.0% 
96 76.0% 1.1% 21.1% 0.6% 0.6% 0.5% 0.0% 0.0% 
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Generation of read-through mRNAs 
 
The generation of read-through mRNAs occurs when the RNA polymerase fails 
to terminate transcription at the Ge site, instead continuing to transcribe the Ig 
and downstream gene(s) to generate a polycistronic mRNA. It has been 
hypothesised that generation of read-through mRNAs is a mechanism by which 
the virus controls gene expression.  To investigate how the generation of read-
through mRNAs could contribute to repression of viral transcription, the number 
Fig 5.5. The relative abundances of V, P and I mRNAs at 24, 48 and 96 h p.i. 
The number of reads that were generated from the V, P and I mRNAs were 
calculated: 0 and 0+3 G inserts (V), 2 and 2+3 G inserts (P) and 1 and 1+3 G 
inserts (I). The bars show standard deviation values based on three 
independent experiments. 
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of reads overlapping the Ig were compared to the average coverage of the gene 
immediately upstream (Fig 5.6). The coverage at 96 h p.i. was to low for 
accurate analysis, but the overall pattern of polycistronic mRNA production is 
similar at 24 and 48 h p.i. There is a greater proportion of read-through mRNAs 
at 24 and 48 h p.i. in the M-F Ig compared to the NP-V/P, V/P-M, F-SH and HN-
L Igs. A greater proportion of read-through RNAs at the M-F Ig was observed at  
earlier time points.  It is a well characterised observation of many 
paramyxoviruses. The mechanism is not well understood, but it is thought that it 
may serve to inhibit the expression of the F protein or allow the RNA 
polymerase greater access to the downstream genes SH, HN and L. The read 
through at NP/V/P, V/P-M and SH-HN is relatively equal. Unfortunately, at 48 h 
p.i. the F-SH Ig displays greater variation most likely due to random priming.  
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Collectively, analysis of PIV5 strain W3 transcription at the later time points (24, 
48 and 96 h p.i.) indicates that the processivity of the RNA polymerase does not 
significantly change during the course of the infection. This further suggests that 
modulation of RNA polymerase processivity is not responsible for repression of 
viral transcription and establishment of persistent infection.  
 
The generation of defective interfering genomes (DIs) produced as an 
erroneous by-product of viral replication has been associated with the ability of 
paramyxoviruses to establish persistent infections (see Introduction section 
1.5). DIs are shorter than the full-length viral genome and contain either the TrC 
promoter or both the TrC and Le promoters, giving them a replicative advantage 
Fig 5.6. Analysis of the generation of read-through mRNAs at the intergenic 
regions of PIV5 strain W3  compared to the average coverage of the gene 
immediately upstream. The bars show standard deviation values based on 
three independent experiments.  
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over the viral genome. Competition for RNA polymerase between viral genomes 
and DIs could result in repression of virus transcription. Furthermore, copyback 
DIs are dsRNA products and therefore could induce the host IFN response, 
which could also result in repression of viral transcription. The generation of DIs 
was investigated by bioinformatic analysis of HTS data; more details are 
provided in chapter 3 section 3.1.3. The analysis was conducted using ViReMa 
(Viral Recombination Mapper) software that identifies recombination events by 
detecting reads that map to two separate areas of the genome. This can be 
applied to the identification and production of DIs as reads that are generated 
from DIs would also map to two separate regions of the genome. The analysis 
was conducted at each time point, but no reads which map to two separate 
areas of the genome were detected, demonstrating that significant levels of DIs 
were not generated during the course of the PIV5 strain W3 infection described 
above. Therefore, DIs do not play a role in repression of viral transcription 
under these experimental conditions.   
 
To investigate whether repression of viral transcription could be due to the host 
IFN response, A549 cells were pretreated with IFN or mock-treated prior to 
infection with PIV5 strain W3 at an MOI of 10 pfu/cell. RNA was extracted at 6, 
12, 18, 24 and 96 h p.i. and subjected to polyA selection and library preparation 
followed by Illumina sequencing. The data were directionally analysed using the 
established bioinformatic pipeline, and the abundance of viral mRNAs was 
calculated (Fig 5.7). Establishment of the IFN response in A549 cells infected 
with PIV5 strain W3 delayed the peak of mRNA abundance by 24-48 h p.i. The 
abundance of viral mRNAs in pretreated cells peaks at similar levels to that of 
cells not pretreated with IFN, 7% and 6% of total cellular reads at 48 and 12 h 
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p.i. respectively. By 96 h p.i. the abundance of viral mRNAs was shown to be 
<0.23% of total cellular reads in pretreated and non-pretreated cells 
demonstrating a similar transcriptional “shut-off”. This experiment would require 
repetition to ascertain a more representative result. These preliminary results 
demonstrate that the repression of virus transcription at late times p.i. is not IFN 
dependent. This conclusion is supported by following the expression of virus 
proteins in A549 cells, cultured in the presence of Ruxoltinib, which blocks IFN 
signalling, and in A549/Npro cells, which cannot make IFN. In both cases, the 
switch off of viral protein synthesis follows the same kinetic pattern as that 
observed above in A549 cells (R.E. Randall & D.F Young, personal 
communication). 
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5.0.2 Comparison of PIV5 strain W3 and PIV5 strain CPI+  
 
In contrast to the W3 strain of PIV5, previous observations by Professor 
Randall’s group had shown that in cells infected with the PIV5 CPI+ strain the 
vast majority of cells die during the later stages of infection. Also, in contrast to 
PIV5 strain W3, which established a persistent infection easily, it is difficult to 
establish cell lines that are persistently infected with PIV5 strain CPI+. To 
investigate whether the high death rate of CPI+-infected cells is due to a lack of 
viral transcription repression at later times p.i., A549 cells were infected with 
PIV5 strain CPI+ at an MOI of 10 pfu/cell. RNA was extracted at 6, 12, 18, 24, 
Fig 5.7. Kinetics of viral mRNA production in A549 cells infected with PIV5 
strain W3 at an MOI of 10 pfu/cell in the presence and absence of 12 h 
pretreatment with IFN.  The data were directionally analysed using the 
established bioinformatic pipeline. The number of viral mRNA reads was 
compared to total cellular reads from which the cytoplasmic and 
mitochondrial rRNA reads had been removed.  
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48 and 96 h p.i. and subjected to cytoplasmic and mitochondrial rRNA reduction 
library preparation and sequencing. The data were directionally analysed using 
the established bioinformatic pipeline (see chapter 3.0), and the abundance of 
viral genomes and mRNAs was compared to total cellular reads from which 
remaining rRNA reads had been removed (Fig 5.8A).  Overall, PIV5 strain CPI+ 
demonstrated a transcription profile significantly different from that of PIV5 
strain W3. W3 and CPI+ exhibited similar levels of viral mRNA generation 
between 6 and 12 h p.i., reaching 4.59% and 4.86% of total cellular reads, 
respectively. However, after 12 h p.i. the abundance of viral mRNAs continued 
to increase during PIV5 strain CPI+ infection, the overall abundance of mRNAs 
peaking at 17.3% at 18 h p.i., which is a more than four-fold increase in 
comparison to the peak abundance of PIV5 strain W3 viral mRNAs. The most 
significant increase in viral mRNAs during CPI+ infection occurred between 12 
and 18 h, rising from 4.86 to 17.3% of total cellular reads. The abundance of 
viral mRNAs then remained approximately constant at 24 and 48 h, before 
halving to 8.86% of total cellular reads at 96 h p.i. The reduction in the 
abundance of viral mRNAs by 96 h p.i. reflects the death of the majority of 
infected cells.  
 
The abundance of viral genomes for PIV5 strain CPI+ increased over time. 
There was a sharper increase in the abundance of viral genomes between 48 
and 96 h p.i. from 0.36% to 4.78% of total cellular reads. This is different from 
W3, for which the abundance of viral genomes gradually increased up to 48 h 
p.i. to 2.9% of total cellular reads. This analysis would need to be repeated for 
PIV5 strain CPI+ to ascertain a representative result.  
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To corroborate these observations, A549 cells were infected with PIV5 strain 
W3 or CPI+ at an MOI of 10 pfu/cell or mock-infected. The cells were 
metabolically labelled using 35S-methionine at 24, 48 and 72 h p.i. (Fig 5.8B). 
NP was observed as being generated at 24, 48 and 72 h p.i. during a PIV5 
strain CPI+ infection, whereas PIV5 strain W3 again demonstrated a clear 
transcriptional shut-off with NP only observed at 24 h p.i.  The radioactive 
labelling experiment thus corroborated the transcriptional results.  
 
PIV5 strain CPI+ transcription was analysed as previously conducted for PIV5 
strain W3, including assessing the abundance of viral mRNAs, templated and 
non-templated, and the generation of read-through mRNAs during the CPI+ 
infection was analysed as described for W3 (Appendix III). The abundances of 
viral mRNAs, both templated and non-templated, remained stable throughout 
the infection. The generation of read-through mRNAs also remains constant 
over time. Taken together these results suggest that, similar to W3, the RNA 
polymerase processivity does not change over the course of the infection.  
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Although previous observations made by Professor Randall’s group has shown 
that >90% of the cells die following infections with PIV5 strain CPI+, it was 
possible to establish cell lines persistently infected with this strain. This required 
the surviving cells to be cultured for many weeks without subculturing, replacing 
the culture medium regularly. Eventually the surviving cells started to divide and 
could be passaged, although for the first few passages they often showed CPE, 
for example fusion foci within the monolayers. The observations that, in striking 
contrast, the majority of cells infected with PIV5 strain W3 survived the infection, 
and that viral transcription was switched off in W3-infected cells but not in CPI+-
infected cells, suggest that shut-off of viral transcription facilitated the early 
establishment of persistence by the latter. Therefore, it was of interest to 
determine whether viral transcription was also repressed in PIV5 strain CPI+ 
persistently infected cells, and, if so, whether this was due to the selection of 
mutant viruses, the presence of DIs or some other mechanism. To investigate 
this, total RNA was extracted from cells persistently infected with PIV5 strain 
W3 or CPI+ and subjected to rRNA reduction library preparation and 
sequenced. The data were then directionally analysed, as in previous 
experiments. The abundances of viral mRNAs and genomes were measured in 
relation to total cellular reads, from which remaining rRNA reads had been 
removed (Table 5.2). The PIV5 strain W3 data show a greater abundance of 
viral genomes, at 2.5% compared to viral mRNAs, at 0.03%. In contrast, CPI+ 
demonstrate a greater abundance of viral mRNAs, at 6.3%, compared to viral 
genomes, at 4%. These results indicate that PIV5 strain CPI+ generates a 
much higher proportion of viral mRNAs than PIV5 strain W3 in persistently 
infected cells. The abundance of viral mRNAs generated by PIV5 strain CPI+ is 
approximately 2.5 fold less compared to the peak viral mRNA abundance 
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observed in the lytic during the time course described above at 18-48 h p.i. (Fig 
5.8A). The abundance of viral mRNAs has decreased at 96 h p.i. during the lytic 
infection most likely reflecting infected cell death. The decrease in the 
abundance of viral mRNAs in the persistently infected cell lines compared to the 
lytic infection indicates repression of viral transcription.  
 
Table 5.2. Percentage of viral genome reads and viral mRNA reads compared 
to total cellular reads in PIV5 strain W3- and CPI+- persistently infected cell 
lines. 
 
 
 
 
 
The relative abundances of individual viral mRNAs were analysed by using 
FPKM values as previously described, using the RSEM software (Fig 5.9). The 
transcriptional profiles of the two PIV5 strains display some interesting 
differences. The PIV5 strain W3 transcription gradient is largely negative, 
decreasing from the NP gene generating the most abundant mRNAs to the L 
gene producing the least abundant mRNAs. However, the F gene produced a 
low abundance of mRNAs compared to downstream genes SH and HN. In 
addition, there is a sharp decrease in viral mRNA abundance between the HN 
and L genes. In contrast, PIV5 strain CPI+ produced more V/P mRNAs than NP 
mRNAs. The M, F, HN and L genes display a negative gradient, with a 
substantial decrease between the F and HN genes, and there was a greater 
abundance of V/P, M and F mRNAs in the PIV5 strain CPI+ infection, whereas 
 
genome mRNA 
W3 2.5 0.03 
CPI+ 4.0 6.3 
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PIV5 strain W3 generated a greater abundance of HN mRNAs. The level of L 
mRNAs was relatively equivalent between the PIV5 strain W3 and CPI+ 
infections. The numerous differences between the transcription profiles of 
strains W3 and CPI+ during persistent infection could reflect differences in 
mRNA stability, or they may suggest a significant difference in the infection 
dynamics of the two strains and indicate that the mechanism of establishing 
persistent infections may be specific to the strain. This analysis would have to 
be repeated to obtain a representative result.  
 
To investigate whether the selection of mutant viruses may have been involved 
in the establishment of persistent infections, the BWA alignments of the 
sequence reads generated from the genomes of PIV5 strain W3 and CPI+ in 
persistently infected cell lines were compared to the alignments of genome 
reads from the W3 and CPI+ lytic infections described above at 6 and 96 h p.i. If 
the selection of virus mutations were involved in the observed switch off of virus 
protein synthesis observed in cells infected with the W3 strain of PIV5 and the 
establishment of persistence, there should have been evidence of the mutations  
present in infected cells at 96 h p.i. However, no mutations were identified 
either by 96h p.i. or in persistently infected cells lines. Whilst no mutations were 
detected in cells infected with CPI+ at 96h p.i., several polymorphic mutations 
were identified in the CPI+ persistently infected cell lines but all of these, but 
one, were synonymous mutations. The exception was located at position 13093 
of the genome (amino acid residue 1560 of the L protein), an A to T change in 
17% of the reads that would change a phenylalanine residue in the L protein to 
a leucine residue.  
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As previously discussed the presence of DIs has been associated with the 
repression of viral RNA synthesis and the establishment of persistent infections. 
Therefore cell lines persistently infected with PIV5 strains W3 or CPI+ were 
investigated for the presence of DIs. No DIs were identified in the W3 
persistently infected cells. However, whilst DIs were not detected during the lytic 
CPI+ infection, DIs were detected in the CPI+ persistently infected cells lines. 
The analysis quantifies the number of reads that map to two different regions 
and identifies their genome positions (see chapter 3.0.3 for further details). This 
allows the abundance of DIs to be ascertained. The DIs make up approximately 
0.02% of total viral reads in cells persistently infected with CPI+. This finding 
suggests that the generation of DIs in the small proportion of CPI+ infected cells 
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Fig 5.9. Abundances of W3 or CPI+ mRNAs in persistently infected cell lines. 
The data were directionally analysed using the established bioinformatic 
pipeline. The abundances of viral mRNAs were quantified by using FPKM 
values obtained using the RSEM software.  
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that survive the infection may play a role in the establishment of persistence by 
CPI+.  
 
5.1 Analysis of the mechanism of repression of viral protein synthesis  
 
Previous work has shown that phosphorylation of the P protein, which is a 
subunit of the RNA polymerase complex, plays a significant role in the 
regulation of polymerase activity. A study by Sun et al (2013) demonstrated the 
importance of the phosphorylation of a serine residue at position 157 in the P 
protein as a mechanism for down-regulating viral gene expression). The amino 
acid sequences of the P proteins of PIV5 strains W3 and CPI+ were aligned in 
order to identify non-synonymous differences that could account for differences 
in the viral transcription and replication profiles. This analysis showed that at 
position 157 PIV5 strain W3 has a serine residue whereas strain CPI+ has a 
phenylalanine residue. Interestingly, analysis of a number of other PIV5 isolates 
showed that the incidence of either a serine or a phenylalanine at position 157 
occurred at approximately a rate of 1:1.  
 
To investigate whether phosphorylation of the P protein at serine 157 may be 
responsible for the shut-off of viral transcription observed in W3-infected cells 
and the establishment of persistence, a recombinant virus (rPIV5-W3(F157)) 
using the W3 backbone was generated by Professor Goodbourn (St George’s 
Hospital, London), in which the serine at position 157 had been mutated to a 
phenylalanine. Analysis of the consensus sequence of the recombinant virus 
showed that this was the only mutation present in the genome.   
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To assess cell survival after infection, A549 cells were infected at an MOI of 10 
pfu/cell with either the W3 parental virus with a serine residue at position 157 
(PIV5-W3(S157)) or rPIV5-W3(F157). Phase contrast microscopy revealed that, 
in contrast to the parental virus (PIV5-W3(S157)), >90% of cells had died by 72 
h p.i. following infection with rPIV5-W3(F157) (Fig 5.10B). Additionally, the 
infected cells were metabolically labelled using 35S-methionine at 24 and 72 h 
p.i. As previously observed (Fig 5.1-3), PIV5-W3(S157) displayed repression of 
viral transcription at later times p.i., whereas rPIV5-W3(F157) demonstrated no 
observable shut-off of viral protein synthesis at later times p.i.  
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Fig 5.10. Analysis of protein synthesis of PIV5-W3(S157) and rPIV5-
W3(F157) (A) A549 cells were infected with PIV5 W3 (PIV5-W3(S157)) or 
rPIV5-W3(F157) at an MOI of 10 pfu/cell. At 24, 48 and 72 h p.i. cells were 
metabolically labelled for 1 h using 35S-methionine. The polypeptides present 
in the total cell extracts were separated by SDS-PAGE on a 4-12% 
polyacrylamide gel, and the labelled polypeptides were detected using a 
phosphoimager. (B) A549 cells were mock-infected or infected with PIV5 W3 
or rPIV5-W3(F157) at 10 pfu/cell and imaged by phase contrast microscopy. 
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These results identify a single point mutation resulting in replacement of the 
serine residue at position 157 in the P protein by a phenylalanine residue to be 
responsible for the ablation of the transcriptional shut-off observed in PIV5 
strain W3.  
 
To investigate the effect of the mutation of a serine to a phenylalanine on virus 
transcription, A549 cells were infected with either PIV5-W3(S157) or rPIV5-
W3(F157) at an MOI of 10 pfu/cell. RNA was extracted at 24 h p.i. and 
subjected to cytoplasmic and mitochondrial rRNA reduction library preparation 
followed by sequencing. The sequencing data was then directionally analysed 
using the established bioinformatic pipeline. The abundance of viral mRNAs 
and genomes was compared to total cellular reads after the remaining nuclear 
and mitochondrial rRNA reads were removed (Fig 5.11).  
 
The abundance of viral mRNAs of PIV5-W3(S157) and rPIV5-W3(F157) 
displayed very different profiles at 24 h p.i. PIV5-W3(S157) accounts for 2.3% 
of total cellular reads. In contrast, rPIV5-W3(F157) viral mRNAs accounted for 
12.3% of total cellular reads, a six-fold increase compared to PIV5-W3(S157). 
These results strongly suggest that phosphorylation of a serine at position 157 
of the P protein is responsible for the inhibition of viral transcription. 
Interestingly, the abundance of viral genomes is relatively equal, at 1.8% and 
2.4% of total cellular reads for PIV5-W3(S157) and rPIV5-W3(F157) 
respectively.  
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5.2 Analysis of PIV5 persistence in AGS cells 
 
Previous observations have demonstrated the presence of a persistent PIV5 
infection in the commercially available AGS cell line (Young et al., 2007). This 
cell line was derived from a human gastric adenocarcinoma and is commonly 
used in biomedical research. Since the persistently infected cells do not exhibit 
cytopathology, this could indicate that the virus may be defective. The genetic 
characteristics of the virus were determined. The virus (PIV5-AGS) was isolated 
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Fig 5.11. Abundance of viral mRNA and genome reads for PIV5-W3(S157) 
and rPIV5-W3(F157) at 24 h p.i.. The data was directionally analysed using 
the established bioinformatic pipeline. The abundance of viral mRNA and 
genome reads was compared to the total cellular reads from which remaining 
cytoplasmic and mitochondrial rRNA reads were removed. Standard 
deviations were obtained from three independent experiments.  
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from the AGS cells, and A549 cells were infected with PIV5-AGS at an MOI of 
10 pfu/cell. Total RNA was extracted at 24 h p.i. from these cells and from the 
persistently infected AGS cell line. The RNAs were subjected to polyA selection 
and libraries were sequenced on the MiSeq platform (Illumina). The data were 
directionally analysed using the established bioinformatic pipeline, and the 
genome sequences were determined (as significant abundance of virus 
genomes were co-purified along with the polyA tail mRNAs). The data were 
originally aligned against the PIV5 strain W3 reference sequence (accession 
no. JQ743318) using Bowtie2 software and visualized using Tablet, and 
differences were identified in order to derive the final sequences. The 
consensus sequences revealed only two differences at positions 6910 and 
7445, which were polymorphic in both genomes and were comprised of G and 
A residues. These results show that the virus in the persistently infected AGS 
cells was able to replicate autonomously, although it gave a small plaque 
phenotype on Vero cells (D.F. Young, personal communication). 
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The genome sequence of the AGS virus revealed the presence of a serine at 
position 157 in the P protein. Immunofluorescence was conducted to ascertain 
whether AGS-infected cells display a similar NP and HN profile, which indicate 
whether the infected cells are actively transcribing the virus, similar to that of 
PIV5 strain W3, potentially indicating a similar mechanism by which persistence 
is established. A549 cells persistently infected with AGS were fixed and 
Fig 5.12. Immunoflurescence of AGS persistently infected cells. Persistently 
infected cell were grown in monolayers on coverslips for 24 h, and then fixed 
and immunostained using anti-NP and anti-HN antibodies (red). DAPI was 
used as a counter stain for nuclei (blue). The cells were visualized using an 
Evos microscope. 
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immunostained at 24 and 96 h p.i. using anti-NP and anti-HN antibodies (Fig 
5.12). Similar to the situation with PIV5 strain W3 (Fig 5.1), NP was detected in 
the majority of infected cells at 96 h p.i. Also, as observed in cells infected with 
PIV5 strain W3, HN was detected in only a proportion of cells, indicating that at 
late times p.i. only these cells were transcribing and replicating the viral 
genome. Although further work needs to be carried out, these results suggest 
that the presence of a serine at position 157 of the P protein in the AGS virus 
may result in the repression of viral transcription at late times p.i., thereby 
facilitating the establishment of persistence in the commercially available cells. 
Unfortunately, the persistently infected cell line could not undergo analysis of 
virus transcription and replication using the bioinformatic pipeline previously 
described due to technical reasons. 
 
A phylogenetic analysis was also conducted to determine the relatedness of 
strain AGS to the 17 other PIV5 strains for which genome sequences are 
available, using the MEGA7 software (Fig 13) (Kumar et al., 2016). The 
phylogenetic tree suggests that strain AGS is most closely related to human 
PIV5 isolates, indicating that the virus may have been present in the original 
biopsy or that it may have been contaminated in the laboratory during isolation 
of the AGS cell line.    
 
Taken together these results show that the presence of a serine a position 157 
of parainfluenza viruses may be an indicator of the virus ability to easily 
establish a persistent infection through the repression of viral protein synthesis 
at late time p.i.. A characteristic that can have long reaching consequences 
such as the ability to persistently infect a commercially available cell line.  
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Fig 5.13. Phylogenetic analysis of the complete genome sequences of PIV5 
strains. Constructed using a general time reversible model using MEGA 7 
software. The animals from which the strains were isolated are provided. The 
red circles indicate strains used in this study.  
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Discussion 
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6.0 Establishment of a pipeline for the analysis of negative-strand RNA 
viral transcription and replication 
 
The development of HTS has revolutionized biomedical research, including 
virology. There are numerous library preparation and sequencing methods that 
can be employed to answer specific biological questions in great detail. For 
research into negative-strand viruses HTS offers unparalleled opportunities to 
gain an understanding of the dynamics of viral infection. 
 
Previous research has demonstrated that paramyxoviruses control viral gene 
expression by stop-start transcription and the consequent generation of a 
transcription gradient, with genes at the 3’ and 5’ ends of the genome 
generating the most and least abundant mRNAs, respectively. Traditionally, 
gene expression studies and investigations of transcription by paramyxoviruses 
have been conducted using ultra violet-treated viruses and northern blot 
analysis (Abraham and Banerjee, 1976; Ball and White, 1976; Collins and 
Wertz, 1983; Huang and Wertz, 1982, 1983). More modern methods include the 
use of microarray analysis or quantitative PCR, for which the target nucleic acid 
sequence must be known. Owing to the ability to assemble data de novo into 
genomes of previously unknown sequence, HTS does not require any such 
prior knowledge. Additionally, unlike earlier methods, HTS can identify novel 
transcripts, gene fusions and gene variants with great precision. Typically, in 
gene expression and transcriptome studies using HTS, the total mRNA of 
infected cells is isolated by polyA selection and then sequenced, thereby 
generating an overview of all of the viral mRNAs present in the cell at the time 
of RNA extraction. 
	 167	
 
The initial aim of this study was to investigate whether the pattern of 
paramyxovirus transcription changed during infection. Initial investigations 
employed polyA selection of mRNAs from infected cells using the TruSeq 
stranded mRNA library preparation kit (Illumina), which isolates RNAs 
containing polyA tracts by hybridisation to oligo(dT) beads. This library 
preparation method generates directional data, which can, but does not 
automatically, facilitate bioinformatical separation of sequence reads based on 
directionality. For paramyxoviruses (and this could be applied to all negative-
strand RNA viruses), bioinformatic steps allow the separation of viral genome 
(negative sense) reads from viral mRNAs and antigenome reads (positive 
sense). A preliminary investigation of the PIV5 strain W3 transcriptome, in 
which directional analysis was not conducted, generated a relatively flat 
transcription gradient in genes downstream of the M gene, which was 
unexpected as it did not agreed with published work showing a decreasing 
transcription gradient from the NP to the L gene (Karron and Collins, 2013; 
Lamb and Parks, 2013). However, after conducting directional analysis of the 
same data and separating viral genome reads from viral mRNA and 
antigenome reads, the true transcription profile was revealed as consistent with 
that published previously. 
 
Viral mRNA and antigenome reads cannot be separated using directional 
analysis as they are both positive sense. However, the contribution of 
antigenome reads to the transcriptional gradient appeared to be minimal and 
must have been less than the read coverage of the L gene, which was very low. 
I concluded from this that the shape of the transcription gradient and further 
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downstream analysis of the read data would not be significantly affected by the 
presence of a small proportion of antigenome reads. In summary, PIV5 strain 
W3 displayed a transcription gradient from the 3’ to the 5’ end of the genome, 
with genes at the 3’ end (starting with NP) producing the most abundant 
mRNAs and genes at the 5’ end (ending with L) producing the least abundant 
mRNAs. Over 50% of the viral reads isolated by polyA selection were of viral 
genome origin. These results highlight a major disadvantage of isolating viral 
mRNAs by polyA selection, as a significant proportion of viral reads in this 
fraction originated from genomes, which probably co-purified with viral mRNAs 
through molecular hybridization during RNA extraction and polyA selection.  
 
Although viral genomes co-purified with polyA RNAs, this method could not be 
used to accurately quantify viral genomes. Therefore, a study was conducted to 
ascertain whether sequencing total infected cellular RNA, following depletion of 
cytoplasmic and mitochondrial rRNA, would facilitate the quantification of not 
only viral mRNAs but also viral genomes and, potentially, DIs. A comparison of 
library preparation methods, using polyA selection or rRNA reduction, was 
undertaken. Although there was a very slight decrease (<1%) in the abundance 
of viral mRNA reads generated by the latter method, this was not significant to 
downstream analysis. Furthermore, the coverage observed in read alignments 
using both methods was sufficient for downstream analysis even at 6 h p.i., 
when the abundance of viral mRNAs was at its lowest. These results revealed 
that total RNA with rRNA reduction library preparation could be employed to 
quantify the relative abundance of viral mRNAs and therefore the viral 
transcriptional gradient. Additionally, the abundance of viral genomes could be 
quantified, and the presence of DIs could be established.  
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These experiments demonstrated the advantages of using rRNA reduction, 
stranded sequencing and directional analysis for investigating the relative 
abundance of viral mRNAs. Additionally, the use of rRNA reduction allows the 
simultaneous quantification of viral mRNAs and genomes. The establishment of 
this workflow offered a powerful opportunity to investigate both the transcription 
and replication of paramyxoviruses, and could be applied to other negative-
strand viruses. Previously, the analysis of transcription and replication was 
conducted using traditional approaches such as mini-replicon systems and 
mutational analysis. These can be employed to answer specific questions such 
as the importance of particular regions of the genome, and still have an 
essential role to play in negative-strand virus research. However, they cannot 
provide a complete overview of the infection dynamics of the virus. The 
workflow established in this study utilizes HTS to analyse viral transcription and 
replication simultaneously, thus providing unique insights into negative-strand 
virus infections.  
 
6.1 Analysis of viral transcription for the rubulaviruses PIV5, PIV2 and 
MuV and the respirovirus PIV3 
 
 
The pipeline described above was employed to analyse simultaneously the 
transcription and replication of the prototype paramyxovirus, PIV5 strain W3 (a 
rubulavirus). Initially, this analysis was conducted over a 24 h time course in 
order to determine viral infection dynamics during an acute infection. The 
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analysis was then extended to human isolates of two additional rubulaviruses, 
PIV2 and MuV, and a respirovirus, PIV3. 
 
6.1.1 Kinetics and abundance of viral mRNAs and genomes 
 
 Although PIV5 strain W3, PIV2, MuV and PIV3 all showed a clear 
transcriptional gradient of mRNA abundance, as described in detail below, there 
were differences in the kinetics of transcription between these viruses. PIV5 
strain W3 displayed a significant increase in the abundance of viral mRNAs 
between 6 and 12 h p.i., increasing from 0.4 to 4.5%, respectively. The peak of 
viral mRNA abundance occurred at 12 h p.i. There was a slight decrease in the 
abundance of viral mRNAs at 18 and 24 h p.i., by which time the viral mRNA 
reads accounted for 2.3% of total cellular reads. Interestingly, PIV2 and MuV 
exhibited a similar transcription pattern at 6, 12 and 18 h p.i.. Between 6 and 12 
h p.i., PIV2 and MuV displayed an increase in the abundance of viral mRNAs 
from 0.4 and 0.5 to 8 and 9.8%, respectively. The abundance of viral mRNAs 
then approximately doubled between 12 and 18 h p.i. to 16 and 16.9% for PIV2 
and MuV, respectively. This increase represents the peak abundances of viral 
mRNAs for MuV, after which time there was a slight decrease to 15.9% of total 
cellular reads by 24 h p.i. However, the abundance of PIV2 mRNAs continued 
to increase to 19% at 24 h p.i. PIV3 transcription occurred at the earliest times 
p.i., with 9.7% of total cellular reads being of viral mRNA origin by 6 h p.i. 
Thereafter, viral mRNA abundance continued to rise until 12 h p.i., at which time 
viral mRNA reads made up 17.5% of total cellular RNA reads. At later times in 
infection, the abundance of PIV3 mRNAs decreased slightly, so that by 24 h p.i. 
they contributed 11.5% of total cellular reads.  
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The abundance of viral genomes exhibited a similar pattern for all four viruses, 
gradually increasing over time and not rising above 2.9% of total cellular reads. 
Interestingly, the abundance of viral genomes did not seem to be dependent on 
the abundance of viral mRNAs, as PIV5 strain W3 displayed a peak abundance 
of transcripts that was four-fold less compared to the other viruses, whereas 
these viruses had comparable genome abundances. Additionally, growth 
curves conducted using PIV5 strain W3 and PIV2 (appendix III) demonstrated 
that they had released newly synthesized viruses in equivalent amounts at 24 h 
p.i. (7 x 106 and 1 x 107  pfu/ml respectively), indicating that an increase in the 
abundance of viral transcripts did not correlate to an increase in the generation 
of new viruses.  
 
6.1.2 Intracellular spread of infection during viral replication 
 
The abundance of viral genomes increased approximately three-fold between 6 
and 12 h p.i. for all four viruses. The detection of viral replication at early times 
in infection was unexpected, as the current model requires there to be sufficient 
amounts of NP0 available in the cytoplasm for encapsidation of new synthesized 
viral genomes and antigenomes to allow the virus RNA polymerase to switch 
from a transcription to a replicative mode. Unfortunately, a 0 h time point was 
not taken for PIV2, MuV or PIV3, and therefore it was not possible to ascertain 
whether viral replication was occurring prior 6 h p.i.. Any future analysis should 
include this time point. PIV5 strain W3 exhibited an increase in the abundance 
of viral genomes between 0 and 6 h p.i. demonstrating viral replication prior to 6 
h. Radioactive labeling of infected cells showed that NP was being generated 
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by each virus at early times, although at 6 and 12 h p.i. it was present only at 
low abundances. However, immunofluorescence studies showed that even by 
3–6 h p.i. NP was present, and, rather than being evenly distributed throughout 
the cytoplasm, was present in a small number of cytoplasmic foci that were 
restricted in their location within infected cells. As infection proceeded, the 
number of foci increased to a point at which the cytoplasm was full of them. It 
has been suggested for PIV5 that the cytoplasmic foci contain the NP, P and L 
proteins, as well as genomic RNA, and may represent areas of active viral 
transcription and replication (Fearns et al., 1994; Carlos et al., 2009). There is 
also evidence that other members of the order Mononegavirales, including 
rabies virus (discussed further below), may replicate in similar foci. If, as seems 
likely, the cytoplasmic foci are sites of viral transcription and replication, the 
data in combination suggests a model for paramyxovirus replication in which, 
following infection, viral transcription occurs initially at (random) sites within the 
cytoplasm where incoming genomes reside. The viral mRNA is then translated 
on ribosomes localized around the viral genome, resulting in a local build-up of 
replicative proteins until the concentration of NP0 and other viral proteins in the 
vicinity of the foci becomes sufficient to facilitate the switch from transcription to 
genome replication. Thereafter, the newly replicated genomes are dispersed to 
new sites within the cell, and so the process continues until there are replicative 
sites distributed throughout the cytoplasm. The proposed new model of virus 
transcription and replication is summarized in figure 6.1. In this model, although 
viral replication occurs at localized sites very early in infection, maximal levels of 
viral transcription may not be observed until later times, when there are more 
replication foci. Also, there would presumably be asynchrony at different foci as 
to whether a switch between viral transcription and replication has occurred.  
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Fig 6.1 A schematic of the new model of paramyxovirus transcription and 
replication. The blue box represents the infected cell membrane and the grey 
circle indicates the nucleus. The green circles represent foci of virus 
transcription and replication. The darker green circle with the dark green 
solid outline is the foci generated from the infecting virus nucleocapsid 
complex. The solid red lines represent the virus genomes which are 
transcribed by the virus polymerase complex and translated by host cell 
ribosomes to produce virus proteins including NP (represented by black 
circles). A build up of NP at the local sites and not in the cytoplasm allows 
the virus to switch to replicative mode and produce antigenomes 
(represented by red dashed lines) and new virus genomes that require 
encapsidation with NP. The new encapsidated virus genomes then spread 
throughout the cell to create new foci (secondary foci) as indicated by the 
solid arrows. Where the process is repeated. The dashed arrows indicated 
the nucleocapsid spread from the secondary foci to multiple new foci 
indicated by the light green circles with the dashed outer line. The foci are 
eventually dispersed throughout the cytoplasm.  
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Although a restricted number of cytoplasmic foci were observed at early times in 
infection with all three viruses analysed (PIV2 could not be included in this 
analysis), preliminary results suggested that there are differences in how viral 
infection spreads intracellularly within infected cells. For PIV5 and MuV, there 
were initially only a few small cytoplasmic foci, presumably initiating at sites of 
incoming viral genomes. As their number increased, the foci appeared to be 
randomly distributed through the cell. For PIV5 strain W3, the cell became full of 
small cytoplasmic foci between 6 and 12 h p.i.. Thereafter, as viral transcription 
plateaued and then declined, there was a decrease in the total number of foci 
because they appeared to fuse and form larger cytoplasmic bodies. Similarly in 
MuV infected cells at late times in infection, large cytoplasmic foci accumulated. 
The formation of these large inclusion bodies may provide a stable environment 
for the maintenance of viral genomes and protect the genomes from the host 
immune response. This would allow infected cells to survive the infection and 
be reactivated at later times. The establishment of persistence is discussed 
further below.  
 
 The pattern of viral spread within infected cells appears to be different for PIV3, 
which replicates faster than PIV5 strain W3 and MuV. Indeed, the amount of 
viral mRNAs within PIV3-infected cells at 6 h p.i. was 18-fold higher that that in 
cells infected with PIV5 strain W3 or MuV, and this correlated with a higher 
abundance of NP. Furthermore, although numerous cytoplasmic foci were 
detected in PIV3-infected cells by 3-6 h p.i., rather than being evenly distributed 
through the cytoplasm these foci were localized to a specific region of the cell, 
from which the infection appeared to spread out rapidly. Also, there was no 
evidence for the formation of larger inclusion bodies in PIV3.  
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The differences in the intracellular spread of cytoplasmic foci formed by PIV3, 
compared to PIV5 strain W3 and MuV, suggests a different mechanism by 
which the virus genomes are dispersed throughout the cell and form new foci 
for viral replication and transcription. This may be dependent on the genera, 
PIV5 strain W3 and MuV being rubulaviruses whereas PIV3 is a respirovirus. 
The way in which rabies virus (a rhabdovirus) spreads intracellularly during an 
infection has recently been investigated by Nikolic et al., (2017). Following 
replication in inclusion bodies (known as negri bodies for this virus), newly 
encapsidated genomes are ejected from inclusion bodies and dispersed 
throughout the cell by microtubules (Lahaye et al., 2009). The ejected 
nucleocapsid complexes subsequently form new negri bodies. When the 
formation of microtubules was disrupted, the encapsidated viral genomes were 
not distributed and remained close to the original inclusion body. Eventually, 
newly formed negri bodies fused with the original body, creating a single larger 
inclusion body.  
 
During the course of these studies, there was no evidence for the formation of 
large inclusion bodies in cells infected with PIV3. However, Zhang et al., (2017) 
observed that large PIV3 inclusion bodies were formed from the fusion of 
smaller inclusion bodies and required acetylated α-tubulin. Additionally, the 
formation of the larger inclusion bodies led to an increase in viral replication. 
The difference between Zhang results and the results obtained from this study 
could be due either to strain differences in the virus used, or to cell-type specific 
differences. Interestingly, a study by Zhang et al., (2013) demonstrated that 
mutation of a leucine to an alanine residue at position 478 of NP abolished the 
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ability of PIV3 to form inclusion bodies through distrusting the interaction of the 
disordered C-terminal tails of NP present in NP-RNA and the C-terminal end of 
P. However, the N0-P interaction was not affected by this mutation. This study 
also shows that formation of inclusion bodies was critical to RNA synthesis. 
Overall, these studies suggest that the NP-RNA-P interaction, and possibly the 
interaction of this complex with host tubulins, plays a critical role in the 
formation of inclusion bodies. It is also of note that the NP proteins of PIV5 
strain W3 share between 50-60% identity with their orthologue in PIV2 and MuV 
(rubulaviruses) but share little common sequence with their orthologue in PIV3 
(respirovirus) (Lamb and Parks, 2013). In contrast, the C-terminal domain of P, 
which is responsible for binding to the N-RNA complex, has a relatively well 
conserved secondary structure in members of the family Paramyxoviridae 
(Lamb and Parks 2013). If there is a critical role for the NP-RNA-P interaction in 
the formation and dispersal of viral genomes, it is possible that, given the 
conserved secondary structure of the P protein that mutations in the NP protein, 
such as that observed for PIV3 by Zhang et al., (2013), this could account for 
the differences in the mechanism of viral genome dispersion in the cytoplasm 
between rubulaviruses (PIV5 strain W3 and MuV) and respiroviruses (PIV3).  
 
6.1.3 Viral transcription profiles 
 
Analysis of the transcriptional profiles conducted by calculating the abundances 
of virus mRNAs at each time point effectively allows the quantification of the 
transcription gradient. Any changes observed in the transcript abundances may 
indicate a change in viral RNA polymerase activity and therefore in the control 
of viral transcription and ultimately gene expression. All four viruses clearly 
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displayed a transcription gradient, with genes at the 3’ end of the genome 
(starting with NP) producing the most abundant mRNAs, and those located 
towards the 5’ end (ending with L) generating the least abundant. The 
transcription gradient of each virus remained relatively unchanged throughout 
the infection, and any slight changes may reflect differences in the stability and 
turnover of viral mRNAs. Therefore, from this analysis there was no evidence of 
temporal control of relative mRNA abundance.  
 
Although for any given virus the transcriptional gradient remained unchanged 
during infection, there were clear differences in the shape of the gradient 
between the four viruses. PIV2 displayed a significant decrease in the relative 
abundance of V/P mRNAs compared to the upstream NP mRNA. In genes 
downstream of V/P, a consistent, continuous decrease in the transcription 
gradient was observed. For MuV, there were similar levels of the NP and P/V 
mRNAs early in infection, but at later time the V/P gene displayed a greater 
abundance of transcripts compared to the upstream NP gene. This may have 
been due to differences in the stability of viral mRNAs. There was a significant 
decrease in the abundance of mRNAs between the V/P and M genes, with 
genes downstream of V/P displaying a decreasing transcriptional gradient. PIV3 
exhibited a flatter gradient in the P/D/C, M, F and HN genes. A flatter 
transcription gradient was also observed at 24 h p.i. during PIV5 strain W3 
infection. However, this most likely reflects differences in the stability of mRNAs 
and not changes in the processivity of the RNA polymerase as by 96 h p.i. 
(observed during the persistence chapter analysis Fig 3) PIV5 strain W3 again 
exhibits a decreasing gradient.  
 
	 178	
A common feature of all of the viruses is a significant decrease in relative 
abundance of L mRNAs compared to HN mRNAs (from the upstream gene), the 
latter being at least two-fold less abundant. The decrease in the abundance of L 
mRNA was particularly obvious for PIV3, for which there was an eight-fold 
decrease in the abundance between the HN and L genes. This was 
unexpected, since PIV3 exhibits a level of conservation in the Ig. Therefore, if 
the level of L mRNA is dictated by the rate of transcription termination and re-
initiation at the HN-L Ig region, this cis-acting element cannot be primarily 
responsible for determining the ratio of HN to L mRNAs. It is possible that 
sequences within the Ge of HN and the Gs of L are involved, but these are also 
conserved in PIV3. Also, the rate of read-through at the HN-L Ig is not 
significantly lower compared to the other genes, indicating that the rate of 
termination and re-initiation is similar and does not account for the lower 
abundance of L mRNAs. Alternatively, the lower abundances of L mRNA may 
indicate that, during transcription, the RNA polymerase disengages from the 
genome not only at gene junctions but also (randomly) within genes. If this is 
the case, then any truncated mRNAs would not be polyadenylated and 
consequently would be rapidly degraded (Dreyfus and Regnier, 2002; Wickens 
et al., 1997). Given the very long length of the L gene, only a very small 
proportion of L mRNAs may be full-length, polyadenylated and therefore stable, 
resulting in the observed large difference between the relative abundance of HN 
and L mRNAs.  
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6.1.4 Read-through mRNAs and transcription termination 
 
The precision of RNA polymerase processivity can be observed in the 
generation of read-through mRNAs, which are generated when the RNA 
polymerase fails to terminate transcription at the Ge signal, instead continuing 
to transcribe the Ig and downstream gene(s) and releasing a polycistronic 
mRNA. The overall pattern of read-through mRNA generation remains stable 
throughout infection for all four viruses. There are significant similarities among 
the viruses in read-through mRNA generation. PIV5 strain W3, PIV2 and PIV3 
displayed a greater abundance of M-F read-through mRNAs compared with the 
other gene junctions. However, the abundance of the dicistronic M-F mRNA 
was different. For PIV5 strain W3, approximately one third of transcripts were 
read-through, whereas PIV2 and PIV3 displayed a much higher proportion 
(approximately 98%). These results are particularly interesting because the cis-
acting elements that direct effective transcription termination in 
paramyxoviruses differ significantly between rubulaviruses and respiroviruses. 
These results suggest that the viruses have evolved specific mechanisms to 
retain the proportion of M-F read-through mRNAs, thus suggesting that this has 
an essential role in viral growth.  
 
The results for PIV5 strain W3 displayed similar relative abundances of read-
through mRNAs to those observed by Rassa and Parks (1998). Read-through 
transcripts at NP-V/P, V/P-M and SH-HN were produced in a relatively equal 
proportions, thus corroborating the observation made by Rassa and Parks 
(1998), although the proportions obtained in that study were higher (~15%) than 
in this study (~9%). The HTS results displayed an approximately three-fold 
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greater abundance of read-through mRNA generation at the M-F genes 
compared to the V/P-M genes, and this remained relatively consistent 
throughout infection. However, unlike the Rassa and Parks study, which found 
read-through production at the M-F genes to be higher at early times in infection 
compared to late times (approximately 50% and 20%, respectively), the results 
observed here showed that the relative abundance of read-through generation 
at the M-F genes remained relatively constant. In contrast to the other viruses, 
MuV Enders strain displayed a 100% read-through rate at the F-SH genes, 
confirming previous results showing that this strain does not produce any 
monocistronic SH mRNAs (Takeuchi et al., 1991, 1996). Takeuchi et al., (1991) 
detected no bicistronic SH-HN mRNAs and relatively abundant (~40%) read-
through at the SH-HN genes similar to the results obtained here. MuV Enders 
strains also displayed a high level of M-F read-through mRNAs (~27%), similar 
to that observed for PIV5 strain W3.  
 
Numerous studies have corroborated a higher proportion of read-through 
mRNAs at the M-F genes in a number of different paramyxoviruses including 
NDV, MeV and PIV5 (Hiebert et al., 1985; Paterson et al., 1984; Rozenblatt et 
al., 1982; Wilde and Morrison, 1984). Two hypotheses have been put forward to 
explain why paramyxoviruses have evolved a mechanism to achieve this. 
Firstly, that this inhibits expression of the F protein, thus facilitating a decrease 
in the cytopathic effects of infection. An increase in F protein abundance has 
been shown to increase cell-to-cell fusion (Horvath and Lamb, 1992a, b). 
Therefore, inhibiting expression of the F protein may be beneficial for viral 
growth by decreasing this cytopathogenic effects. A study by Lingemann et al., 
(2015) suggested that in PIV3, where the Ge, Ig and Gs signals are highly 
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conserved, the high rate of M-F read-through was due to an 8 nt insert in the M 
gene Ge signal that is also present in the strain used in this study. A mutant 
virus in which this insert was deleted displayed a decrease in the read-through 
at the M-F junction and a subsequent increase in expression of the F protein, 
which resulted in an increase in plaque size probably due to a higher rate of 
cell-to-cell fusion. Additionally, F is a neutralizing and protective antigen during 
PIV3 infection, and increased expression of F due to a decrease in M-F read-
through resulted in an increase in F-specific serum IgG antibody titres, 
suggesting that the down-regulation of F may be a control mechanism for 
helping the virus to evade the host immune response (Lingemann et al., 2015).  
 
The second hypothesis is that the greater abundance of M-F read-through 
transcripts may act to increase the access of RNA polymerase to the 
downstream genes HN and L (and SH in some paramyxoviruses). A study by 
Parks et al., (2001) using minigenomes in which the Ig of the M-F gene junction 
had been altered showed that an increase in the generation of M-F read-
through mRNAs resulted in an increase in expression of the L protein, resulting 
in an decrease in viral growth and lower viral titres compared to WT PIV5. A 
study by He and Lamb., (1999) showed that switching the HN and L Igs led to 
greater expression of the L protein but conferred slower viral growth and smaller 
plaques. Additionally, Shabman et al., (2013) demonstrated that, for Ebola virus 
(filoviridae), under- or over-expression of L resulted in inhibition of viral 
transcription. However, studies using recombinant SeV and rabies virus 
(rhabdovirus) showed that an increase in the level of L increased virus growth 
(Finke et al., 2000; Kato et al., 1999). These studies suggest that the amount of 
L, and presumably the ratio of L to P and NP, is critical for optimal viral growth. 
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Furthermore, increasing access to downstream genes downstream from M/F 
may counteract the relatively short half-life of the HN protein, as shown by 
Leser et al., (1996).   
 
6.1.5 RNA editing and transcription of the P/V/C/D(I) gene 
 
The P/V/C gene of paramyxoviruses encodes multiple proteins, primarily by an 
RNA editing process that results in the insertion of non-templated G residues at 
the RNA editing site and causes translational frameshifts. It is thought that this 
occurs through RNA polymerase stuttering in a tract of G residues by a similar 
mechanism as that occurring during polyadenylation (Hausmann et al., 1999). 
This results in the production of the V, I and P mRNAs (rubulaviruses) 
generated from the insertion of 0 or 0+3 G residues, 1 or 1+3 G residues and 2 
or 2+3 G residues, respectively. The respiroviruses (PIV3) produce the P, V and 
D transcripts from the insertion of 0 or 0+3 G residues, 1 or 1+3 G residues and 
2 or 2+3 G residues, respectively. The respiroviruses also produce the C 
protein, but this is generated through an additional ORF close to the 3’ end of 
the P gene and therefore cannot be quantified by HTS.  
 
In general, for a given virus the proportions of transcripts generated via RNA 
editing remained stable throughout viral infection. A recent study by Qui et al 
(2016) demonstrated an increase in RNA editing at early times in NDV, 
suggesting that this stability might not apply to all paramyxoviruses. There were 
clear differences between the viruses in the ratio of mRNAs produced with 
different numbers of G residue insertions. Although work by Thomas et al., 
(1998) showed that for PIV5 the insertion of 0 and 2 G residues (producing V 
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and P mRNA) occurs at a ratio of approximately 1:1, the analysis of HTS data 
clearly demonstrated that PIV5 strain W3, as well as PIV2, displayed a ratio of 
2:1 of V:P mRNA generated through 0 and 2 G residue inserts, respectively. 
These transcripts accounted for 98% of all the transcripts generated from the 
P/V gene, and the generation of I mRNAs accounted for <2%. In contrast, MuV 
demonstrated a more equivalent generation of V and P transcripts, and 
approximately 5% of mRNAs were I transcripts. PIV3 RNA editing processes 
generated transcripts containing 0, 1 and 2 G residues at a ratio of 
approximately 5:3:1 and generating the P, V and D mRNAs. This result for PIV3 
is in contrast to that observed by Kolakofsky et al., (2005), who found PIV3 
inserts of 1 to 6 G residues at equal frequency.  
 
It is thought that the generation of transcripts in the observed proportions 
usually reflects the functional needs for the translated proteins. If this is the 
case, these results suggest that, for PIV2 and PIV5 strain W3, there is a 
requirement for more V protein than P. This may be because the V proteins are 
IFN antagonists and therefore it is important to produce them in a burst as early 
as possible in infection. In contrast, although the P protein is an essential 
component of the viral RNA polymerase complex, high level of expression of P 
may be required only once virus replication and secondary transcription have 
been initiated. Only a small number of transcripts would results in the I protein, 
which has a stop codon soon after the RNA editing site resulting in a protein 
with only a few unique amino acids after the N-terminal domain common to 
P/V/I. No function has been ascribed to the I protein, and, as I mRNA is only 
present at very low levels, it suggests that it may be non-essential for virus 
growth.  
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The generation of accessory protein transcripts by PIV3 is particularly 
interesting. Although an ancestral ORF is present in the V mRNA, there are two 
stop codons downstream of the editing site that would result in the production of 
a truncated V protein that is unlikely to function as an IFN antagonist. 
Consequently, it is generally accepted that V has no function in PIV3 infection. 
However, the results obtained from this analysis show that one third of P/D/C 
transcripts would encode the truncated V protein, a significantly higher 
proportion than would encode D, or by comparison, the truncated I proteins of 
PIV2 and PIV5. Such a high proportion of V mRNA generation suggests it may 
retain an important function in PIV3 replication. Although the primary function of 
the V protein of paramyxoviruses has been linked to the role as IFN 
antagonists, it may also play important roles in the control of viral transcription 
and replication. For example, several studies have shown that, for a number of 
paramyxoviruses, including SeV, PIV2 and PIV5, the V protein, through its N-
terminal P/V common domain, can interact with NP and L to inhibit RNA 
synthesis (Horikami et al., 1996; Nishio et al., 2008). Also, a study by Precious 
et al., (1995) demonstrated that PIV5 V may have a role in keeping NP0 soluble 
prior to encapsidation of the viral genome or antigenome, and thus the V protein 
of PIV3 may have a similar function.  
 
The analysis of RNA editing, in particular the insertions of higher proportions of 
2 G residues compared to 1 G residue by PIV2 and PIV5 strain W3, 
emphasizes the precision of the RNA editing mechanism by the viral RNA 
polymerases. Hausmann et al (1999) demonstrated that the cis-acting element 
that directs insertion of the G residues is a 6 nt sequence upstream of the AnGn 
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tract of the RNA editing site. The tri-nucleotide immediately upstream of this 
tract is of particular importance, as mutations in it alter the frequency at which G 
residues are inserted at the RNA editing site. Iseni et al., (2002) also suggested 
that hexamer phasing may play an important role in the ability of cis-acting 
elements to direct RNA polymerase activity during transcription, including RNA 
editing although this has not been characterized. Kolakofsky (2016) suggested 
that as the NP monomers are displaced from the nucleocapsid complex by the 
RNA polymerase they are known to move over the surface of the L subunit and 
reform the nucleocapsid complex as the template viral RNA exits the active 
cavity of the RNA polymerase and it is the NP monomers interaction with L (the 
catalytic subunit of the polymerase) as they move across the surface of L that 
dictates the RNA polymerase activity namely stuttering and pausing at specific 
sequnces. The cis-acting elements responsible for RNA editing must be in the 
correct hexamer phase position for efficient RNA polymerase function. The RNA 
editing and hexamer phasing of the rubulaviruses is highly conserved (3′-
A3UUCUC4-5’, with the hexamer phasing 3′-NAAAUU CUCCCC-5’). These 
conserved elements may reflect a fitness selection of the virus to allow high 
rates of transcription for mRNAs that contain 2 G inserts and whose translated 
proteins have an essential role in viral growth. Interestingly, the 3 nt upstream 
of the conserved editing site, which are within the 6 nt cis-acting sequence 
identified by Hausmann et al., (1999), are different between PIV5, PIV2 and 
MuV (CUA, UAU and CUU. respectively). These tri-nucleotide sequences 
upstream of the highly conserved RNA editing site may determine the 
differences in the insertion of G residues observed among the rubulaviruses. 
Conversely, there is no conservation of hexamer phasing in the respiroviurses, 
and that this is reflected in the non-conserved nature of the insertion of G 
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residues at the RNA editing site that differs between viruses in this genus. This 
can be observed in SeV where the insertion of 1 G residue is made at a higher 
frequency whilst human PIV3 the frequency of 1 to 6 G insertions was 
suggested to occur at a ratio of 1:1 (Galinski et al., 1992; Kolakofsky et al., 
2005; Pelet et al., 1991). However, the results obtained here demonstrate that 
this is not the case for human PIV3, and that the proportion of G insertions for 
this virus reflects a more precise mechanism of RNA editing by the RNA 
polymerase.  
 
Taken together, the above analysis suggests that there is no temporal control of 
paramyxovirus transcription. RNA polymerase processivity directed by cis-
acting elements in PIV5 strain W3, PIV2, MuV and PIV3 remained stable 
throughout the infection, with the relative abundances of viral mRNAs 
(templated and non-templated), remaining relatively stable. The differences in 
the transcription profiles of the viruses may indicate that cis-acting elements 
directing the activity of the RNA polymerase have evolved to generate 
abundances of viral mRNAs, and therefore of their translated proteins, that 
reflect the growth requirements of the virus. Paramyxovirus transcription and 
replication are directed by cis-acting elements such as the gene start (Gs), 
intergenic region (Ig) and gene end (Ge). The cis-acting elements in the 
rubulaviruses and respiroviruses differ significantly. The sequences of the Gs 
and Ge of the genes found in the viruses used in this study are shown in 
Appendix IV. These show that the rubulavirus Gs sequences uniformly start with 
an a residue. The individual viruses contain between 1 and 4 conserved 
residues compared to the respirovirus PIV3 Gs that contains 8 conserved 
residues. The Igs of the rubulaviruses differ greatly in their sequences. The 
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PIV5 strain W3 and PIV2 show that V/P-M and M-F and HN-L contain longer Igs 
compared to the other genes. In comparison MuV contains shorter Igs. PIV3 
contains a trinucleotide 3’-GAA-5’ Ig. Interestingly, the Ge of all of the viruses 
show very little conservation which could account for the differences in the rate 
of read-through between the different genes. However, this does not offer an 
insight into the observed higher rate of read-through between the M-F genes 
observed in all four viruses. The identification of sequences that are essential to 
maintaining the virus transcription profiles is beyond the scope of this project 
and requires further investigation. Studies by Rassa and Parks (1998-2001) 
suggested that cis-acting elements such as the Ge and the length of the U-tract 
may work in tandem to direct RNA polymerase activity. Kolakofsky et al., (2005, 
2016) and Iseni (2002) suggested that hexamer phasing is crucial for the RNA 
polymerase to recognize the cis-acting elements that direct viral transcription 
and RNA editing. Hexamer phasing has been shown to be crucial in initiation of 
RNA synthesis at the Le promoter for paramyxoviruses (see Introduction 
section 1.2). The differences between the cis-acting elements of viruses in 
different paramyxovirus genera may indicate the employment of different 
mechanisms of control, even though this may result in similar outcomes as was 
observed for the increased read-through at the M-F genes. These cis-acting 
elements do not seem to elicit a temporal control of RNA polymerase 
processivity, indicating a role for other factors, such as host cell factors that 
could be involved in changes to viral transcription kinetics during infection.  
 
The role of cellular proteins that could play a role of paramyxovirus transcription 
and replication is not well characterized. Studies have shown that heat shock 
protein 70 and 90 (Hsp70 and Hsp90) played a role in MeV and MuV 
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polymerase maturation through interactions with the L protein, inhibition of 
which resulted in a reduction in the virus ability to replicate (Bloyet et al., 2016; 
Connor et al 2007; Katoh et al., 2016). Other studies have shown that cellular 
kinases such as PLK-1 Akt-1 can inhibit virus RNA synthesis through 
phosphorylation of the P protein, the role of these shall be discussed in greater 
detail below in section 6.3.  
 
Together, the analysis described above may provide the opportunity to 
generate a more accurate virus gene expression profile by combining the FPKM 
values with the percentage RNA editing and read-through values. However, due 
to time constraints this could not be attempted here but shall be included in a 
larger study which is currently being undertaken.  
 
6.2 Ratio of genome to antigenome during viral replication 
 
The analysis of the ratios of genome to antigenome conducted on PIV5 strain 
W3 demonstrated some interesting preliminary observations of the dynamics of 
viral replication at early times in infection. The analysis presented here 
suggests a complete reversal of the genome to antigenome ratio between the 
point of infection and early times in infection. Input virus displayed a 
genome:antigenome ratio of 9:1, but by 6 h p.i. this had almost completely 
reversed to a ratio of 1:4. This finding is supported by the study of Irie et al., 
(2014), which demonstrated a similar change in SeV infections. This was 
correlated to the presence of the viral C protein, with the Le promoter being 
stronger that the TrC promoter in viruses lacking C expression. However, in the 
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presence of C this was reversed so that the TrC promoter was stronger. Thus, 
at early times in infection, prior to the synthesis of large amounts of the C 
protein, the Le replication promoter may be stronger, resulting in more 
antigenomes than genomes being produced. After transcription and translation 
of the C gene, the strength of the TrC promoter may increase, resulting in the 
generation of more genomes than antigenomes. However, PIV5 and other 
rubulaviruses do not encode a C protein, and therefore a different viral protein 
with a similar function may be responsible for the observed change. 
Alternatively, the switch in the ratio of genomes to antigenomes may be due to 
modifications to the RNA polymerase at early versus late times in infection. 
However, modifications of the RNA polymerase could possibly result in changes 
in viral transcription dynamics over time, as both processes use the same 
promoter and RNA polymerase complex. However, the results obtained during 
this study showed that the processivity of the RNA polymerase remains 
remarkably stable throughout the course of a 96 h infection. Therefore, 
modifications in the RNA polymerase are an unlikely source of the changes in 
genome to antigenome ratio. Alternatively, the switch may be the result of 
multiple RNA polymerases simultaneously functioning on a single viral genome 
template. This may result in an initial accelerated proliferation of antigenomes 
compared to genomes. 
6.3 Transcription and replication are repressed during establishment of 
PIV5 persistence 
 
Initial phase contrast microscopy and immunofluorescence experiments 
showed that the majority of cells infected with PIV5 strain W3 survived the 
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infection. HTS revealed that, after 24 h p.i., viral genomes were maintained 
throughout the infection at a relatively constant level, accounting for 
approximately 1-3% of total cellular reads. HTS analysis and radioactive 
labeling of infected cells demonstrated that viral transcription and protein 
synthesis were progressively shut off after 12-24 h p.i. Thus, although at 12 h 
p.i. viral mRNA reads accounted for 4.5% of total cellular reads, by 96 h p.i. 
they represented <0.2%. The conclusion that viral transcription had been shut 
off in the majority of cells at late times in infection was supported by 
immunostaining the cells for the presence of the HN protein. Unlike the NP 
protein, which is stable for days, HN has a relatively short half-life of a few 
hours (Leser et al., 1996) and thus the observation that cells were positive for 
NP but negative for HN at 96 h p.i. indicated that viral transcription was 
repressed in HN-negative cells. However, the pattern of the viral transcriptional 
gradient remained relatively similar over this time period, suggesting that 
changes in RNA polymerase processivity were not responsible for this shut-off. 
Preliminary results obtained from conducting an identical time course 
experiment in cells in which an IFN response had been established by 
pretreating the cells with IFN prior to infection with PIV5 strain W3 suggested 
that the repression of protein synthesis at later times was not IFN-dependent, 
as infected cells either pretreated with IFN or not pretreated exhibited a similar 
“shut-off” by 96 h p.i. This experiment would need to be repeated in order to 
obtain a reproducible result. Additionally, the presence of DIs has been shown 
to play a role in the repression of viral protein synthesis (Huang and Baltimore, 
1970; Roux et al., 1991). However, bioinformatic analysis showed no evidence 
for the generation of DIs during PIV5 strain W3 infection over a 96 h period.  
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PIV5 strain CPI+ shares >99% nucleotide sequence identity with PIV5 strain 
W3 (strain CPI+ lacks the SH gene). However, phase contrast microscopy and 
immunofluorescence experiments revealed that the majority of cells infected 
with PIV5 strain CPI+ die by 96 h p.i. and, unlike PIV5 strain W3, persistent 
infections are not easily established. Preliminary results obtained from HTS 
analysis of PIV5 strain CPI+ showed that the kinetics of transcription are 
significantly different from those of PIV5 strain W3. The abundance of viral 
mRNAs peaked at 18 h p.i., at 17.3% of total cellular reads. This represents a 
four-fold increase in peak viral mRNA abundances compared to PIV5 strain W3. 
By 96 h p.i., the abundance of viral mRNAs in the few surviving CPI+-infected 
cells was still higher than that of viral mRNAs expressed by PIV5 strain W3 at 
its peak transcription rate, accounting for 8.86% of total cellular reads. An 
analysis of viral transcription similar to that described above was also 
conducted on PIV5 strain CPI+-infected cells, in order to investigate the 
transcriptional gradient, the efficiency of RNA editing and the abundance of 
read-through mRNAs. However, no obvious difference between the overall 
patterns of transcription for strains W3 and CPI+ was observed that could 
account for the higher level of viral mRNA generation in CPI+-infected cells or 
why this was not repressed at later times in infection, as was observed for PIV5 
strain W3.  
 
Differences in the overall levels of viral transcripts may reflect differences in the 
cytopathogenic nature of the infection. Previous observations in Professor 
Randall’s laboratory have demonstrated that the majority of cells infected at a 
high MOI with PIV2, MuV and PIV3 die by 48 h p.i. The results obtained in this 
study show a similar outcome for cells infected with PIV5 strain CPI+, whereas 
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the majority of PIV5 strain W3-infected cells survived the infection and easily 
established a persistent infection. The more than four-fold increase between the 
peak abundance of mRNA reads observed in PIV2, MuV, PIV3 and PIV5 strain 
CPI+ compared to PIV5 strain W3 may reflect a more cytopathogenic infection, 
in which RNA synthesis is not repressed, resulting the induction of cytokines 
and ultimately cell death. 
 
Although most cells infected with PIV5 strain CPI+ died at late times in infection, 
a small proportion of cells survived and eventually began to grow while being 
persistently infected with the virus. To determine whether any viral mutations 
were selected during the establishment of CPI+ persistently infected cells, 
perhaps resulting in viruses exhibiting an inhibition of viral transcription at later 
times in infection, the reads generated from the viral genome of PIV5 strain 
CPI+ in persistently infected cells were analysed. A single mutation was 
identified in the L gene at the nucleotide 13093 (amino acid residue 1560 of the 
L protein) which would result in a phenylalanine to leucine change in the 
protein. However, this mutation was not present in any of the reads aligning at 
that genome position at 96 h p.i. during the PIV5 strain CPI+ time course 
analysis, and therefore is unlikely to represent a population of viruses that had 
been selected for its ability to establish persistence. HTS analysis showed that 
the abundance of viral genomes in PIV5 strain CPI+ persistently infected cells 
accounted for 4% of total cellular reads, whereas in W3 persistently infected 
cells it accounted for 2.5%. However, the abundance of viral mRNAs in these 
cells contributed 6.3% of the total reads compared to 0.03% in W3 persistently 
infected cells. There were slight differences in the transcriptional gradient 
between strain W3- and strain CPI+-infected cells that may result from 
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differences in the mechanisms by which the two viruses establish persistent 
infections. Slight differences in the abundance of viral mRNAs may be the result 
of differences in the stability and translation of mRNAs. As this was a single 
experiment, it would need to be replicated to ensure reproducible results. 
Strikingly, although no DIs were detected in PIV5 strain W3 persistently infected 
cells, they accounted for approximately 4% of the viral reads in PIV5 strain 
CPI+-infected cells. Given that DIs have previously been linked to repression of 
RNA synthesis and the establishment of persistent infections (Huang and 
Baltimore, 1970; Roux et al., 1991), it may be the presence of PIV5 strain CPI+ 
DIs reduces viral replication in CPI+-infected cells to a level compatible with cell 
survival and the establishment of a persistent infection. A similar mechanism for 
the establishment of persistence was recently identified by Xu et al., (2017), 
which showed that in SeV infection although the majority of cells die a small sub 
population of cells infected with DIs survive by inducing pro-survival factors 
TNF22/TRAF1 resulting in the establishment of a persistent infection. Although 
there was no clear evidence for the presence of DIs at 96 h p.i. following a high 
MOI infection with PIV5 strain CPI+, >99% of infected cells died and DIs may 
have been generated in the small proportion of surviving cells at a low level that 
precluded their detection during bioinformatic analysis. Collectively, these 
results indicate that, despite the high percentage of sequence identity between 
the two PIV5 strains, different mechanisms may have been involved in 
establishing persistence.  
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6.3.1 Analysis of differences in the transcription kinetics of PIV5 strains W3 and 
CPI+  
 
A major question that arose from this work was the molecular basis for 
differences in the kinetics of viral transcription between strains CPI+ and W3 
and for their different abilities to establish persistent infections. Since numerous 
studies have shown a role for the P protein as a regulator of viral RNA synthesis 
(Fuentes et al., 2010) any differences in the P proteins between these strains 
were of particular interest. Of note was a difference at amino acid residue 157 
of the P protein. PIV5 strain W3 contained a serine residue at this position, 
whereas PIV5 strain CPI+ contained a phenylalanine. This was particularly 
interesting, as work by Sun et al., (2009) showed that a serine at position 157 
could be phosphorylated by cellular kinase PLK-1, resulting in a reduction in 
viral gene expression. PLK-1 is a serine/threonine protein kinase that plays an 
essential role in the modulation of the cell cycle (Eckerdt and Strebhardt, 2006). 
It binds to its target by a SSP motif, which is present at position 157. To 
investigate whether this difference explains the biological properties of strains 
W3 and CPI+, a recombinant virus was produced by the Professor Steve 
Goodbourn laboratory using the PIV5 strain W3 backbone but containing a 
phenylalanine residue at position 157 of the P protein. This virus, rPIV5-
W3(F157), displayed no shut-off of transcription of protein synthesis at later 
times in infection, and, furthermore, the majority of infected cells had died by 72 
h p.i. This result strongly suggests that phosphorylation of a serine at position 
157 of the P protein is primarily responsible for the observed transcriptional 
shut-off at later times during PIV5 strain W3 infection, and that it plays a 
significant role in the establishment of a persistent infection. Additionally, 
another cellular serine/threonine kinase, AKT1, has been shown to play a role 
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in the regulation of viral gene expression, but a direct interaction between this 
kinase and the P protein was not demonstrated (Sun et al., 2008). Interestingly, 
a study by Pickar et al., (2014) showed a similar result for MuV, in which 
phosphorylation of a threonine residue at position 101 of the P protein was 
shown to inhibit viral RNA synthesis. Any future study could include the use of 
phosphomimetics, which utilizes the structural similarity of amino acids which 
cannot be phosphorylated to other phosphorylated amino acids namely serine, 
tyrosine and threonine. By replacing the latter with the former, the non 
phosphorylated amino acids mimicks the phosphorylated amino acid with 
minimal structural changes to the protein thereby allowing characterization of 
the role of phosphorylation in the activity of the protein. This method could be 
employed to better characterise the phosphorylation of the P protein at specific 
sites that could play a role in the establishment of persistence in PIV5 and/or 
other paramyxoviruses.  
 
6.4 Role of inclusion bodies in the establishment of persistence 
 
Preliminary immunofluorescence results demonstrated the formation of 
inclusion bodies at later times in infection with PIV5 strain W3. The production 
of inclusion bodies in PIV5 strain W3 may be correlated to the repression of 
viral RNA synthesis observed at later times in infection. A study by 
Chatziandreou et al., (2002) demonstrated that, in cells persistently infected 
with PIV5 strain CPI-, which is sensitive to IFN, RNA synthesis was repressed 
and the viral nucleocapsids formed inclusion bodies, thus possibly indicating a 
role in the inclusion body formation for viruses in which RNA synthesis is 
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repressed for genome maintenance. The P protein has been shown to play a 
role in the formation of inclusion bodies in PIV5 and PIV3, as previously 
discussed (Fearns et al., 1996; Carlos et al., 2009). Therefore, it is possible that 
phosphorylation of the P protein and the role of this protein as a subunit of the 
RNA polymerase that interacts with NP-RNA results in an inhibition of viral 
transcription, thereby resulting in the formation of inclusion bodies that provide 
stable environments for viral genome maintenance with little or no active viral 
transcription and the establishment of a persistent infection. Inclusion bodies 
were observed forming at later times during MuV infection. Although, the MuV 
Enders strain displayed a higher rate of viral mRNAs generation compared to 
PIV5 strain W3, and a higher rate of cell death, the formation of inclusion bodies 
may indicate the selection of viruses in which virus RNA synthesis is repressed 
in order to establish a persistent infection in a small population of surviving 
cells.  
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Appendix II 
 
 
 
 
 
Fig I .Transcription of PIV5 strain CPI+ genes at 6, 12, 18 , 24, 48 and 96 h pi.. 
The data were directionally analysed using the established bioinformatic 
pipeline. The FPKM values on the y-axes were obtained using the RSEM 
software  
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Fig II. Abundance of V, P and I mRNAs generated by PIV5 strain W3 during 
infection. The number of reads that were generated from the V, P and I mRNAs 
were calculated: 0 and 0+3 G inserts (V), 2 and 2+3 G inserts (P) and 1 and 
1+3 G inserts (I) from the R1 and R2 files using a 10 nt search string upstream 
and downstream of the RNA editing site. 
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Appendix IV – Table showing the Gs and Ge sequence of each gene, including 
the length of the U tract depicted by A followed by the number of As found in 
the U-tract and the length of the Ig 
 
PIV5 
W3 gene gene start gene end 
length of Ig (Ge to 
downstream Gs) 
 
NP aggtccggaa ggctttaaagA7 1 
 
V/P aggcccggac agggttttagA6 16 
 
M aagcccgaac tgattcaaagA4 23 
 
F aagcacgaac aatttttaagA7 4 
 
SH aggaccgaac tattttaaagA6 1 
 
HN aggcccgaac tggttttaagA6 13 
 
L aggccagaat ttagtttaagA6 - 
 
Consensus a*g***g*a* ****t***ag 
 
     
PIV2 gene gene start gene end 
length of Ig (Ge to 
downstream Gs) 
 
NP agattccggt ataatttaagA6 3 
 
V/P aggcccggac taaatttaatA7 46 
 
M aggacacaat tcaatctaacA7 28 
 
F aggccaaaat acaatttaagA6 8 
 
HN aggtgtcgta gatatttaagA6 42 
 
L aggccagaat tttatttaagA5 - 
 
Consensus ag******** ***at*taa* 
 
     
MuV gene gene start gene end 
length of Ig (Ge to 
downstream Gs) 
 
NP aagcccggaa agtctttaagA6 2 
 
V/P aggcccggaa cctattaaatA6 1 
 
M aagcacgaac gaaattatagA6 1 
 
F aagcctagaa tcctgcaattA6 7 
 
SH aagaatgaat agacataaagA6 4 
 
HN agccagaaca gattattaagA6 1 
 
L aggccagaat tccttttaagA6 - 
 
Consensus a********* ********** 
 
     
PIV3 gene gene start gene end 
length of Ig (Ge to 
downstream Gs) 
 
NP aggattaaag aataaataagA5 3 
 
P/D/C aggattaaag tacaaataagA5 3 
 
M aggattaaag aaggataatcA5 3 
 
F aggacaaaag ttaaaattatA6 3 
 
HN aggagtaaag agggaaatatA6 3 
 
L aggagcaaag aaaaagtaagA5 - 
 
Consensus agga**aaag ****a***** 
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